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bp base pair 
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Absolute abundance : Total number (count) of a specific type of organism or OTU 
present in a specimen1 
Relative abundance : Measurement of the number of organisms, sequences or OTUs 
detected in a specimen, in relation to all others in that            
specimen1 
Chimera : Hybrid PCR product, resulting from an aborted extension product 
acting as a primer in a subsequent PCR cycle. When this product 
prime DNA synthesis of an improper template, the resulting 
hybrid products may be falsely interpreted as novel organisms2 
Commensal : In this study commensals refer to GIT microbiota inhabiting the 
GIT without harming to the host. These organisms benefit from 
the host and may provide beneficial functions  (mutualistic 
properties) to the human host3 
Coverage : The number of times a gene or genome is sequenced3 or the 
number of sequences obtained per specimen in a single 
sequencing run1 
Diversity : Is a combination of richness (the number of different organisms) 
and evenness (a measure of the skew in abundance of community 
members) within a specimen4 
Dysbiosis : Changes in the normal or healthy state microbiota composition1 
Enterocytes : Epithelial cells participating in mucosal barrier function5 
Evenness : A measure of how evenly all organisms are represented within a 
community4 
Goblet cells : A subset of epithelial cells that produce mucin and other major 
components of mucus6 
Meconium : The newborn’s first intestinal discharge7 
Microbiome : Defined as the collection of genes from trillions of microbial 
genomes colonizing the human body8 
Microfold (M) cells : Specialised epithelial cells presenting antigens to immune cells9 
Mock community : A mixture of bacteria, representative of the specimen analysed. 
The mock community allows for evaluation of the reproducibility 
and efficacy of DNA extraction methods by excluding biological 
variation inherent in clinical specimens10 
Mycobiome : Primarily refers to fungal biota in an environment11 
Operational taxonomic unit : A group of organisms with 16S rRNA gene sequences grouped 
together based on their level of sequence identity.3 These clusters 
roughly represent taxa at phylogenetic levels defined by user-
defined sequence similarity cut-offs.12 Generally, sequences with 
95 % similarity are assigned to the same genus and those with 97 
% similarity to the same species.13 
3 
Overdispersion : The incident where a dataset contains greater variance than 
expected in a statistical model14 
Paired-end sequencing : Obtaining sequence information from opposite ends of long 
templates, providing data on both ends of the fragment of 
interest15 
Paneth cells : Epithelial cells responsible for the protection of other epithelial 
cells via secretion of a variety of bactericidal molecules such as 
lysozymes, defensins, cathelicidins and c-type lectins such as 
RegIIIc)6 
Phylotypes : Assignment of clustered 16S rRNA sequences to a taxonomic 
group based on sequences from a known reference database1 
Q score (Phred score) : Determines how accurately each of the nucleotides is called 
during Illumina sequencing; and are therefore essential for 
identification and removal of low quality reads from raw 
sequencing data.16–18 
Read : A short stretch nucleotide sequence produced from sequencing a 
targeted region of a single DNA fragment3 
Richness : The number of different types of organisms present within a 
specimen4 
Segmented filamentous bacteria  : Commensal bacteria sharing strong similarities with the genus 
Clostridium19 
Virome : The collection of all viruses residing in or on humans (i.e. the viral 
component of the human microbiome)20 
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Background: Meconium microbiota have recently gained great interest; however very few studies 
have included meconium specimens when longitudinally characterizing the infant GIT microbiota. 
This study therefore aimed to longitudinally characterize meconium microbiota profiles during the 
first seven months of life and to compare these profiles with those from maternal faecal specimens 
using quality controlled Illumina MiSeq sequencing data. 
Methods: We sampled infant meconium and maternal faecal specimens at birth, as well as two 
subsets of infant faecal specimens at 4-12 and 20-28 weeks of life. We extracted nucleic acid from 
faecal specimens using the automated QIAsymphony
®
SP instrument. Using Illumina Miseq 
technology, we sequenced the V4 region of the bacterial 16S rRNA gene. We determined whether 
sufficient reads were sequenced using accumulation curves; whether any contamination occurred; 
and whether our sequencing approach was reproducible. The relative abundances of taxonomically 
classified operational taxonomic units (OTUs), and the Shannon diversity and Bray Curtis dissimilarity 
indices served to characterize faecal specimens from participants. Log ratio biplots and generalized 
linear mixed models served to statistically determine differences between faecal bacterial profiles.  
Results: Faecal specimens were collected from 90 mothers and 107 infants at birth, 72 infants at 4-
12 and 36 infants at 20-28 weeks of age. We classified OTUs from two non-template controls which 
were indicative of potential contamination. Correcting for contamination resulted in a loss of 10 % of 
OTUs classified. Our reproducibility analysis correlated with increased concentrations of template 
used during library preparation. Based on diversity measures, meconium specimens harboured the 
most diverse bacterial profiles. The highest proportions of OTUs classified from meconium belonged 
to the phylum Proteobacteria (60 %), while the phylum Firmicutes was most abundant at 4-12 weeks 
(49 %) and 20-28 weeks (64 %) of life. The phylum Actinobacteria was at its highest at 4-12 weeks of 
age (26 %) and its increased proportions were associated with breastfeeding at 6-10 weeks of life. 
Firmicutes constituted the majority (79 %) of bacteria from maternal faecal specimens. No mother-
infant pairs clustered at any of the time points studied, but infant bacterial profiles became more 
adult-like with increased age. An increase in infant age significantly affected bacterial proportions of 
87 OTUs. Interestingly, we observed that infants exposed to HIV had higher proportions of the genus 
Leuconostoc and higher diversity indices compared to HIV unexposed infants at 4-12 weeks of age. 
Conclusion: Our study highlights that reproducibility may be worsened by the use of low template 
concentrations during library preparation, which may also skew diversity measures. We conclude 




 The human gastrointestinal tract (GIT) is home to a complex community composed of 
approximately 100 trillion microbial cells and 3.3 million microbial genes.1–3 These microbial 
inhabitants perform various functions essential for the host’s health,4–6 and have even been 
described as a vital “organ” due to their homeostatic properties.7–9 Despite these findings, studies 
have not yet been able to define a core GIT microbial profile across human hosts.10,11 Not only are 
these microbial profiles highly diverse,12–14 but the composition of these profiles are also influenced 
by a number of external factors, including medication, diet, age, genetics and environment.15  
The first two years of life, have been considered as the most critical period during which the 
GIT microbiome is established.16 Since early life microbial profiles contribute to the establishment of 
successive GIT microbiota profiles, and have been shown to contribute to health and disease,16–22 
they are key profiles to study when investigating the complexity of faecal bacterial profiles later in 
life. Recently, studies have made interesting observations with regards to the conventionally 
considered “sterile” uterus and now suggest an even earlier colonization stage of the infant GIT 
referred to as in-utero colonization.23 Since studies have recently identified microbiota from the 
previously considered sterile meconium,24–27 studies may need to also investigate the role of 
prenatal factors when studying the dynamics of early life microbial profiles. In support of this, a 
number of influencing factors, such as prematurity, prolonged rupture of fetal membranes, 
intrapartum antibiotic administration and maternal diabetes status, have already been associated 
with patterns of colonization of meconium microbiota.28–30 Such factors may provide an even earlier 
influence on successive bacterial colonization and resultant health and disease states.31–34 
The first chapter of this dissertation provides an updated overview of the literature 
focussing on the function of the GIT microbiome, techniques used to study it, questions around a 
“core” microbiome and the development of the early life GIT microbiota. The second chapter 
describes the experimental and computational approaches used to the generate Illumina Miseq 
sequencing data for studying the GIT bacterial profiles from infants and their mothers. The third and 
final chapter provides quality controlled high-throughput sequencing information on the bacterial 
composition of meconium specimens in a large cohort. It also compares bacterial profiles from 
meconium specimens to those of maternal faecal specimens. In addition, Chapter 3 provides 
bacterial profiles of a subset of infants at two later time points, 4-12 weeks and 20-28 weeks of age, 
and determines how these profiles relate to maternal faecal bacterial profiles. Finally, we also 
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 The gastrointestinal tract (GIT) is home to 1014 microbial cells which have been referred to as 
a “virtual organ” essential for the host’s health. Despite the wide range of techniques available to 
study our GIT inhabitants, it still proves difficult to describe what a “healthy” GIT microbiota profile 
should look like and whether a common core microbiota exists for all humans. Reasons for this have 
been ascribed due to considerable inter-individual variation, fluctuation over time, and a wide range 
of factors (such as age, diet, geography, genetics and medication) influencing microbial profiles 
throughout life. Although a number of factors have been shown to influence adult GIT microbiota 
profiles; early life colonizers seem to act as pioneers for colonization later in life. Conventionally, it 
has been accepted that early life GIT colonization occurs directly after birth and that factors such as 
mode of delivery, feeding practices, weaning, geography and the use of antibiotics primarily shape 
these profiles. Recent studies, however, have now suggested that colonization actually occurs prior 
to the process of birth and that in-utero colonization of the GIT may be important in establishing GIT 
microbial profiles later in life.  
 This review explores some of the beneficial functions the GIT microbiota provides to its host 
which includes maintenance of the GIT-barrier function, protection from pathogen colonization, 
immune system maturation and metabolic functions. It also discusses a number of techniques 
commonly used to study the GIT microbiota. These techniques range from conventional culture and 
molecular approaches which target known bacterial components within samples; to high-throughput 
culture and molecular techniques which provide comprehensive insights of both the known and 
unknown bacterial components of our GITs. This review highlights the challenges around identifying 
a core microbiome and emphasises the importance of early-life colonizers as pioneers for bacterial 
colonization later in life as well as their role in health and disease states during both early and later 
life. Furthermore, it accentuates that the importance of in-utero colonization is becoming apparent 
due to its influence on successive bacterial colonisation; its association with immune system 
maturation; and possible contributions to both early and later life disease. Based on the associations 
between specific meconium profiles and neonatal sepsis, infant mucus congestion, and even 
premature birth; insight into meconium microbiota profiles may be of great value for manipulation 







1.1  The human gastrointestinal microbiota is a vital ‘organ’  
 
 Humans have been described as “superorganisms” harbouring 100-fold more microbial 
genes in the GIT compared to human genes.1 These GIT inhabitants are essential for the host’s 
health2–6 and have even been referred to as a “virtual organ”.3,7,8 Functions performed by this ‘virtual 
organ’ include maintenance of the GIT-barrier function, protection from pathogen colonization, 
immune system maturation, bile acid metabolism, fermentation of undigested polysaccharides and 
vitamin production.9 The following section describes in detail the biological functions of the GIT 
microbiota for the host. 
 
1.1.1 The epithelial barrier function of the GIT microbiota 
 The GIT barrier system is comprised of two main layers known as the epithelial cell and 
mucus layers.10 GIT epithelial cells generally function to absorb nutrients and to retain water and 
electrolytes.11 However, together with the GIT mucus, it also functions as a barrier preventing 
undesired antigens from entering the host.12 Malfunctioning of this defence system may result in 
infection and inflammation.10  
 The intestinal epithelial layer functions as a physiological barrier by sampling antigens, 
secreting anti-microbial peptides, producing digestive enzymes, shaping mucosal immune responses 
and by providing essential barrier functions for prevention of microbial infection.13 However, in 
order to exert these functions, the epithelial cell layer relies on a network of specialized epithelial 
cells, such as endocrine cells, Microfold (M) cells, Goblet cells, Paneth cells and columnar epithelial 
cells.10 The GIT microbiota have been shown to influence the development of some of these cells.12 
Maturation of enterocytes, for example, is enhanced during intestinal colonization with Escherichia 
coli strains,14 while M cells have been shown to increase after the introduction of Salmonella 
typhimurium to the GIT.15,16 A reduction in Goblet cells has been observed in germ-free animals and 
animals with specific bacterial profiles.17–21 Finally, Paneth cells have been shown to express 
bactericidal proteins after being stimulated by Gram-positive and Gram-negative bacteria as well as 
bacterial components such as lipopolysaccharides and lipoteichoic acid.22,23 This in turn also 
influence the mucus layer (essential for protection of the epithelial cell layer against pathogens), 
since Goblet and Paneth cells secrete mucins and antimicrobial peptides which contribute to the 
mucosa’s viscous and protective properties.24,25  
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1.1.2 Colonization resistance against enteric pathogens 
Colonization resistance (CR) is a term used to describe the role of the GIT microbiota in 
protection against colonization and invasion by enteric pathogens.26 This concept is supported by 
studies showing an increase in susceptibility to enteric infections as a result of disruption of GIT 
microbiota during antibiotic administration.27,28 Three mechanisms have been proposed to describe 
colonization resistance elicited by GIT microbiota.26 The first being “direct inhibition” suggesting that 
bacteria can impede the growth of other bacterial species by releasing bacterial toxins or inhibitory 
metabolites such as acetate and butyrate.29–31 The second mechanism is described as “nutrient 
depletion” which suggests that efficient utilization of nutrients by commensals makes nutrient 
niches inaccessible for pathogens.32 This can be explained by the intestinal “food-web” during which 
several primary and secondary bacterial fermenters efficiently deplete high-energy nutrients 
resulting in limited nutrient sources for incoming pathogens.32,33 The third mechanism, described as 
“indirect inhibition”, is explained by the microbiota’s ability to stimulate the host to act upon enteric 
pathogens. Stimulation of the host’s specialized epithelial cells results in the production of 
antimicrobial peptides, immunoglobulin A (IgA) and secretion of mucin, which mediate pathogen 
clearance from the GIT lumen.19,34–36 
1.1.3 Maturation of the host’s immune system is modulated by GIT microbiota 
Studies in mice have shown that both the innate and adaptive immune systems are 
negatively impacted in the absence of commensal GIT bacteria.37,38 This can be explained by the fact 
that immune responses are elicited during recognition of bacterial molecules via innate immune 
receptors.39 Toll-like receptors (TLRs), for example, detect various microbe-associated molecular 
patterns (MAMPs). Lipoproteins and lipoteichoic acids are detected by TLR2, lipopolysaccharides 
(LPS) by TLR4, flagellin by TLR5 and CpG deoxyribonucleic acid (DNA) by TLR9.39,40 These, and other 
receptors known as NOD-like receptors (NLRs) and G protein-coupled receptors (GPCRs) receptors39 
are present on epithelial and immunological cells throughout the entire gastrointestinal tract, and 
upon stimulation, coordinates a cascade of innate and adaptive immune responses to control 
infection.41,42 Two main functions of commensal bacteria in stimulating the host’s immune responses 
are to prevent bacterial infection and to elicit systemic immune responses (discussed in Sections 
1.1.3.1 and 1.1.3.2). 
1.1.3.1 Immune-related effects of the GIT microbiota in preventing bacterial infection 
Immunological protection against bacterial infections involves a variety of innate and 
adaptive immune cells of both epithelial and lymphoidal origin37 (Figure 1). Epithelial cells are the 
first set of host cells which pathogens encounter and play an essential role in ensuring minimal 
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bacterial contact and invasion of the epithelial cell layer. LPS from Gram positive bacteria stimulate 
enterocytes via TLR4 to produce the antibacterial lectin RegIIIg which spatially segregates the 
luminal microbiota from the epithelial layer by maintaining an approximately 50 micrometer zone 
between the host and the microbiota.23,43,44 Gram negative LPS and flagellin A, as well as Gram 
positive lipoteichoic acids are bacterial products that modulate mucin production.45 These bacterial 
products activate pathways known to have a  strong secretagogue effect on goblet cells, increasing 
mucin secretion.46 Increased mucin secretion, in turn results in a larger mucus barrier which protects 
epithelial cells against pathogens.46 Bacterial molecules are recognised by TLRs on Paneth cells and 
MyD88 signalling is activated.34 This results in Paneth cells secreting antimicrobial peptides which kill 
luminal pathogens and prevent penetration of the host epithelial layer.34,47,48  
 The second set of immune cells participating in innate defence against luminal pathogens 
are innate lymphoid cells (ILCs).49 These cells are grouped into three main groups, which are all 
regulated indirectly via epithelial, myeloid and dendritic cell responses to the GIT microbiota. The 
first group, T-bet+ILCs, produce cytokines to limit epithelial cell permeability.49 The second group, 
GATA3+ILCs, also produce cytokines, however their role is not yet determined in microbial 
regulation.49 Finally, the third group, RORgt+ ILCs promote antimicrobial protein and mucin 
production by epithelial cells.49 Both T-bet+ILCs and RORgt+ILCs can also be directly influenced by 
microbial signals via immune receptors such as TLRs and natural cytotoxicity receptors (NCRs). 
In addition to the innate immune responses, adaptive immune responses are also influenced 
by GIT microbiota.50,51 Macrophages and dendritic cells (DCs) are mononuclear phagocytes that 
sample bacteria via M cells within Peyer’s patches, where they interact with B and T cells.37,52 Plasma 
cells are generated from B cells and secrete IgA in the lamina propria which is transcytosed to the 
intestinal lumen where it binds to bacteria and prevents translocation across the epithelial barrier.53 
14 
 
Figure 1. Schematic representation of immunological protection against bacterial infections by gastrointestinal 
microbiota 
1. Gram positive lypopolysaccharides (LPS) stimulate enterocytes via toll like receptor (TLR) 4. This results in antimicrobial 
protein secretion and spatial segregation of luminal microbiota from the epithelial layer. 2. Increased mucin secretion via 
Goblet cells following stimulation from gram negative LPS and flagellin A, as well as gram positive lipoteichoic acids. 3. 
Paneth cells secrete antimicrobial peptides as a result of MyD88 signalling when TLRs recognise bacterial molecules. 4. T-
bet+ILCs are a group of innate lymphoid cells (ILCs) limiting epithelial cell permeability by the production of cytokines. 5. 
Another group of ILCs (RORgt+ ILCs) contribute to antimicrobial protein and mucin production by stimulating epithelial 
cells. Both these groups of ILCs receive bacterial stimulation indirectly via other immunological cells such as dendritic cells 
(DCs) or directly via TLRs and natural cytotoxicity receptors (NCRs). 6. Bacteria entering Peyer’s patches via Microfold (M) 
cells are sampled by macrophages and DCs, where they interact with B and T cells.  Activated B cells differentiate into IgA 












Luminal bacteria                   Antigen                      Antimicrobial peptides                Dendritic cells 
Macrophages                        T-bet+ILC                   RORgt+ILC               T cell                      B cell 
Plasma cell                            Immunoglobulin A                    
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1.1.3.2 Complex bacterial profiles in the GIT also shape systemic immunity.   
Immunological responses elicited by GIT microbiota do not only protect the host from 
bacterial infections, but also promote and regulate systemic immune responses54 (Figure 2). Ivanov 
et al. (2009), while studying the role of commensal microbiota on the host’s immune system in a 
murine model, showed that segmented filamentous bacteria (SFB) stimulate DCs which promote 
CD4+ T cell differentiation into T helper 17 (Th17) cells.55 Th17 cells predominantly protect the host 
against extracellular pathogens by secreting interleukin-17 (IL-17), IL-17F and IL-22.56 Such 
inflammatory responses, have however also been implicated as a primary mediator of autoimmune 
disease.57 Another murine model study by Mazmanian et al. (2005), on the immunomodulatory 
activities of a bacterial molecule in germ-free and conventionally raised mice, supports the role of 
commensal bacteria in the development of the host’s immune system.58 The former study showed 
that Bacteroides fragilis (a common colonizer of the lower intestinal tract of mammals) produces a T-
cell dependent antigen known as polysaccharide A (PSA) which stimulates CD4+ T cell maturation. It 
has been proposed that B. fragilis and/or PSA activates DCs in the GIT associated lymphoid tissue 
(GALT), whereafter they migrate to lymphoid organs to signal Th1 cell cytokine production via an IL-
12 pathway.58 Not only do these Th1 cells protect against intracellular pathogens,57 they also reduce 
allergic disease by down-regulating systemic Th2 and Th17 responses.42,59 In addition, Pang et al. 
(2013) observed suppressed allergic airway responses in mice which were treated with non-
pathogenic E. coli.60 This study observed an increase in Th1 cytokines and IL-10-secreting 
immunosuppressive T regulatory (Treg) cells in the para-tracheal lymph nodes of the treated mice, 
supporting the role of these common colonizers in preventing allergic diseases. Finally, Atarashi and 
colleagues61 showed that 17 non-pathogenic strains of Clostridial clusters IV, XIVa and XVIII act as a 
community to promote growth and differentiation of immunosuppressive Treg cells in germ-free 
mice. Oral administration of these strains also alleviated allergic diseases such as colitis and allergic 




Figure 2. Schematic representation of gastrointestinal microbiota shaping systemic immunity  
1. Dendritic cells (DCs) and macrophages sample antigen in the lamina propria and Peyer’s patches of the small intestine. 
DCs also sample antigen by extending their dendrites into the intestinal lumen. 2. The interactions between DCs and 
microbial associated molecular patterns (MAMPs) allow DCs to present antigen to naïve T cells in the mesenteric lymph 
nodes. DCs present epitopes together with major histocompatibility complex (MHC) class II and specific 
immunomodulatory cytokines to naïve CD4
+
 T (Th0) cells. 3. After proliferation and activation of various T cell subets, they 
enter systemic circulation via the efferent lymph, and home to mucosal surfaces inside and outside of the gut. 4. IL-4 and 
IL10 cytokines are responsible for Th2 cell differentiation. Overproduction of Th2 cytokines and subsequent IgE production 
contribute to inflammatory responses (such as allergic airway responses) via mast cell degranulation, eosinophilia and 
mucus hypersecretion in the respiratory tract. 5. Bacteroides fragilis produces polysaccharide A which signals Th1 cell 
cytokine production via an IL-12 pathway. Th1 cytokines, IFN-γ and IL-10, have been shown to supress Th2 and Th17 
cytokines involved in asthma pathogenesis and pro-inflammatory responses, however, may also contribute to pro-
inflammatory responses such as irritable bowel disease. 6. Clostridium clusters IV, XIVa and XVIII stimulate T regulatory 
(Treg) cell differentiation via the TGF-β cytokine. Treg cells downregulate Th2, Th1 and Th17 pro-inflammatory responses. 
7. Segmented filamentous bacteria stimulate the differentiation of Th17 cells via the TGF-β, which produce cytokines 
involved in pro-inflammatory responses and allergic diseases.   
 Other commensals                   Pathogenic bacteria                Bacterial antigens 
Bacteroides fragilis                    Clostridium clusters               Segmented filamentous bacteria 
B cell                              T cell                               Macrophage                           Dendritic cell 
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1.1.4 Metabolic functions of GIT microbiota 
 GIT microbiota have been shown to impact on their host’s health by a range of metabolic 
functions.62 The following section will focus on two specific functions: The production of short chain 
fatty acids (SCFAs) and the metabolism of bile acids.  
 SCFAs are well known bacterial metabolites produced by intestinal bacteria.63 These 
metabolites are produced by fermentation from undigested dietary carbohydrates and mainly 
consists of butyrate, acetate and propionate.64 Specific bacteria, such as anaerobes and members of 
the Firmicutes and Bacteroides phyla have been shown to be involved in these fermentation 
processes.65 SCFAs, especially butyrate, have been associated with increased intestinal barrier 
function and protection against diet-induced obesity and insulin resistance.66–68 In addition, SCFAs 
also play a crucial role in promoting anti-inflammatory responses.69 Low levels of SCFAs have been 
associated with a number of inflammatory disease states such as inflammatory bowel disease 
(ulcerative colitis, Crohn’s disease)70–72 and allergic airway disease.73  
 Bile acid metabolism is another important metabolic function in which GIT microbiota are 
involved.74 Bile acids are associated with a range of biological activities such as emulsification of 
lipids and lipid-soluble compounds, regulation of cholesterol metabolism, activation of cell signalling 
pathways during cell apoptosis, energy metabolism, inflammatory responses, glucose metabolism, 
and protection of the intestinal mucosa from microbial invasion.75 GIT microbiota modifies the bile 
acid pool circulated throughout the body by a range of biotransformations.76 One of these 
transformations, known as deconjugation, is essential for further modifications of bile acids into 
secondary bile acids.77 Deconjugation is dependent on bile acid hydrolase (BSH) enzymes which are 
produced by Gram-positive bacterial species, belonging to genera such as Lactobacillus, 
Bifidobacterium, Enterococcus and Clostridium as well as two Gram-negative Bacteroides strains.77 
BSH activity and resultant deconjugated bile acids may play an important role in controlling weight 
gain and lowering cholesterol in the host.78 It may also, however, compromise normal lipid digestion, 
promote gastrointestinal diseases such as diarrhea, inflammation and colon cancer, and may also 
cause gallstones.77 
 Ultimately, the GIT microbiota forms a vital component of the human body and its functions 
are undoubtedly crucial for the host’s immune system development and metabolic responses. As a 
“healthy GIT microbiota” could be delineated by its functional core,79 bacterial profiles from the GIT 
may possibly be used as markers for health and disease.71,80–83 Consequently, studies focussing on 
the GIT microbiome as a baseline for health and disease need to use optimal laboratory tools and 
downstream analyses to ensure detection of both high and low abundance bacterial species.84–89 The 
following section therefore focusses on techniques used to study the GIT microbiota, highlighting 
their advantages as well as their limitations. 
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1.2  How to study our microbial inhabitants?  
 
 Microbiological studies date back as far as 300 years when Antonie van Leuwenhoek made 
his first observation through a handcrafted microscope.90–93 Since then, our bacterial inhabitants 
have become a topic of great interest, especially during the last twenty years when their role in 
disease became more apparent.94–97 Studying the GIT microbiome, however, has proven to be 
challenging due to the vast number of diverse bacterial species inhabiting the GIT.98 This section 
describes the tools and techniques used to study the GIT microbiome, highlighting their strengths 
and weaknesses (Table 1), and emphasising the benefits of high-throughput technology for both 
culture-dependent and -independent techniques. 
 
1.2.1 Culture-dependent techniques 
1.2.1.1 Conventional culture 
 Ever since Pasteur and Koch introduced culture-based detection of bacteria during the 
1800s, also referred to as the “golden age of microbiology”; culture has been the primary 
contributor to our microbial knowledge until the 1990s.95,99 The primary aims of classical 
microbiology have been to isolate microbes using differential media and to identify them by their 
biochemical properties.92 The major concern with regards to culture, however, has been its inability 
to cultivate the majority of GIT microbiota under standard laboratory conditions;100–102 resulting 
from a gap in the knowledge of GIT microbiota’s optimal environmental conditions as well as 
practical considerations regarding time and cost.96 Conversely, recent advances in culture techniques 
have resulted in rephrasing the term “unculturable” to “as-yet uncultured” after recognising that the 
ability to culture is in actual fact dependent on the determination and innovation of the 
microbiologist.103,104 “Culturomics” is a term introduced by Lagier et al. (2012) which is characterised 
as a high-throughput approach to culture what is now considered the “as-yet uncultured” 
components of the microbiota.105 
 
1.2.1.2 High-throughput culture or “culturomics” 
 Despite the concern around unculturable bacteria, microbial culturing is still regarded as a 
valuable tool in microbiology. One of the advantages of microbial culturing over molecular 
techniques is that it allows for demonstrating mechanistic and experimental links between biological 
aspects of viable microbes (such as growth, metabolism and pathogenesis) and their host’s 
physiology.106,107 In addition to the information provided on the ecological role of microbial 
communities and their interactions on host health and disease states; culture-based methods are 
19 
 
also useful for obtaining complete microbial genome sequences used for analysing their genetic 
traits and evolution.99,106,107 
 Recognising the importance of culture, researchers are now making use of a new concept 
called “culturomics” for the extensive assessment of microbial profiles by high-throughput culture.108 
This high-throughput approach uses comprehensive culture conditions mimicking natural 
environments for large-scale isolation of GIT microbiota; together with matrix-assisted laser 
desorption ionization time-of-flight (MALDI-TOF) mass spectrometry and/or 16S rRNA/rpoB gene 
amplification or sequencing  to rapidly and accurately identify microorganisms.109 In the face of it 
being labour intensive, this approach allows microbiologists to isolate functional and viable aerobic 
and anaerobic microbiota at large scale; and to discover new species never described previously in 
the human GIT.105,107,110 The study by Lagier et al. (2012) identified 174 species which have not 
previously been described in the human gut and 31 species never described prior to culturomics.105 
In addition, high-throughput culture methods have also been able to demonstrate the impact of 
antibiotic pressure on gut microbiota.110 Despite these findings, however, studies have shown 
discrepancies between bacteria identified using high-throughput sequencing and high-throughput 
culturing; and therefore these techniques are ideal complementary approaches in order to better 
understand our GIT microbiota repertoires.105,111 
 
1.2.2 Culture-independent techniques 
1.2.2.1 Targeted approach 
 The limitations that have been associated with culture greatly encouraged researchers to 
develop culture-independent techniques to study what were previously considered to be 
“unculturable” bacteria. Culture-independent techniques mainly rely on sequence variation within a 
specific gene which is amplified using polymerase chain reaction (PCR). The most commonly used 
bacterial target is the 16S rRNA gene which is highly conserved amongst all bacteria, however 
contains enough variation to distinguish species at lower taxonomic levels.112,113 Despite its 
enormous contribution in the field of microbiology114–116 and in particular GIT microbiology,93,117,118 
bacterial diversity analysis based on specific variable regions of the 16S rRNA gene are not without 
its own limitations. Some of the major areas of concern when studying the GIT microbiota and using 
16S rRNA-based techniques are whether optimal DNA extraction was performed; which areas of the 
16S rRNA gene should be targeted; and whether any PCR bias occurred.119  
 The importance of effective DNA isolation in whole community analysis has been 
demonstrated using mock communities as well as a range of specimens such as supragingival plaque, 
bronchoalveolar lavage, drinking water biofilms, colonic biopsies and faecal specimens.84,120–123 
Isolation of GIT microbiota from faecal specimens has important considerations to take into account 
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such as immensely variable microbial loads, high bacterial diversity (which includes both the Gram-
positive and Gram-negative bacteria with hard and easy to lyse cell walls), inhibitory compounds 
such as complex carbohydrates, bile salts and bilirubins, as well as undigested material.119 Also of 
concern when using culture-independent techniques is selection of the 16S rRNA hypervariable 
region (V1 - V9). These species-specific sequences constitute useful targets for microbial studies, 
however, whole community analyses is somewhat limited when targeting a single region due to their 
varying degrees of sequence diversity and inability to differentiate amongst all bacteria.124 
Moreover, the selection of primers targeting the V1-V2 regions of the 16S rRNA gene, for example, 
led Palmer et al. (2007) to the erroneous conclusion that Bifidobacteria were only minor 
components of infants studied throughout the first year of life.125 Since PCR forms the basis of 16S 
rRNA-based molecular techniques, and bias in the PCR reaction may result in incorrect microbial 
population data, PCR bias also needs to be addressed. PCR biases may result from the presence of 
PCR inhibitors, variation in accessibility of the priming site, primer universality, the number of copies 
of the target gene, the formation of chimeras and decreased amplification rates for abundant PCR 
products in later PCR cycles.119,126 
 A wide range of 16S rRNA-based techniques have been used to study the GIT 
microbiota.80,93,100,127–133 Sanger sequencing (which is still as a gold standard sequencing technique), 
now also referred to as “first-generation sequencing”, was used to generate a large proportion of 
the sequence data publically available for microbial identification.134 Since its initiation in 1977 by 
Frederick Sanger,135 this technology has been very successful in sequencing 16S rRNA genes of up to 
1500 base pairs in length which enables researchers to study genera and species not identified using 
culture-based techniques.134 However, despite its success in sequence-based studies, this technology 
is limited by the fact that purified DNA from a single species needs to be cloned into vectors and 
transformed into competent bacterial cells prior to sequencing. This makes the technology prone to 
cloning-biases, contributes to its expense and limits throughput. As the interest in microbiome 
projects grew, the demand for more time- and cost-effective techniques with higher throughput 
(known as high-throughput technologies) soon arose. The following section solely focuses on high-
throughput sequencing technologies which has greatly contributed to our current understanding of 
GIT microbiota in human health and disease.93  
 High-throughput sequencing (second and third generation sequencing), also known as Next 
generation sequencing (NGS) or massively parallel sequencing, is responsible for an enormous 
increase in the number of 16S rRNA genes sequenced.92 Compared to first generation sequencing, 
high-throughput sequencing does not require sub-cloning of bacterial DNA.136–138 These technologies 
also have the ability to simultaneously sequence DNA from diverse environments containing various 
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bacterial species during a single sequencing reaction. By increasing the scale of operations and 
resultantly the number of nucleotides and copies of each nucleotide sequenced per run, it allows for 
a more cost and time effective approach to sequencing.92,138 Second generation sequencing (SGS) 
primarily make use of three platforms.139,140 The 454 GS FLX Pyrosequencer from Roche was the first 
NGS platform commercially introduced in 2004.139–141 This sequencing-by-synthesis technology 
applies emulsion PCR142 to beads containing a single template molecule which is followed by 
pyrosequencing.138,143,144 The second SGS platform introduced commercially in 2006 is known as 
Illumina from the company Illumina (formerly known as Solexa).139–141 This sequencing-by-synthesis 
technology applies bridge amplification145 to single template molecules captured on a glass surface. 
This is followed by sequencing-by-synthesis during which nucleotide incorporation is detected by the 
use of reversible dye-labelled terminators.136 The third SGS platform introduced commercially in 
2007 was SOLiD from the company Life Technologies (formerly known as Applied Biosystems).139–141 
This sequencing-by-ligation technology uses the same bead and emulsion chemistry as 454 GS FLX 
pyrosequencing, however sequencing is initiated by a DNA ligase instead of polymerase.136,146 
 During the past four years, both 454 GS FLX pyrosequencing and Illumina sequencing of the 
16S rRNA gene has been successfully used to sequence complex bacterial profiles from the human 
GIT.132,147–154 These two techniques have provided great insight of our GIT bacterial communities, 
especially regarding the impact of dysbiosis on human health. Although both these techniques have 
their own advantages and limitations, Illumina sequencing seems to be less expensive, produces a 
lower sequencing error rate155 and provides much better coverage which is essential for studying the 
highly diverse and complex GIT environment.156 One limitation of Illumina sequencing (which has 
been its inability to target more than one hypervariable region)157 has recently been resolved.158 
Indeed, recent studies showed that 454 pyrosequencing primers, targeting two hypervariable 
regions, can be modified to be compatible with Illumina technology.158 In addition, a study by Ong et 
al. (2013) successfully developed a shotgun short-read sequencing approach for constructing and 
assembling 16S rRNA amplicon sequences spanning the V3-V6 hypervariable regions using Illumina 
technology.159 Although a single hypervariable region (in spite of the recent advances in Illumina 
technology) has been and still is widely used when perfoming sequencing on the Illumina platform; 
Illumina technology is still the preferred choice due to its high accuracy and throughput when 
compared to 454 pyrosequencing.158 However, to date, no consensus has been reached with regards 
to which hypervariable region to target using Illumina Miseq technologies.160 Mizrahi-Man et al. 
(2013) recommended the use of the V3 and V4 regions for studying bacterial communities after 
performing in silico analysis of seven different amplicon designs,160 while Ong et al. (2013) strongly 
recommends targeting the V3-V6 regions using a shotgun approach.159 Of note, the V4 region is 
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regarded one of the more robust 16S rRNA hypervariable regions in terms of reliable taxonomic 
classification.161 The V4 region also provides species richness estimates similar to that of full length 
sequences;162,163 and has been targeted by a number of studies assessing the GIT microbiota by way 
of Illumina sequencing.88,163–167 
 
1.2.2.2 Non-targeted approach 
 Third generation NGS technology involves high-throughput sequencing of all microbial genes 
without prior amplification of the target gene.140 Unlike second generation, third generation 
sequencing (TGS) do not rely on base-specific signalling and imaging resulting from numerous 
enzymatic reaction cycles.168 TGS relies on direct reading of a single molecule of DNA, also referred 
to as single molecule sequencing (SMS).169 This has allowed for circumventing some of the major 
limitations of second generation technologies such as PCR bias, sequencing errors and short reads 
related to PCR amplification and/or “wash-and-scan” steps. Other advantages of TGS technologies 
include higher throughput, shorter run times, reduced cost and the use of small amounts of starting 
material.169 These TGS or SMS technologies can be grouped into three categories, each providing 
novel approaches to the field of DNA sequencing.168,169 The SMRT sequencer from Pacific 
Biosciences, for example, uses a sequencing-by-synthesis approach (as SGS does); however the 
SMRT sequencer synthesizes single molecules of DNA which results in single molecules of DNA 
polymerase being detected. Another example is the Nanopore sequencing technologies by Oxford 
Nanopore Technologies, which detects individual nucleotides as single molecules of DNA are 
positioned in the vicinity of a nanopore or threaded through one.170 A major limitation of the latter, 
however, is the anticipated error rate versus throughput tradeoff.171  
  Another non-targeted approach to sequencing is whole genome shotgun (WGS) sequencing 
which has been recognized as the most comprehensive method for metagenomics investigations.172 
Advantages of WGS sequencing approaches include no prior amplification of a target gene 
(producing less biased results compared to PCR depended approaches);173 as well as the ability to 
survey an entire genome (providing a complete profile of the whole community studied). Moreover, 
WGS sequencing approaches not only provides taxonomic information but also offers direct 
information regarding the community’s functions.173 Despite these advances, limitations of shotgun 
sequencing experiments include increased cost and the need for greater computational resources 
due to the number of sequences generated.174 Typically, 2-10 Gb of sequences are generated per 
sample when performing WGS on paired-end generating platforms such as the Illumina HiSeq, 
potentially costing hundreds of dollars per specimen.174 However, performing WGS sequencing on 




Table 1. Advantages and limitations associated with culture-dependent and -independent techniques used to study the gastrointestinal tract microbiota 
Category Techniques / 
technology 





Description Advantages Limitations 
Shared between techniques Specific to technique Shared between 
techniques 





Selective media is used to cultivate 
specific bacteria95,104 
Provides the opportunity to 
study functional 
characteristics94,99 
Provides the opportunity to 
obtain complete genome 
sequences99 
Detects viable bacteria99,108 
Inexpensive94 
Limited equipment needed176  Culture results are 




Large number of 









High-throughput isolation of bacteria 
using various selective and/or 
enrichment culture conditions105     
and identification using MALDI-TOF 
or 16S rRNA/rpoB 
amplification/sequencing109 
Cultivation of previously considered 
“unculturable” species108 
Potential to detect low abundant 
species105  
Very labour intensive 








Amplification and quantification of 
specific bacterial groups/species by 
targeting specific regions of the 16S 
rRNA gene. The concentration of the 
amplicon is measured as 
amplification occurs95,177 
Detection of specific 
bacterial groups/species 




Reliably quantifies the amount of 
DNA targeted94,95 
Phylogenetic identification95 
Primer- or probe-based 
targeting which results in 
detection of previously 
identified bacteria only94,95 
No community-wide 
assessment of all bacteria 
present in a specimen94 
Optimal DNA extraction is 
needed as differential lysis 
of bacterial cells will 









16S rRNA amplicons are denatured 
based on their nucleotide sequences 
using a denaturing gradient gel95,178 
Inexpensive tool for diversity 
studies94 
Semi-quantitative95 
Communities from different 
treatment groups are easily 
compared94 
Poor reproducibility94 




Fluorescently labelled 16S rRNA 
amplicons are digested using a 
restriction endonuclease, followed by 
digital detection of fluorescently 
labelled fragments on a gel95,180 
Inexpensive tool for diversity 
studies94 
Semi-quantitative95 
Communities from different 
treatment groups are easily 
compared94 
Reproducible94 






Table 1. Advantages and limitations associated with culture-dependent and -independent techniques used to study the gastrointestinal tract microbiota (continued) 
Category Techniques / 
technology 





Description Advantages Limitations 
Shared between techniques Specific to technique Shared between 
techniques 
Specific to technique 





oligonucleotide probes are designed 
to hybridize target bacteria 16S 
rRNA sequences95 
Detection of specific 
bacterial groups/species 




Primer- or probe-based 
targeting resulting in 
detection of previously 
identified bacteria  
only94,95 
No community-wide 
assessment of all bacteria 
present in a specimen94 
Optimal DNA extraction is 
needed as differential lysis 
of bacterial cells will 







Fluorescence is detected during 
hybridization of fluorescently 
labelled 16S rRNA amplicons with 
oligonucleotide probes spotted on a 
glass slide95,181 
High-throughput detection of 
specific bacterial groups/species 
from complex communities95 
Semi-quantitative95 
Phylogenetic identification95 
Commonly used to compare 
microbiota between different 
populations95 
Cross-hybridization94,95 
Difficult to detect low-
level species95 
Only detects sequences 
contained on the chip 
(uncharacterized 
phylotypes are not 








Cloning of the full length 16S rRNA 
amplicon occurs prior to sequencing, 
followed by detection of nucleotide 
sequences using capillary 
electrophoresis95,136 
 
Increased taxonomic resolution 
from the 16S rRNA gene94 
Optimal DNA extraction is 
needed as differential lysis 
of bacterial cells will 
influence the microbial 
composition detected95 
PCR bias95 
Shorter read lengths 








A clone library insert is 
needed to sequence the 










Emulsion PCR of 16S rRNA gene and 
pyrosequencing95,136,138,146 
High throughput and low 
cost per base (compared to 
First and Third generation 
sequencing)169 
 
Longer read lengths, high numbers 
of bases aligned and lowest 
number of duplicate reads 
(compared to Illumina and 
SOLiD)182 
Shorter run time and bigger insert 
size (compared to Illumina)92 
Up to three hypervariable regions 
per read157 
Lower number of reads 
and bases per run 
compared to other 
Second generation 
technologies92,182 
Higher error rates 







Table 1. Advantages and limitations associated with culture-dependent and -independent techniques used to study the gastrointestinal tract microbiota (continued) 
Category Techniques / 
technology 





Description Advantages Limitations 
Shared between techniques Specific to technique Shared between 
techniques 
Specific to technique 









Bridge amplification of 16S rRNA 
gene  using reversible dye-labelled 
terminators136,146 
High throughput (compared 
to First and Third generation 
sequencing)169 
Low cost per base (compared 
to First and Third generation 
sequencing)169 
Higher number of reads and bases 
per run (compared to 454 GS FLX 
pyrosequencing)92 
Lower cost factor and error rates 
(compared to 454 GS FLX 
pyrosequencing)92 
Optimal DNA extraction is 
needed as differential lysis 
of bacterial cells will 





Shorter read lengths 
(compared to Third 
generation sequencing)169 
Lower number of reads 
and bases per run 
(compared to 
SOLiD)92,182 
Shorter read lengths 
and insert size 
(compared 454 GS FLX 
pyrosequencing)92 
Longer run time 
(compared to 454 GS 
FLX pyrosequencing)92 
Only one hypervariable 
region per read157 
SOLiD154 Yes94 
Emulsion amplification of 16S rRNA 
gene followed by sequencing 
initiated by a DNA ligase instead of 
polymerase136,146 
Higher number of reads and bases 
per run (compared to other Second 
generation technologies)182 
 
Shorter read lengths 
(compared to other 
Second generation 
technologies)182 
Lowest number of reads 
and bases aligned 
(compared to other 
Second generation 
technologies)182 
Highest number of 
duplicate reads 









Table 1. Advantages and limitations associated with culture-dependent and -independent techniques used to study the gastrointestinal tract microbiota (continued) 
Category Techniques / 
technology 





Description Advantages Limitations 
Shared between techniques Specific to technique Shared between 
techniques 
Specific to technique 
Culture independent (continued) 
High-throughput 







Uses an enzymatic template 
replication system (as second 
generation sequencing does), 
however it resolves the problem of 
detecting the incorporation of a 
single nucleotide against a large pool 




wide assessment of bacteria 
present in a specimen94 
Longer reads and bigger 
insert size (compared to First 
and Second generation 
sequencing)92,169 
Shorter run time (compared 
to Second generation 
technologies)92 
No PCR bias168 
Lower cost per run 
(compared to Second 
generation technologies)169 
No PCR bias139 
Real-time detection of base 
incorporation against a large pool 
of potential nucleotides169 
Long read lengths169 
 
Optimal DNA extraction is 
needed as differential lysis 
of bacterial cells will 
influence the microbial 
composition detected95 
Moderate raw read 
accuracy (compared to 




High error rates169 
Lower throughput 
(compared to Second 
generation 
technologies)169 







A single strand of DNA is passed 
through the nanopore which results 
in the development of a residual 
ionic current. This current is 
dependent on the nucleotide passing 
through the nanopore at that time. 
This results in the sequence of bases 
in the DNA molecule being captured 
by the change in ionic current183 
No PCR bias183 
Label free single-molecule 
approach which can be scaled for 
high-throughput analysis183 
Long read lengths169 
 
Temporal resolution for 
detecting individual 
nucleotides with high 
sensitivity is problematic 
for currently available 
optical and electrical 
technologies183 
Trade-offs agains error 











The entire genome of a microbe of 
interest is randomly sheared into 
millions of DNA fragments which are 
sequenced. These fragments are 
then aligned against one another to 
form continueous sequences called 
contigs and mapped to a reference 
genome174 
 
No gene restrictions; less bias 
compared to target-based 
approaches; more comprehensive 
insight into the genomic and 
organismal composition (including 
gene and species information and 
metabolic potential); and can be 




may result in incomplete 
assemblies of 
genomes174 




DGGE: Denaturing gradient gel electrophoresis; DNA: deoxyribonucleic acid; FISH: Fluorescence in situ hybridization; MALDI-TOF: Matrix-assisted laser desorption ionization time-of-flight mass spectrometry; PCR: Polymerase 
chain reaction; rRNA: ribosomal ribonucleic acid; T-RFLP: Terminal restriction fragment length polymorphism 
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1.3 Is there a core gastrointestinal microbiome? 
As discussed above, the GIT microbiota can be considered as a “virtual organ” due to its role 
in human physiology and health,6 its host-dependent metabolic functions,3 its role in energy 
consumption and redistribution,184 and its ability to maintain and repair itself.185 However, beneficial 
properties of this “virtual organ” rely on the composition of the microbiota, since changes in 
intestinal microbiota profiles have been associated with disease states.186,187 Understanding the 
composition of a “healthy” GIT microbiota, as well as factors influencing its composition, may aid in 
the design of therapies to modulate and maintain healthy profiles.98 
Despite the promising prospects in understanding the composition of a “healthy” GIT 
microbiota, studying these communities are rather complex. Not only does the adult human GIT 
harbour around 1014 microbial cells,3,85,184,188,189 but considerable inter-individual variation has also 
been described.100,190,191 This, together with fluctuation over time191 and a wide range of factors 
influencing microbial profiles (such as age, diet, genetics, environment as well as personalised 
medicines),98 have made it difficult to define a “healthy GIT microbiota profile”. In addition to the 
complexity of microbial profiles, bacterial cells are not the sole inhabitants of the GIT. The GIT 
virome (constituting around 109 viral particles per gram of faeces),192 for example, also reflects high 
inter-individual diversity and is influenced by factors such as diet.193 These viruses my transmit genes 
in the form of bacteriophages to their bacterial hosts, conferring antibiotic resistance, increased 
pathogenicity and perhaps even new metabolic capacity.193–196 Interestingly, recent studies are also 
suggesting beneficial effects of enteric viruses for the host.197,198 The study by Kernbauer and 
colleagues,199 for example, clearly showed that the murine norovirus (a mammalian enteric virus) 
restored abnormal intestinal morphology and aberrant immune development of lymphocytes in 
germ-free and antibiotic treated mice. This may affect outcomes when defining inter-relationships 
between microbial community structure and function, and physiological states of the host.196 In 
addition, interactions have also been reported between the GIT microbiome and the GIT mycobiome 
(constituting of 106 micro-organisms per gram of faeces), which impacts on the pathophysiology of 
GIT inflammatory diseases.200 Despite its complexity, however, studies have postulated that a core 
intestinal microbiome does exist, representing a conserved set of health-related symbionts which 
have coevolved with humans.87,201 
 A core intestinal microbiome has been described as “the stable part of the microbiota 
present within the vast majority of human beings”202,203 as well as “the number and types of bacteria 
that are shared among different individuals”.201 Microbiome studies using high-throughput 
sequencing and micro-array analyses have demonstrated that two major butyrate-producing phyla, 
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the Firmicutes and the Bacteroidetes, are found across healthy adult intestinal tracts and represents 
around 90 % of the gut bacterial population (Figure 3).1,79,87,100,191,204,205 Other phyla also found in the 
intestinal tracts of healthy adults, but with reduced abundance, are Actinobacteria, Proteobacteria 
and Verrucomicrobia.87,100,202,205 Even though these findings suggest a shared phylogenetic core 
between healthy individuals at phylum-level; challenges in defining a common core at lower 
taxonomic levels may be explained by the fact that humans harbour more than 1,000 species-level 
phylotypes. In addition, each of these phylotypes consists of clusters of sequences with high 16S 
rRNA diversity.98  
Figure 3. Major gastrointestinal phyla identified by using different techniques such as high-throughput 16S rRNA gene 
sequencing and phylogenetic microarray analysis 
 
 Despite the high inter-individual diversity observed at species-level; individuals may in actual 
fact share a small subset of species commonly detected in healthy adult faecal specimens.152,205 
Studies have also shown that species-level phylotypes have unique functional properties and could 
be crucial role players in the microbial community and may potentially contribute to the host’s 
health or diseases states.71,80–83,206 It is clear from previous sections of this review that specific 
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bacterial species or members from specific genera or phyla are responsible for protection against 
pathogens,20,27,28,207 elicit systemic immune responses55,58,60,61 and provide metabolic functions of the 
host.208 Early life GIT colonizers are regarded as essential pioneers of these processes,209 and studies 
have shown that the development of GIT microbiota during infancy may hold profound 
consequences for health later in life.210–215 The following section describes the GIT profiles during 




1.4 The gastrointestinal microbiota early in life 
 
 The development of the infant GIT microbiota is influenced by a number of factors such as 
mode of delivery, feeding practices, host genetics, the use of pre-, pro- and antibiotics, geographic 
location and lifestyle.216,217 Since the GIT has been considered sterile in utero,218,219 studies have 
focused primarily on factors influencing these early profiles from the time of birth.220 Recent studies 
now suggest in-utero colonization of the GIT221 which could be a key contributor to microbial profiles 
of the infant GIT later in life.222,223 In support of this, studies have suggested that initial colonizers 
prepare the environment for later colonizers such as obligate anaerobes.224 The following sections 
will describe current knowledge around the composition of the infant GIT microbiota, factors 
associated with its development and findings regarding in-utero colonization and the meconium 
microbiota.    
 
1.4.1 The composition of the GIT microbiota in infants  
 An understanding of the GIT microbiota early in life has been established by both culture-
dependent and -independent studies. Conventional culture-based studies on healthy breast- and 
bottle-fed infants during the 20th century have shown that aerobic and facultative anaerobic bacteria 
are predominantly the first colonizers of the infant GIT.225,226  Enterococcus, Staphylococcus and 
Streptococcus spp. within the phylum Firmicutes; as well as Enterobacter spp. within the phylum 
Proteobacteria have been identified as the pioneers in GIT colonization during the first week of 
life.225,227 Anaerobes, such as Bifidobacterium spp. within the phylum Actinobacteria; Bacteroides 
spp. within the phylum Bacteroidetes; and Clostridium spp. within to the phylum Firmicutes are soon 
to follow during the first and second week of life.225,227 Bifidobacteria rapidly reach high levels during 
this time and have been considered the most prevalent genus at the age of one month.226,228 
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Culture-independent studies have shown similar findings with Bifidobacterium, Clostridium and 
Bacteroides as  the dominant anaerobes.224  
 Even though bacterial diversity seems to be low shortly after birth with only a select group of 
facultative bacteria and anaerobes identified, a study using a 16S rRNA microarray approach showed 
that bacterial profiles quickly diversify after the first few days of life.229 Up until six months of age, 
infant intestinal bacteria cluster by individuals and inter-individual diversity is much greater 
compared to changes observed over time.229 Although still distinct, by the end of the first year of life, 
bacterial profiles had transitioned to an “adult-like” profile, probably due to the introduction of solid 
foods.229 These profiles were largely comprised of the main phyla, Firmicutes, Bacteroidetes, 
Proteobacteria, Actinobacteria and Verrucomicrobiota, commonly inhabiting the adult GIT. 
 Despite these findings, conflicting data have also been reported around the composition of 
GIT microbiota in infants.226,228–234 A good example is the controversy around the colonisation of the 
genus Bifidobacteria (well known for the health benefits it provides to the host).230 For many years, 
culture-based and species-specific DNA targeted approaches have suggested that Bifidobacteria 
constitute the dominant component of the infant GIT microbiota.226,228,231–233 However, this does not 
always seem to be the case as considerable variation in Bifidobacterial colonization has been 
reported by other studies.229,234 For example, using microarray technology a study by Palmer et al. 
(2007) concluded that Bifidobacteria constituted only minor components of faecal microbiota at any 
age ranging from birth to adulthood.229 In contrast with the findings from Palmer and colleagues,229 a 
study using GS-FLX Titanium pyrosequencing reported a predominance in Bifidobacteria from the 
infantile gut.234 These results indicate how the use of different techniques could result in variation in 
study outcomes, as highlighted by reports on optimised protocols for Bifidobacterial detection.235,236 
In addition to the impact of techniques used to study Bifidobacterial colonization, studies have also 
shown that environmental factors such as breast- and formula-feeding influence Bifidobacterial 
profiles in infants.232,237,238 A second example of conflicting data around the composition of GIT 
microbiota in infants was sparked by Jost et al. (2012).239 This study used more than one screening 
method (culture and high-throughput) when concluding that anaerobes outnumbered facultative 
anaerobes in the first days of life, thereby interrogating the “colonization dogma”.239 A third example 
around conflicting data on the composition of GIT microbiota results from studies reporting different 
ages at which an adult-like microbiome is achieved, ranging from the end of the first year of life, to 
around two and a half years of age.229,240,241  
 Nonetheless, an important concept to consider around conflicting data on GIT microbiota in 
infants is the issue of external factors which may influence these profiles (as mentioned for 
Bifidobacteria above). Controversy around GIT microbiota in infants may be explained by early life 
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maternal and environmental factors, such as mode of delivery, early life feeding practices, 
prematurity, hospitalisation, antibiotic use and older siblings.218 Some of these influential factors will 
be described in more detail in the following section.  
 
1.4.2 Early life determinants of the infant GIT microbiota  
 Although a number of factors have been associated with changes in GIT microbiota profiles, 
the first encounters with bacteria that colonize the GIT occurs in mainly four stages.125,242 Recent 
data suggests that initial colonization begins even before birth; referred to as in utero-
colonization.221,243,244 This is followed by the second colonization stage; referred to as the process of 
birth (previously considered as the initial colonization stage).219,223,245–249 The third colonization stage 
is referred to as the period of exclusive milk-feeding (previously considered the second colonization 
stage).250 Finally, the fourth stage of colonization starts when solid food is introduced to the diet.250 
Each of these stages has been associated with changes in early life GIT microbiota profiles which 
may have consequences for health and disease (Table 2). 
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Table 2. Factors influencing the composition of the gastrointestinal tract microbiota and their relation with health and disease 
Colonization stage Influencing factor Impact on GIT microbiota of infants Impact on health and disease 







  ↑ Clostridium cluster I252 ↑ Risk for atopic dermatitis252 
  ↑ Clostridium difficile246,253 ↑ 
 
C. difficile colonization is associated with increased risk 
for eczema, recurrent wheeze, atopic dermatitis215 
  ↑ C. difficile254 ↑ Risk for wheeze, eczema and asthma254 
     Caesarean section delivery results in an increased risk for 
asthma255 




Bifidobacteria colonization is associated with increased 
risk for irritable bowel disease257,258 
 
  ↑ Escherichia coli253 ↑ 
 
E. coli colonization is associated with increased risk for 
Crohn’s Disease257 and atopic sensitization259  
Colonization during exclusive 
milk feeding 






Formula feeding was associated with and increase in 
weight gain and higher serum insulin260 
↑ Serratia and Lactococcus261 ↑ Formula feeding may result in an increased vulnerability 
to develop disease261 
↑ 
 




Staphylococcus and B. fragilis colonization results in an 
increased risk for coeliac disease262 
↑ C. difficile263,264 ↑ 
 
Risk for asthma215,254 
↓ Bifidobacteria233,263 ↓ Bifidobacteria colonization is associated with increased 
risk for inflammatory immune responses265 




Bacteroidetes colonization is associated with increased 








Table 2. Factors influencing the composition of the gastrointestinal tract microbiota and their relation with health and disease (continued) 
Colonization stage Influencing factor Impact on GIT microbiota of infants Impact on health and disease 
Other influential factors Antibiotics ↓ 
 











Micorbial diversity267 ↓ 
 
 
Microbial diversity is associated with an increased risk for 
necrotizing enterocolitis267 
↑ Enterococci (overgrowth)268 ↑ Enterococci colonization is associated with an increased 
risk for necrotizing enterocolitis269 
↓ 
↑ 




Risk for asthma263  
Probiotics ↑ Specific Lactobacillus strains270,271 ↑ 
↑ 
Weight gain and loss270 
Th1 allergic responses271 
↑ Lactobacillus rhamnosus and Bifidobacterium lactis272 ↓ Allergic sensitization and airway disease272 
↑ 
 
Commensal bacteria and specific probiotic strains273  ↑ 
 
Intestinal host defence by maturing intestinal barrier 
function and reducing inflammatory signals273 
↓ Clostridium perfringens207 ↓ Risk for necrotising enterocolitis207 
↑ Lactobacilli and Bifidobacteria274 ↓ Eczema and atopic eczema274 







1.4.2.1 In-utero colonization 
 Interestingly, studies conducted over the past decade have now suggested that bacterial 
colonization of the infant GIT occurs even before birth. This is referred to as the in-utero colonization 
stage during which colonization of the infant GIT microbiota occurs in the previously considered 
“sterile” maternal womb.243 Pioneer species colonising the GIT before birth may play an essential 
role in shaping the GIT environment for successive bacterial colonization224,244 and may also play a 
role in much earlier immune system development than previously considered.275,276 The suggestion 
of an in-utero bacterial colonization stage originated from microbial detection in meconium 
specimens, placenta, umbilical cord blood, amniotic fluid and fetal membranes.244,275–279 New 
perspectives on GIT colonization prior to birth, with emphasis on the meconium microbiota, will be 
the main focus of Section 1.4.3. 
 
1.4.2.2 Colonization during birth 
 Mode of delivery has been identified as a key determinant factor of the newborn’s GIT 
microbiota. Vaginally delivered infants are colonized with microbes similar to those in the maternal 
vaginal microbiota.248 These include Bifidobacterium, Bacteroides, Lactobacillus, Prevotella and 
Atopobium spp..247,248,280,281 In contrast, Ceasarean delivered infants have slower diversifying 
microbiota.282 GIT microbial communities in Caesarean section delivered infants resemble those of 
the maternal skin with Corynebacterium, Staphylococcus and Propionibacterium spp. 
predominating.248 In addition, high levels of Clostridium difficile are characteristic in these infants, 
together with low levels of Bifidobacterium, Lactobacillus and Bacteroides spp..247,264,280,283 Of note, 
birth by Caesarean section has been associated with a number of disease states such as allergy and 
obesity.213,284,285 
 
1.4.2.3 Colonization during exclusive milk feeding  
 Breast milk is a rich source of diverse bacteria286 and several studies have shown mother-to-
infant transfer of breast milk bacterial strains.287–290 Despite breast milk harbouring a diverse 
collection of bacteria, a “core” breast milk microbiome has been identified by the use of 
pyrosequencing technology.291 Members from the genera Bifidobacterium, Lactobacillus, 
Bacteroides, Prevotella, Staphylococcus and Streptococcus are common colonizers of breastfed 
infants, however Bifidobacterium is considered as the dominant GIT inhabitant of these 
infants.232,260,292,293 Breast milk bacteria have been suggested to contribute to important functions in 
the infant GIT such as immune system modulation294 and protection against infection.295,296 In 
addition, breast milk oligosaccharides act as prebiotics which is of benefit to specific intestinal 
bacteria.297,298 In contrast to breastfed infants, the GIT microbiota of formula fed infants is less 
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dominated by Bifidobacteria.232,292,293,299,300 In addition, formula-fed infants have a more diverse 
microbiome280 with higher Enterococcus,301 Clostridia,232,301 Bacteroides232,300 and 
Enterobacteriaceae292,299 counts compared to infants being breastfed. Formula-fed induced changes 
in intestinal microbiota have been hypothesized to contribute to adulthood diseases such as 
inflammatory diseases, obesity, cardiovascular disease and insulin resistance.260,302 
 
1.4.2.4 Colonization during the introduction of solid foods 
 The introduction of solid food is another factor which adds to the succession of the infant’s 
GIT microbiota. Solid foods have been shown to promote shifts from the highly variable infant GIT 
microbiota profiles towards more stable adult-like profiles.229,303 A species-specific probe-based 
study showed a significant decrease in Bifidobacteria after the introduction of solid foods, as well as 
an increase in the overall microbial diversity.304 Another shift towards adult-like microbiota profiles 
is evident from the increase in strictly anaerobic Clostridial proportions, while a significant reduction 
is evident for facultative anaerobes (conventionally considered the first colonizers of the infant’s 
GIT).304 Bifidobacteria and Bacteroides, however, still dominated the GIT of infants, which is in 
agreement with results from previous studies.304 A metagenomic study showed a sharp, but 
sustained, increase in the abundance of the Bacteroidetes phylum after the introduction of solid 
foods.241 This sharp increase in Bacteroidetes, their ability to break down complex plant 
polysaccharides,305 and the GIT microbiome’s rapid response to altered diets,306 may explain the role 
of GIT microbiota in preparing the infant for adult-like solid foods.  
 Despite the changes in the proportion of bacteria during weaning, many of the primary 
influences on GIT microbiota profiles are still evident following the introduction of solid foods. 
Fallani et al. (2011) reported that the influence of mode of delivery, geographical region and pre-
weaning feeding persisted after weaning.304 This study, for example, highlighted the effect of 
exclusive milk feeding on subsequent faecal microbial profiles by comparing the GIT microbiota 
profiles of formula-fed infants to breastfed infants. Moreover, Fallani and colleagues304 reported 
that compared to formula-fed infants, breastfed infants displayed a rapid reduction of C. perfringens 
and C. difficile species, together with a lagging increase of C. leptum after the introduction of solid 
foods. In addition to these findings, the effect of breastfeeding prior to weaning was reported by 
another study showing a sharp increase in the counts of Bacteroides spp., Clostridia, Enterobacteria, 
Enterococci and Streptococci in breastfed infants receiving solid food.307 These changes were not 
observed for infants receiving formula.307 Another example of primary influential factors on faecal 
microbial profiles later in life is geographical origin. Fallani et al. (2012) showed that bacterial 
profiles associated with geographical origin, prior to weaning, still persisted four weeks after the 
introduction of solid foods.304 These findings highlight that changes in the microbiota are indeed 
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associated with weaning; however initial factors such as exclusive milk feeding and geographical 
origin seem to be key determinants in faecal microbial profiles later in life.    
 
1.4.3 New perspectives on GIT microbiota profiling: The meconium microbiota 
 The concept of a sterile womb and fetus has drastically changed with recent studies 
describing the isolation of bacteria from infant meconium specimens, which were conventionally 
considered to be sterile.244 This paradigm shift from infants “being born sterile” to “being born 
dirty”308 has been supported by bacteria detected from the placenta, amniotic fluid, fetal 
membranes and umbilical cord blood.275–279 Interestingly, all of these specimen types have been 
shown to contain bacteria common to the GIT, which further suggests in-utero colonization of the 
fetal GIT. In addition, murine models have confirmed in-utero mother-to-offspring bacterial transfer. 
Jimenez et al. (2005) inoculated pregnant mice with a genetically labelled bacterial strain and 
isolated the labelled strain from the amniotic fluid of the inoculated mice.279 This group conducted 
the same experiment a few years later, however this time isolated the labelled bacterial strain from 
the meconium of pups born to inoculated mice.244 In both these studies, this labelled bacterial strain 
could not be detected in non-inoculated control groups, supporting the in-utero transfer of bacteria 
from the maternal GIT to the GIT of the developing infant.  
 Despite the evidence of in-utero bacterial transfer, the process by which this occurs                
is still not clear (Figure 4).242 One hypothesis is that ascending microbiota of the vagina and cervics 
colonize the “sterile” infantile gut.309 This is supported by studies on preterm birth, showing 
microbial invasion of amniotic fluid by vaginal bacteria.310,311 Another hypothesis for mother-to fetus 
transfer, not necessarily associated with preterm birth, is bacterial dissemination in the maternal 
bloodstream followed by transplacental invasion.309,312 Hematogenous transfer has been suggested 
to occur when maternal oral bacteria enters the bloodstream during periodontal disease states.312–
315 Another possibility of hematogenous transfer is that bacteria from the maternal GIT lumen enter 




Figure 4. Schematic representation of proposed in-utero mother-to-fetus efflux of maternal microbiota  
1. In-utero gastrointestinal colonization may result from vaginal and cervical microbiota migrating into the amniotic fluid. 
These ascending bacteria cross the cervix into the amniotic fluid which is swallowed by the fetus. Maternal bacteria may 
also disseminate in the maternal bloodstream which is followed by transplacental invasion. 2. One possibility of 
hematogenous bacterial transfer is when maternal gastrointestinal (GIT) bacteria enter the maternal systemic circulation. 
Maternal GIT microbiota may be transported from the intestinal lumen via extending dendrites of the dendritic cells (DCs). 
These antigen presenting cells transfer luminal bacteria into the maternal systemic circulation where it can be transferred 
transplacentally to the fetus. 3. Maternal GIT bacteria are transferred transplacentally from the endometrial arterioles to 
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 Interestingly, both facultative and strict anaerobes were identified in meconium of 
newborns.256 This is in contrast with the “colonization dogma” which suggests that facultative 
anaerobes are the pioneer bacteria of the newborn GIT. Despite these contradictory findings, the 
findings by Tsuji and colleagues256 are in support of the findings by Jost and colleagues239 which also 
interrogated the “colonization dogma” by showing that anaerobes outnumbered facultative 
anaerobes in the first days of life.239 In addition, strictly anaerobic bacterial strains from the 
bacterium Bifidobacterium longum subsp. longum have also been isolated from meconium 
specimens.317  In support of the “colonization dogma”, however; a study using high-throughput 
sequencing identified predominantly Proteobacteria and Firmicutes in the meconium of healthy 
neonates.222 Proteobacteria were represented by the family Enterobacteriaceae of which the genera 
Escherichia and Shigella were most abundant. Firmicutes were mainly represented by lactic acid 
bacteria of which the most abundant genera were Leuconostoc, Enterococcus, Lactococcus, 
Staphylococcus and Streptococcus.222 Of note, differences in meconium microbiota profiles have 
been shown for infants born at a lower gestational age; infants born to mothers using antibiotics or 
probiotics during pregnancy; infants born to diabetic mothers; and infants exposed to prolonged 
rupture of membranes in-utero.269,275,319,320 These changes may influence successive bacterial 
colonisation, immune system maturation and may also contribute to both early and later life 
disease.277,321–323 Knowledge of meconium microbiota profiles may allow in-utero manipulation in 
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 High-throughput sequencing has provided great insight into our GIT microbial inhabitants. 
However, despite the advances associated with sequence-based techniques, they are not without 
their own limitations. The aims of this chapter therefore were to assess the data generated using 
Illumina Miseq sequencing technology. We mainly aimed to determine whether we had sequenced a 
true representation of bacteria present from the faecal specimens under study and whether we 
introduced any biasing factors during our experimental and sequencing approaches. 
 Using the QIAsymphony
®
 SP instrument, we extracted nucleic acid from faecal specimens 
sampled from apparently healthy mothers and their infants at birth as well as a subset of infants at 
4-12 and 20-28 weeks of age. Following nucleic acid extraction, we sequenced the V4 region of the 
bacterial 16S rRNA gene using Illumina-Miseq sequencing technology. We then filtered raw 
sequenced reads based on their quality scores and other sequencing artifacts and clustered and 
classified them using a bio-informatics workflow. Quality assessment following the bio-informatics 
workflow included determining whether sufficient sequencing depth was obtained for the 
specimens under study; evaluation of contaminants from non-template controls; and determining 
sequencing reproducibility using technical repeats. We also determined whether low template 
concentrations used during library preparation had any effect on the reproducibility of our 
sequencing results.  
  Faecal specimens were collected from 90 mothers and 107 infants at birth; as well as 72 
infants at 4 to 12 and 36 infants at 20 to 28 weeks of age. The quality scores from Illumina’s 
sequencing software indicated that 82% of the bases sequenced had passed quality filters with a 
quality score greater than 30. Following the bio-informatics workflow, the ability to detect bacteria 
at genus-level was greatest for meconium specimens. This was followed by infant faecal specimens 
collected at later time points. Maternal faecal specimens showed the lowest ability to detect 
bacteria at genus-level. We observed potential contamination of 69 bacterial genera within our two 
non-template controls, which were corrected for across all sequencing reactions. Correction resulted 
in a loss of 10% of OTUs from faecal samples. Overall, the experimental reproducibility of our 
sequencing approach was estimated at R2 = 0.85. We noted that as template concentrations used for 
library preparation increased, reproducibility measures also increased.  
Great care needs to be taken when planning and executing microbiome 16S rRNA gene high-
throughput sequencing. Our results clearly emphasise that low template concentrations, used during 
library preparation, may result in reduced sequencing reproducibility. We also show the importance 




2.1  Introduction 
 
 As discussed in the literature review (Chapter 1), Illumina sequencing of the 16S rRNA gene 
has been successfully used to sequence complex bacterial profiles from the human GIT.1–3 One of the 
reasons for this is that the GIT contains a highly diverse microbial community,4,5 requiring large 
amounts of reads to fully describe hundreds to thousands of taxa inhabiting it.6,7 In the event that 
sequencing is not performed with sufficient depth, researchers may miss out on the less abundant 
species, resulting in representational bias of the species inhabiting the GIT.8,9 Despite these concerns 
around the depth of sequencing, other factors may also impact the community profiles of the GIT. 
These include, for example, sequencing artifacts,10 sampling strategies,11 DNA isolation protocols,1213 
DNA template concentration, 14 variation among technical replicates,15 library contamination16 and 
data adjustment prior to analysis.17,18 
 The sequencing quality needs to be high in order to perform high quality downstream 
analyses.10 Although sequencing output is filtered by Illumina sequencing analysis software, several 
sequencing artifacts, such as poor quality reads, chimeras and reads with adapters, still remain in the 
dataset.16 It is therefore advisable to perform additional quality control steps to filter high quality 
reads obtained from sequencing softwares to exclude for sequencing artifacts.10 The number of 
specimens tested also affects the estimate of the community’s diversity and species richness,19 since 
the number of different types of organisms within any community tend to increase with the number 
of specimens tested.11 Another important aspect of concern when studying GIT microbiota profiles is 
the protocol used to isolate microbial DNA from the faecal specimens.20 Studies have shown that the 
use of low DNA template during library preparation may impact on the variability of the sequencing 
results14 and may also result in cross-contamination during the generation of amplicons using 
PCR.21,22 Cross-contamination may result in false-positive PCR products, therefore leading to a false 
representation of diversity within and between specimens, and affect data analyses. Furthermore, 
the data obtained from microbiome studies are multivariate count data which are statistically 
challenging to analyse due to over-dispersion and the number of zeros they contain.23 Even though 
zero values may represent rare components or components truly absent from the community, these 
zero values may compromise analyses of the microbiome data.23  
The specific objectives for this chapter were (i) to provide summary statistics of the data 
metrics obtained from the Illumina Miseq sequencer software CASAVA version 1.8.2 (which includes 
quality statistics and the number of reads sequenced); (ii) to provide data metrics obtained from the 
bio-informatics workflow performed (which includes the number of filtered and trimed reads as well 
as the number of OTUs classified); (iii) to assess if sequencing was performed with sufficient depth in 
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order to measure all genera present within faecal specimens; (iv) to determine whether any 
contamination occurred during library preparation and to correct for it, if necessary; (v) to assess 
whether DNA concentrations used during library preparation had any effect on the technical 
reproducibility of this study; (vi) to determine the intra-individual diversity for faecal specimens 
under study; and finally (vii) to determine if there were any correlations between DNA 
concentrations used for library preparation, the number of reads sequenced, the number of OTUs 
classified and intra-individual diversities measured. 
 
2.2   Materials and methods 
 
2.2.1 Study design and setting 
We conducted a pilot study nested within the Drakenstein Child Health Study (DCHS), a birth 
cohort study, which aims to investigate the epidemiology, risk factors and aetiology of lower  
respiratory tract infections and their impact on child health in a low middle income country.24  
The Drakenstein municipality (Figure 5) is a peri-urban sub-district within the Cape 
Winelands, Western Cape, South Africa, with an estimated population of around 200 000.25 The 
public health sector in the Drakenstein municipality is comprised of 23 medical facilities,  including 
one centralized hospital, Paarl hospital.26 Paarl hospital offers obstetric care, which includes routine 
ultrasound for all pregnant women at 20-24 weeks of gestation, as well as all hospital-based 
paediatric care. The public health system, together with its close proximity to the University of Cape 








Figure 5. Geographical location (in purple) of the Drakenstein Child Health Study, Western Cape, South Africa  
Source for country map: http://en.wikipedia.org/wiki/Administrative_divisions_of_South_Africa#/media/File:Map_of_ 





2.2.2  Ethics statement 
Both the DCHS and our pilot study received approval from the Faculty of Health Sciences, 
Human Research Ethics Committee (HREC) of the University of Cape Town, South Africa. The HREC 
reference numbers assigned to these studies were 401/2009 for the DCHS, and 742/2013 for this 
pilot study. 
2.2.3 Study participant reqruitment 
Enrolment of pregnant mothers occurred at 20 to 28 weeks of gestation upon routine 
antenatal ultrasound scanning at Paarl Hospital or primary health care facilities in two semi-rural 
areas, TC Newman and Mbekweni. In order for mothers to be enrolled, they had to provide 
informed consent and had to be residents of one of the two semi-rural areas mentioned above. 
Infant enrolment occurred at birth. Routine study follow-ups took place during public sector and 
vaccination clinic visits, scheduled at six, ten and 14 weeks, as well as six months of age.  
2.2.4 Faecal specimen collection and selection 
Collection of faecal specimens from mothers and their infants occurred at birth. All faecal 
specimen containers were labelled with pre-printed stickers. Caregivers collected maternal faecal 
specimens from bedpans using a sterile spatula attached to the lid of a sterile stool collection 
container. Collection of meconium specimens from newborn infants occurred prior to hospital 
discharge. In the event where hospital-based collections were not possible, the study staff 
encouraged mothers with freezers at home to sample the infant’s first faecal discharge and to store 
specimens at -20 ˚C. In addition to meconium specimens, mothers having a freezer at home also 
collected longitudinal infant faecal specimens one day prior to monthly scheduled visits. Infant 
faecal specimens were decanted from the diaper into a sterile stool collection container using the 
sterile spatula attached to the container’s lid. All faecal specimens immediately received a study 
lable, followed by storage at -20 ˚C. The next day, mothers transported these specimens to the 
clinics in ice boxes containing ice blocks, provided by the study. The process of home collections was 
not monitored in any way. Upon arrival at the clinics, specimens were stored at -20 ˚C, whereafter 
they were transferred to the Division of Medical Microbiology, University of Cape Town on the same 
day.  The study made use of cooler boxes containing ice blocks to transport specimens to the 
laboratory and specimens were stored at -80 ˚C until further processing. 
This pilot study aimed to include as many specimens as possible from mothers and their 
infants at birth, as well as a subset of longitudinal specimens from infants up to the age of seven 
months. Only a small proportion of the total births in the cohort had occurred when samples were 
selected for this study. Specimen selection from mothers and infants included in the DCHS database 
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required that specimens were collected at birth. Longitudinal specimens were included from infants 
in the event that a faecal specimen was collected from the infant at birth and that longitudinal 
collections occurred between 4 and 12 weeks or 20 and 28 weeks of age. When referring collectively 
to these specimens or participants in subsequent sections; we will be using the term “groups under 
study”. 
  
2.2.5 Nucleic acid extraction from faecal specimens 
 Approximately 50 mg of faecal specimen served as the starting material for nucleic acid 
extraction. We performed these extractions using the QIAsymphony DSP Virus/Pathogen Mini Kit
®
 
(Qiagen GmbH, Hilden, Germany), as previously described.27 Fluorometrical DNA quantifications of 
all extractions took place using the Qubit
®
 2.0 Fluorometer (InvitrogenTM, CA, USA) together with the 
Qubit™ dsDNA HS Assay Kit (InvitrogenTM, CA, USA). The lower and upper detection limit of DNA 
concentrations using the Qubit™ dsDNA HS Assay Kit (InvitrogenTM, CA, USA) were 0.05 ng/μl and 60 
ng/μl, respectively. Specimens were excluded from DNA concentration summary statistics (Section 
2.2.9.1) in the event that the DNA concentrations were outside the detection limits of the Qubit™ 
dsDNA HS Assay Kit (InvitrogenTM, CA, USA). 
 
2.2.6 16S ribosomal RNA gene library preparation 
Following nucleic acid extractions, all 16S rRNA gene library preparation steps were carried 
out at the J Craig Venter Instutitute (JCVI), Maryland, United States of America (USA). 
 
2.2.6.1 Faecal specimens and controls  
Faecal specimens were collected from mothers and infants at birth, as well as a subset of 
infants at 4 to 12 weeks and 20 to 28 weeks of age. These specimens are referred to herein as the 
“groups under study”. We also sequenced a set of controls, herein referred to as the “sequencing 
controls”. “Sequencing controls” consisted of positive controls, which included genomic DNA from 
two microbial mock communities known as BEI controls HM-782D and HM-783D (BEI Resources, VA, 
USA) as well as genomic DNA extracted from Escherichia coli; non-template controls which consisted 
of PCR-grade water; and “technical repeats” which consisted of nucleic acid randomly selected from 
the sampling “groups under study”.  
 
2.2.6.2 PCR amplification of 16S ribosomal bacterial DNA 
  We performed two PCR reactions using previously published primers (515F and 806R) 





, MO, USA) . Nucleic acid extracts from faecal specimens of the study participants (described 
in Section 2.2.5) served as template in PCR amplification reactions.  
 The first PCR reaction contained 12.5 μl of 2X MyTaqTM HS Mix (Bioline, MA, USA), 2 μl of 
each primer (10μM initial concentration), 0.75 μl of dimethyl sulfoxide (Sigma-Aldrich
®
, MO, USA) 
and 4 μl of nucleic acid per specimen made up to a final volume of 25.25 μl using PCR-grade water 
(Thermo Fisher Scientific Inc., MA, USA). Positive controls, non-template controls and “technical 
repeats” (described in Section 2.2.6.1) were included at 4 μl each. Genomic DNA of the positive 
control E. coli was added at 15 ng/μl. We performed the PCR in the MJ Research PTC-225 Tetrad 
Peltier Thermal Cycler (MJ Research Inc., Quebec, Canada). Cycling conditions of the first PCR 
included a denaturation step at 95˚C for 3 min, an amplification step proceeding for 10 cycles at 95˚C 
for 30 sec, 50˚C for 30 sec and 72˚C for 1 sec; and a final extension step at 72˚C for 5 min. 
 The second PCR reaction made use of the same set of primers (515F and 806R), but both 
these primers contained sequencing adapters, priming regions as well as 12 to 15 random 
nucleotides. In addition, to facilitate in multiplexing of specimens, the reverse primer was barcoded 
with a 12-base Golay code.28 The second PCR reaction contained 12.5 μl of 2X MyTaqTM HS Mix 
(Bioline, MA, USA), 4 μl of each primer (10μM initial concentration), 0.75 μl of dimethyl sulfoxide 
(Sigma-Aldrich®, MO, USA) and 4 μl of amplified DNA from the first PCR reaction, made up to a final 
volume of 25.25 μl using PCR-grade water (Thermo Fisher Scientific Inc., MA, USA). Cycling 
conditions were the same as for the first PCR reaction; however the amplification step was set at 30 
cycles.  
   
2.2.6.3 Purification of PCR products 
 We purified PCR products using the Agencourt® AMPure® XP PCR Purification kit (Beckman 
Coulter, CA, USA) as per manufacturer’s protocol, with slight modifications. Briefly, we modified step 
2 by adding 0.65 μl of Agencourt AMPure XP solution per PCR reaction volume. Modifications to step 
3 included an additional homogenisation step using the Fisher Vortex Genie 2 (Fisher Scientific, NY, 
USA), followed by quick centrifugation using the GS-6R Centrifuge (Beckman Coulter, CA, USA). At 
step 7, we used Tris-EDTA (pH 8.0) (Amresco, OH, USA) as elution buffer, whereafter modifications 
to step 9 included the transfer of 35 μl of eluent into a new plate. 
 
2.2.6.4 Viewing of PCR products on agarose gels 
 First, we mixed 5 μl of purified PCR products with 2 μl of 1X loading dye and loaded the 
mixture on a 1.5% agarose gel containing 0.1 μg/μl EtBr (InvitrogenTM, CA, USA), submerged in 1X 
TAE buffer (Thermo Scientific, PA, USA). Then 5 μl of the molecular weight marker, TrackitTM 1 Kb 
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Plus DNA Ladder (InvitrogenTM, CA, USA) was loaded on the 1.5% agarose gel. We performed 
electrophoresis for 90 min at 80 V using the Power Pac 300 (Bio-Rad Laboratories Inc., CA, USA) and 
viewed PCR products using the Typhoon 9410 Molecular Imager and Typhoon Scanner Control 5.0 
software (GE Amersham Molecular Dynamics, PA, USA). 
 
2.2.6.5 Quantification of PCR products 
 We quantified PCR products using the Quanti-iTTM dsDNA High-Sensitivity Assay Kit 
(InvitrogenTM, CA, USA), as per manufacturer’s instructions. In order to record DNA absorbance; we 
used the Infinite M1000 Pro
®
 microplate reader (Tecan Group Ltd., Grödig, Austria) equipped with 
Tecan i-ControlTM 1.7 software. 
 
2.2.6.6 Pooling of PCR products at equimolar ratio, purification and gel extraction 
 In order to pool 100 ng of the respective PCR products, we calculated equimolar pooling 
volumes for each PCR product based on their initial DNA concentrations. Following pooling, the 
Nanodrop ND 1000 (Thermo Scientific, DE, USA), equipped with ND-1000 3.7.1 software, served as 
spectrophotometer for quantifying pooled PCR products.  
 Purification of pooled PCR products took place using Agencourt AMPure XP solution 
(Beckman Coulter, CA, USA), as per the manufacturer’s instructions. Slight modifications to the 
protocol included aliquoting the pooled PCR products into volumes of 400 μl to which we added 
Agencourt AMPure XP solution in a 1:1 ratio. We eluted purified PCR products in 60 μl Tris-EDTA 
buffer (pH 8.0) (Amresco, OH, USA) and combined the purified PCR products in a single pool which 
was quantified using the Nanodrop ND 1000 spectrophotometer equipped with ND-1000 3.7.1 
software.  
 Next, we mixed the purified pooled PCR products (6.6 μg) with 5 μl of 1X loading dye and 
loaded the mixture on a 1.5% agarose gel containing 0.1 μg/μl EtBr (InvitrogenTM, CA, USA), 
submerged in 1X TAE buffer (Thermo Scientific, PA, USA) containing 1 μg/μl EtBr (InvitrogenTM, CA, 
USA). Also loaded on the above-mentioned agarose gel was 7 μl of TrackitTM 1 Kb Plus DNA Ladder 
(InvitrogenTM, CA, USA). We performed electrophoresis for 30 min at 35 V, followed by 45 min at 40 
V and 3 hours at 70 V using the Power Pac 300 (Bio-Rad Laboratories Inc., CA, USA). This was 
followed by viewing the pooled PCR product with the Typhoon 9410 Molecular Imager and Typhoon 
Scanner Control 5.0 software (GE Amersham Molecular Dynamics, PA, USA). We then cut the PCR 
product from the agarose gel at the expected target size (between 400 and 500 bp) and gel purified 
it using the QIAquick Gel Extraction kit (QIAgen, MA, USA), as per manufacturer’s instructions. Slight 
modifications for gel purification included centrifugation at 13 000 rpm during step 9, incubation at 
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37˚C for 5 min during step 10 and heating of elution buffer Tris-EDTA buffer (pH 8.0) (Amresco, OH, 
USA) to between 60  and 70 ˚C during step 13. 
2.2.7 16S ribosomal RNA gene sequencing using Illumina MiSeq technology 
Following library preparation steps, we performed 16S rRNA gene sequencing using Illumina 
MiSeq technology at JCVI, Maryland, USA. 
2.2.7.1 Quantification of pooled PCR products for sequencing purposes 
To quantify the pooled PCR products, we used the KAPA Library Quantification Kit K4835 
(KAPA Biosystems, MA, USA) as per manufacturer’s instructions, with slight modifications. These 
modifications included diluting DNA of pooled PCR products at 1:120, 1:1200 and 1:12000 during 
step 1. We performed the 1:120 dilution by adding 2 μl of PCR product to 238 μl of dilution buffer 
(Supplementary data), the 1:1200 dilution by adding 5 μl of the 1:120 dilution to 45 μl of dilution 
buffer (Supplementary data) and the 1:12000 dilution by adding 5 μl of the 1:1200 dilution to 45 μl 
of dilution buffer (Supplementary data). Each of these dilution steps required the use of the Vortex 
Genie 2 (Scientific Industries, NY, USA) before the next dilution was made. We made 1:1200 dilutions 
of our positive control Shrimp Aqu BIOFLOC3-PE-IL55-01. Each PCR reaction contained 6 μl of KAPA 
SYBR® FAST qPCR Master Mix Product (KAPA Biosystems, MA, USA) and 4 μl of either diluted PCR 
product, DNA quantification standards, positive control or non-template control. Performance of all 
PCR reactions took place in triplicate, using the ABI PRISM® 7900HT Sequence Detection System with 
SDS Plate Utility Software Version 2.1 (Applied Biosystems, CA, USA). The PCR cycling conditions 
included a denaturation step at 95˚C for 5 min and an amplification step proceeding for 35 cycles at 
95˚C for 30 sec and 60˚C for 45 sec, as per manufacturer’s instructions. We omitted any failed 
specimens before evaluating the quality of the PCR run by assessing the slope and R2 values. An 
acceptable slope ranged between -3.58 to -3.10 and the accepted minimum for the R2 value was 
0.99. 
2.2.7.2 Integrity and sizes of PCR products for all dilutions 
To determine product sizes for all dilutions described Section 2.2.7.1, we used 0.8% E-Gel® 
pre-cast agarose gels (InvitrogenTM, CA, USA). We loaded a final volume of 20 μl, made up of 16 μl of 
water, 1 μl of 6X TrackIt™ Cyan/Yellow Loading Buffer (InvitrogenTM, CA, USA) and 3 μl of the 
respective pooled PCR product dilutions (described in Section 2.2.7.1). This was followed by loading 
a volume of 5 μl of TrackIt™ 1kb Plus DNA ladder (InvitrogenTM, CA, USA) and performing 
electrophoresis for 30 min. Finally, we viewed the PCR products using the Bio-Rad Gel Doc™ EZ 
System (Bio-Rad, CA, USA).   
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2.2.7.3 Library denaturation and sequencing  
 We prepared sequencing reagents and the DNA library using the MiSeq Reagent Kit v3, 600 
Cycles (Illumina, CA, USA) as per manufacturer’s instructions.29,30 We diluted the PCR products to a 
final concentration of 20 pM by using 10 mM Tris-HCl, pH 8.5 (Life TechnologiesTM, CA, USA). In order 
to obtain a final concentration of 4 pM of denatured DNA product, we added 220 μl of the 
denatured DNA to 880 μl of hybridization buffer (HT1) (provided by the manufacturer). We diluted 
the denatured PhiX control to a final concentration of 4 pM, by adding 220 μl of the denatured PhiX 
control to 880 μl of HT1 buffer. The denatured PhiX control was spiked-in at 25%, by adding 250 μl of 
4 pM denatured DNA to 750 μl of 4 pM denatured PhiX control. We loaded a total volume of 600 μl 
of the denatured DNA library onto the Illumina® MiSeqTM platform as per manufacturer’s 
instructions.31 CASAVA version 1.8.2 software (Illumina, CA, USA)32 served to convert *.bcl files to 
compressed *.FASTQ files. This software also de-multiplexed barcoded specimens by assigning 
specimen names to each of the generated *.FASTQ files. In addition, the software also generated 
sequencing run quality metrics and read counts. 
 
2.2.8 Bio-informatics analysis of the bacterial sequences: YAP workflow 
 The bioinformatics workflow, used to classify 16S rRNA sequences to bacterial taxonomies, 
was carried out at JCVI, Maryland, USA. The workflow performed consisted of a set of tools 
integrated into a computationally efficient workflow using a Python wrapper script called YAP33 
(Figure 6).  
 The first step in the above-mentioned workflow was to perform quality assessments of the 
*.FASTQ files using the read quality statistics embedded in these files. The workflow performed 
these quality assessments using the FASTX toolkit34 via assessment of Phred quality scores (Q 
scores).35 Following the quality assessment, trimming of each of the 300 base-pair long paired-end 
reads took place at a low threshold of Q = 3 using SolexaQA’s Dynamic Trim function.36 The workflow 
incorporated the software FLASH37 to overlap the above-mentioned trimmed paired-end reads. The 
second step of the workflow consisted of a final trim using SolexaQA’s Dynamic Trim function. The 
quality threshold for this trimming step was set at Q = 25. The third step mainly focussed on 
recording and removing any duplicate reads in order to minimize the data size to allevaite 
computational processing. During the fourth step, the workflow determined if all reads were in the 
5’ to 3’ direction. By using the Nearest Alignment Space Termination (NAST) algorithm for multiple 
sequence alignments,38 the workflow removed all reads not corresponding to the 16S rRNA 
reference gene when compared against the SILVA 16S rRNA database.39,40 The fifth step in the YAP 
workflow consisted of removing chimeric reads by comparing each read to the SILVA database using 
the chimera detecting program UCHIME41 integrated into the software mothur.42 A second quality 
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check step followed by aligning reads to the 16S rRNA gene reference region of Escherichia coli 
(downloaded from the National Center for Biotechnology Information (NCBI)). The workflow then 
trimmed the resultant alignment in order to remove overly long reads as well as reads not aligning 
to the targeted V4 region of the 16S rRNA gene. The final step of the workflow aimed to cluster all 
the good quality reads into OTUs using a clustering algorithm implemented in the software, CD-HIT-
EST within the CD-HIT Suite.43 The workflow performed clustering at four sequence similarity levels 
of 90, 95, 97 and 99%. Prior to calculating the final OTU cluster size, the workflow accounted for 
recorded duplicate reads by adding them to the appropriate OTU clusters. Finally taxonomic 
information was assigned to OTUs using the naïve Bayesian classifier within mothur44 as well as a 
normalized Ribosomal Database Project (RDP) training dataset.44 For computational efficiency, only 
an exemplar sequence representing each of the OTU clusters received a taxonomic classification. 
The exemplar of any given cluster lies at the “centroid” of all the sequences in the cluster and is 
equidistant from them. Following taxonomic classification, the software computes the aggregate 
sequence counts for any given taxonomic level by adding together the cluster sizes of OTU clusters 










































Figure 6. Schematic representation of the YAP workflow 
 
 
 The FASTX toolkit:  
Used to perform quality assessments on raw 
sequence reads.  
Lower quality scores across reads indicates a 
higher probability of bases being called incorrectly.  
For example:  
Q = 10 means that the probability of a base being 
called incorrectly is 1 in 10 (accuracy = 90%) 
Q = 40 means that the probability of a base being 
called incorrectly is 1 in 10 000 (accuracy = 99.99%) 
Quality overview 
 
Solexa’s Dynamic Trim function:  
Used to trim reads from both paired-ends at 
points where the quality deteriorates (usually 
at the end of the reads).  
A very low quality threshold (Q = 3) was adopted at 
this stage to minimize the loss of reads prior to 





Used to overlap or “stitch” the two paired-end 
reads together. 
The quality of reads decreases in the 5’ to 3’ 
direction of the generated sequence. This drop in 
quality is addressed by overlapping two paired-end 
reads that have been sequenced twice. FLASH uses 
the quality information of both paired-end reads 
and selects the bases with better quality scores to 
form the overlap. This increases the sequence 
length and the average sequence quality. 
Overlapping reads 
 
Solexa’s Dynamic Trim function:  
Used to trim reads of the overlapped paired-
end reads at points where the quality 
deteriorates.  
This time the quality threshold for trimming is 
higher (Q = 25) as  the quality of paired-end reads 
should be improved by the overlapping step. 
Trimming of 
overlapped reads 
 All duplicate reads are counted and removed 
from the unique reads. Records are kept of 
these counts. 
Multi-million reads can easily be generated by 
Illumina sequencers. Many of these are replicates 
due to high sequencing coverage and duplication 
rates. By only focussing on unique reads, the data 
size is substantially reduced and becomes 
computationally tractable. 
Removal of duplicate 
reads 
 This is done to verify that reads actually belong to 
a portion of the 16S rRNA gene and that all reads 
are orientated in the 5’ to 3’ prime direction. All 
non-16S rRNA reads and reads shorter than 220 
bases (possible primer dimers) are removed 
Quality check #1 Comparing reads to the SILVA 16S rRNA 
database by creating multiple sequence 








Figure 6. Schematic representation of the YAP workflow (continued) 
 
2.2.9 Statistical analysis of sequencing data 
  We used R software version 3.1.145 together with RStudio software version 0.98.50746 for all 
statistical analyses as well as graphical representations of the data. We used the output from the 
Illumina Miseq sequencing software CASAVA 1.8.2,32 as well as the output from the YAP workflow33 
for quality control analyses. From the four sets of OTU tables contructed at 90, 95, 97 and 99% 
sequence similarity; the OTU table constructed at 97% sequence similarity (genus-level) was selected 
for quality control analysis. 
 
 
UCHIME from mothur and SILVA 16S rRNA 
database:  
Used to detect and remove chimeric reads by 
comparing each read to a database of pure 
organisms. 
Chimeras are hybrid PCR products resulting from 
aborted extension PCR products acting as primers 
in subsequent PCR cycles. This results in reads 
being made up of information from more than one 
organism and falsely contributing to diversity. 
Chimera removal 
 
Align reads to the 16S rRNA gene reference 
region of Escherichia coli. Overly long reads and 
reads that do not align to the V4 region are 
trimmed. 
Only reads that align to the target region of 
interest and are of similar length are useful for 
comparison. 
Quality check #2 
 CD-HIT-EST from CD-HIT:  
Used to cluster the remaining good quality 
reads into OTUs 
All reads confirmed to be of 16S origin, reads of 
good quality, and reads aligning to the 16S 
hypervariable region of interest, are now grouped 
together based on their sequence similarities. In 
order to do this, sequence similarity cut-offs needs 
to be set. Clustering at a sequence similarity cut-
off of 99 %, for example, means that only 1 % of 
the nucleotides differ from each other in this 
cluster. The cut-offs used in this workflow were set 
at sequence similarity levels of 90, 95, 97 and 99%. 
Clustering into OTUs 
 
Following clustering, recorded duplicate counts 
are added to the appropriate OTU cluster prior 




Naïve Bayesian classifier within mothur and 
RDP training set:  
Used to assign taxonomic classification to an 
“exemplar” sequence for each OTU. Each 
sequence within an OTU then inherits its 
identity from the identity of the “exemplar” 
sequence (i.e. the OTU cluster it belongs to). 
To avoid wasting computation by running BLAST 
for each sequence, an “exemplar” sequence from 
each OTU is selected. This “exemplar” can be 
considered as the “centroid” for the cluster as it is 
equidistant from every other sequence in the 
cluster. The identities of these “exemplars” are 
then determined using the naïve Bayesian classifier 







2.2.9.1 Summary statistics 
 We used the [summ] and [tab1] functions of the R package epicalc47 to compute summary 
statistics on DNA concentrations used for library preparation; data output from the Illumina Miseq 
sequencer; as well as data output form the YAP workflow. DNA concentration summary statistics 
only included specimens with DNA concentrations measurable using the Qubit™ dsDNA HS Assay Kit 
(InvitrogenTM, CA, USA). Box and whisker plots were constructed for distribution analysis of the data. 
To compare non-parametric variables, we performed the Mann-Whitney-Wilcoxon and the Kruskall-
Wallis tests using the functions [wilcox.test] and [kruskal.test] from the R package epicalc, as 
appropriate.47 The Mann-Whitney-Wilcoxon test served for comparing two non-parametric 
variables, while the Kruskall-Wallis test served for multiple comparisons. By adding the argument 
“notch=TRUE” to the box and whisker plots constructed, we could graphically indicate which 
medians of the multiple comparisons are significantly different at the 5% level.48  
 
2.2.9.2 Evaluation of sequencing depth for studying faecal bacterial communities  
We constructed accumulation curves11 to determine if sufficient numbers of reads were 
obtained following the YAP workflow in order to adequately identify all bacterial genera from faecal 
specimens sampled from mothers and infants at birth, infants at 4 to 12 weeks of age and infants at 
20 to 28 weeks of age. We evaluated the sequencing effort, by constructing accumulation curves of 
the number of genera (identified from OTUs classified at a similarity level of 97%) against the 
number of reads obtained following the YAP workflow using the function [rarefy]49 from the R 
package vegan.50 
 
2.2.9.3 Assessment and correction for potential contamination of the samples processed 
 We determined whether contamination was evident in our sequencing run by analysing the 
two non-template controls. We also determined whether contamination occurred uniformly across 
all PCR plates used during library preparation. This was done by constructing barplots of the relative 
abundance as well as the actual numbers of potential contaminating OTUs at genus-level for the two 
non-template controls and all other sequencing reactions across all PCR plates. In addition, we 
searched the literature to determine what possible sources of contamination might exist for the 
putative contaminant sequences in our run. In correcting for contamination, we calculated the mean 
number of OTUs from the two non-template controls for each of the genera where contamination 
was evident. This mean was then subtracted from all OTUs representing these genera across all 
specimens, including the two non-template controls. The OTU table (at 97% sequence similarity), 
also contained OTUs at higher taxonomic classifications (namely family, order, class and phylum) 
which needed to be corrected. Consequently, we added the resultant numbers of OTUs at genus-
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level to obtain the new number of OTUs at family-level. This was repeated for each of the higher 
taxonomic classifications until the root was reached (Figure 7). 
Taxonomic 
level 


















Root 0 8 6  62 55 
Kingdom 0.1 8 6  62 55 
Phylum 0.1.1 8 6  62 55 
Class  0.1.1.1 8 6  62 55 
Order 0.1.1.1.1 5 5  24 19 
Order 0.1.1.1.2 3 1  38 36 
Family 0.1.1.1.1.1 5 5  24 19 
Family 0.1.1.1.2.1 3 1  38 36 
Genus 0.1.1.1.1.1.1 1 3 2 6 4 
Genus 0.1.1.1.1.1.2 4 2 3 18 15  
Genus 0.1.1.1.2.1.1 1 1 1 12 11 
Genus 0.1.1.1.2.1.2 2 0 1 26 25 
 
 Figure 7. Schematic representation of an OTU table during correction for potential contamination  
 Correction for potential contamination starts at the genus-level when the mean number of OTUs observed in the two 
non-template controls are calculated for each genus and subtracted from each faecal specimen. Following correction at 
genus-level, the resultant number of OTUs at genus-level within a family are added together to obtain the new number 
of OTUs at family-level. This process is repeated for all higher taxonomic levels until the root is reached. The 
calculations are carried out for all genera with OTUs present in the non-template controls and applied to all faecal 
specimens, including the two non-template controls.  
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2.2.9.4 Analysis of variation between “technical repeats” 
To determine technical reproducibility of the sequencing process, the proportions of each 
OTU sequenced from 17 faecal specimens were compared to that of their “technical repeats”. These 
specimens were randomly selected to be sequenced in duplicate. These specimens included three 
mother-infant pairs followed over time; two infants for whom we did not have maternal specimens 
to pair with; and a single mother for whom we did not have an infant specimen to pair with. We 
compared the proportion of each OTU present in the original specimen with those from their 
“technical repeats” using simple linear regression analysis.51 The coefficient of determination (R2) 
was calculated51 for all 17 specimens used for repeat testing. This was also used to determine the R2 
at group level for infant specimens collected at birth, at 4-12 weeks, at 20-28 weeks of age and for 
maternal specimens collected at birth. Figure 8 schematically represents this strategy using two 
specimens, with their repeat measurements, and three OTUs as an example. In addition, we also 
determined the effect of DNA concentration on variation between “technical repeats”. This was 
determined by simply assigning colours to the plotted proportion of variations, based on the DNA 
concentrations of the faecal specimens. DNA concentrations of < 0.05 ng/μl were coded as 0.025 
ng/μl and DNA concentrations of > 60 ng/μl were coded as 65 ng/μl to enable data analysis using R 














OTU Specimen 1  Specimen n 
First measurement Repeat 
measurement 
First measurement Repeat 
measurement 
X 0.15 0.18 0.21 0.07 
Y 0.19 0.25 0.17 0.03 
Z 0.12 0.09 0.05 0.32 
  
 
Figure 8. Schematic representation of reproducibility measurements correlated with DNA concentrations  
The proportion of each OTU sequenced from the specimen (X axis) and its repeat measurement (Y axis) is plotted. The 
bigger the distance between the plot and the diagonal line, the bigger the variation measured for the respective OTU when 
comparing the specimen to its repeat. This variation is also highlighted by the size of each plot, with bigger sizes 
representing larger distances from the diagonal line. Colours are assigned based on the DNA concentrations of each 

































Specimen 1, OTU Z 
Specimen 1, OTU X 
Specimen 1, OTU Y 
Specimen n, OTU X 
Specimen n, OTU Y 
Specimen n, OTU Z 




2.2.9.5 Calculating intra-individual (alpha) diversity  
We calculated the Shannon diversity index (H’)52,53 (equation 3.1) to determine the alpha 
diversity amongst each of the “groups under study”.  
 




Where 𝑖 = species of interest,  
𝑝𝑖 = proportion of species of interest (𝑖) relative to the total number of species, 
ln = natural logarithm,  
Σ = sum of the resulting product across species, and 
s = number of species recorded. 
 
This diversity index measures both the richness and evenness of organisms within the specimen of 
interest. The greater the Shannon diversity index, the greater the diversity within the specimen. 
Figure 9 shows this in context of microbiome studies using OTUs to measure the diversity within, for 
example, nine specimens. 
 
Figure 9. Schematic diagram showing species richness and evenness across nine different specimens  
Each shape within the nine specimens represents an operational taxonomic unit (OTU). The Shannon index increases as 
both richness and evenness increase. The highest diversity will therefore be measured from specimen number 9.   
 
2.2.9.6 Correlations between DNA concentrations used for library preparation, the number of 
reads sequenced, OTUs classified and intra-individual diversity 
 We used the [cor] function of the built-in R package stats45 to investigate the relationships 
between i) the DNA concentrations used for library preparation; ii) the number of reads sequenced; 




all “groups under study”. We also constructed pairwise scatterplots to visually determine the 
correlations between the variables i – iv listed above for all “groups under study”. These pairwise 
scatterplots indicate positive correlations between variables when scatter plots ascents from left to 
right and negative correlations when scatter plots descents from right to left. Strong correlations are 
indicated by plots that cluster as to resemble a straight line (slope). Correlation and pairwise 
scatterplot analyses were repeated separately for maternal faecal specimens collected at birth, 
infant meconium specimens collected at birth, and infant faecal specimens collected at 4 to 10 
weeks and 20 to 28 weeks of age.  
 
2.3  Results 
 
2.3.1 Faecal specimens and controls sequenced using Illumina MiSeq technology 
Faecal specimens from 90 mothers were sequenced. In infants, 107, 72 and 36 faecal 
specimen collected at birth, 4 to 12 weeks and 20 to 28 weeks of age were sequenced, respectively.  
All faecal specimens from both mothers and infants are referred to herein as the “groups under 
study” (n=305). In addition to the faecal specimens collected from the “groups under study”, we 
sequenced a set of controls, herein referred to as the “sequencing controls”. “Sequencing controls” 
consisted of two non-template controls, two BEI controls, Escherichia coli and 17 “technical repeats” 
randomly selected from the “groups under study”. The “groups under study”, together with the set 
of “sequencing controls”, are summarised in Figure 10 and referred to herein as “sequencing 
reactions” (n = 327).  
 
Figure 10. Summary of “sequencing reactions”  
Faecal specimens sequenced from four “groups under study”. These included 90 mothers and 107 infants from which 
faecal specimens were collected at birth as well as 72 infants from which faecal specimens were collected at 4 to 12 weeks 
and 36 infants from which collection took place at 20 to 28 weeks of age. In addition, sequencing was also performed on 17 
faecal specimens randomly collected from the “groups under study” to serve as “technical repeats”. Other “sequencing 
controls” included one Escherichia coli control, two BEI controls and two non-template controls.   
“Sequencing reactions” (n=327) 
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2.3.2 DNA concentration from faecal specimens 
 We were not able to measure the DNA concentration in 19.6% (60/305) of the specimens 
tested. The majority (98.3%, 59/60) of these specimens had DNA concentrations too low to be 
detected by the Qubit™ dsDNA HS Assay Kit’s lower detection limit (0.05 ng/μl). These specimens 
mainly consisted of infant meconium specimens (98.3%, 58/59), together with a single infant faecal 
specimen collected at 24 weeks. DNA concentration exceeding the Qubit™ dsDNA HS Assay Kit’s 
upper detection limit (60 ng/μl) was observed in a single infant faecal specimen collected at 8 weeks 
of age. By excluding for all specimens outside the detection range of the Qubit™ dsDNA HS Assay Kit, 
we observed a statistically significant difference for the DNA concentrations extracted from the 
“groups under study” (p < 0.0001) (Figure 11). Infant meconium specimens collected at birth had the 
lowest DNA concentrations.  
 
Figure 11. DNA concentrations extracted from faecal specimens for all “groups under study” 
Specimens with undetectable DNA concentrations, using the Qubit™ dsDNA HS Assay Kit, were excluded from the box and 
whisker plots. DNA concentrationas are shown for faecal specimens collected from mothers at birth (n=90), meconium 
specimens collected from infants at birth (n=49), faecal specimens collected from infants at 4 to 12 weeks of age (n=71) 
and 20 to 28 weeks of age (n=35). The line within each box plot represents the median value. The median values of box 





 percentile and whiskers show the minimum and maximum values.  
 
2.3.3 Amplicon concentrations from PCR prior to pooling and sequencing  
 Figure 12 shows the amplicon concentrations from the Quanti-iTTM dsDNA High-Sensitivity 
Assay Kit. We observed significant difference in amplicon concentrations when comparing all 
“groups under study” and all “sequencing controls” (p < 0.0001). The median amplicon 






































“Groups under study” 
 Mothers at birth 
 Infants at birth 
 Infants at 4-12 weeks 
 Infants at 20-28 weeks 
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The infant meconium specimens produced significantly lower amplicon concentrations compared to 
the other three groups from the “groups under study” (p < 0.0001) (Figure 12A). All “sequencing 
reactions”, including the two non-template controls, produced amplicons (Figure 12B). The median 
concentration of 6.0 ng/μl (IQR, 4.7 - 7.3) for the two non-template controls were significantly lower 
compared to those from the “groups under study” and the remainder of the “sequencing controls” 
(p < 0.0001). The median amplicon concentration of the “sequencing controls”, excluding for the two 























Figure 12. Amplicon concentrations from PCRs performed prior to pooling and sequencing steps 
A) Amplicon concentrations are shown for faecal specimens collected from “groups under study”, which included mothers 
at birth (n=90), meconium specimens collected from infants at birth (n=107), and faecal specimens collected from infants 
at 4 to 12 (n=72) and 20 to 28 weeks of age (n=36). B) Amplicon concentrations of our “sequencing controls” included 
“technical repeats” (n=17), BEI controls (n=2), an E.coli control (n=1) and non-template controls (n=2). The line within the 
box plot indicates the median values. The median values of box plots are significantly different (at 5% significance level) in 
the event that their notches do not overlap. The areas extending on either side of the notches (green and blue box plots) 








































 Mothers at birth 
 Infants at birth 
 Infants at 4-12 weeks 
 Infants at 20-28 weeks 
 “Technical repeats” 
 BEI controls 
 Escherichia coli control 





2.3.4 Analysis of the sequencing output from Illumina platform generated by CASAVA 
1.8.2 software 
 Quality metrics from CASAVA 1.8.2 software indicated that 94% (IQR, 93.0 - 94.5) of the 
sequencing reaction clusters, generated from “all sequencing reactions” (n = 327), passed Illumina 
sequencing filters. Of the clusters passing Illumina sequencing filters, 82% (IQR, 80.4 - 83.5) had 
bases with a Q score greater than 30. The median Q score of these bases was 33 (IQR, 32.3 - 33.3). 
We found a significant difference in the percentage of clusters that passed filtering (p = 0.0003) for 
the various “groups under study” (n=305). We also observed a significant difference in the 
percentage of clusters for which the bases had a Q score greater than or equal to 30 for the different 
“groups under study” (p < 0.0001). A significant difference was also observed between the “groups 
under study” based on their mean Q scores (p < 0.0001) (Figure 13). Meconium specimens sampled 
at birth yielded the lowest Q scores with nine specimens producing Q scores of less than 30 (Figure 
13). Only the two non-template controls had significantly lower Q scores when compared to the 
“groups under study” (p = 0.018).  
 
Figure 13. Quality scores of bases sequenced from faecal specimens for all “groups under study” 
Quality scores are shown for faecal specimens collected from mothers at birth (n=90), meconium specimens collected from 
infants at birth (n=107), faecal specimens collected from infants at 4 to 12 weeks of age (n=72) and 20 to 28 weeks of age 
(n=36). The line within the box plot indicates the median values. The median values of box plots are significantly different 





and whiskers show the minimum and maximum values. 
 
 The total number of reads sequenced from “all sequencing reactions” (n = 327) was 
17 722 962, with a median number of 43 098 (IQR, 27 706 – 72 353) reads per sequencing reaction. 


































“Groups under study” 
 Mothers at birth 
 Infants at birth 
 Infants at 4-12 weeks 
 Infants at 20-28 weeks 
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median number of 43 198 (IQR, 27 764 – 73 256) reads per faecal specimen. We found a significant 
difference (p < 0.0001) in the median number of reads sequenced from each of the “groups under 
study” (Figure 14A). Infant meconium specimens sampled at birth produced the highest number of 
reads obtained from the sequencer (Figure 14A).  The “sequencing controls” (n = 22) yielded a total 
of 1 126 630 reads. Of these, the “technical repeats” (n = 17) produced 950,706 reads. The two BEI 
controls yielded a total of 57 720 reads and the E. coli control yielded a total of 74 212. Of note, the 
two non-template controls produced a total of 43 992 reads.  
Figure 14. Reads obtained from CASAVA 1.8.2 software and from the YAP workflow for all “groups under study” 
The number of reads are summarised for faecal specimens collected from mothers at birth (n=90), meconium specimens 
collected from infants at birth (n=107), faecal specimens collected from infants at 4 to 12 weeks of age (n=72) and 20 to 28 
weeks of age (n=36). The line within the box plot indicates the median values. The median values of box plots are 





 percentile and whiskers show the minimum and maximum values. A) Reads obtained from CASAVA 1.8.2; B) 
Reads obtained following the first step of the YAP workflow; C) Reads obtained following the second step of the YAP 
workflow; and D) Reads obtained following steps 3 to 6 from the YAP workflow. 
 
 
2.3.5 Sequencing output from the YAP workflow 
 Compared to the sequencing output from CASAVA 1.8.2 software (Figure 14A), we observed 
a significant reduction in the number of reads sequenced (p < 0.0001) as a result of the steps 
performed by the YAP workflow (Figure 14D).  A significant reduction in the number of reads (p < 
0.0001) was already evident following the first step of the YAP workflow (Figure 14B) which 
corresponded to trimming of paired end reads. Another significant reduction in the number of reads 
(p < 0.0001) was noted following the second step of the YAP workflow (Figure 14C), corresponding 
































CASAVA 1.8.2 YAP workflow step 1 YAP workflow step 2 YAP workflow steps 3 to 6 
 Mothers at birth 
 Infants at birth 
 Infants at 4-12 weeks 
 Infants at 20-28 weeks 
A B C D 
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16S rRNA gene reference; and overly long reads, resulted in another significant drop in the number 
of reads (p = 0.0060)(Figure 14D). The total number of OTUs classified by the YAP workflow for all 
sequencing reactions (n = 327) was 121 570, with a median number of 268 (IQR, 161 - 477) OTUs per 
reaction. The OTUs classified for all “groups under study” (n = 305) was 115 536, with a median 
number of 276 (IQR, 164 - 494) OTUs per faecal specimen. 
 
2.3.6 Determining whether the sequencing output from the YAP workflow was 
sufficient for detecting all bacterial genera present from the “groups under study” 
The median number of reads observed for all “groups under study” (n = 305), as a result of 
the YAP workflow, was 10 730 (IQR, 6 660 - 18 068) (Figure 15). Infant meconium specimens 
sampled at birth are most concave-downward indicating that the majority of genera have been 
detected with the reads available (Figure 15). We also see a similar pattern for infants at 4-12 weeks 
and 20-28 weeks, however not as prominent as the meconium specimens (Figure 15). Maternal 
faecal specimens on the other hand have a more linear shape than any of the other specimens, 
indicating that more reads are required to more comprehensively identify all of the genera from 
these specimens (Figure 15). 
 
Figure 15. Accumulation curves comparing the number of reads from the YAP workflow to the number of bacterial 
genera identified 
The median numbers of reads from all “groups under study” are shown by the red solid line with the inter-quartile ranges 
in red broken lines. 
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2.3.7 Potential contamination observed from non-template controls 
 Following the YAP workflow, 67 and 77 OTUs were classified respectively from the two non-
template controls at genus-level.  Together, these OTUs represented 69 genera from the two non-
template controls, herein referred to as “contaminating genera”. The majority of these bacterial 
genera (64%) are in fact common colonizers of the human GIT, while 26% have also been identified 
from laboratory reagents such as DNA extraction kits and molecular biology reagents (Table 3). 
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Table 3. Potential “contaminating genera” from our study assessed according to the genera frequently detected from faecal specimens and laboratory reagents 








Actinobacteria Actinobacteria Actinomycetales Corynebacteriaceae Corynebacterium 7 54 55 Genus Corynebacterium is a typical skin colonizer, however 
within the order Actinomycetales it is one of the most 
frequently detected genera from the GIT.56 
Micrococcaceae Arthrobacter 2 57 55  
Kocuria 1  55 Genus Kocuria is a typical skin and oropharynx colonizer, 
however it has recently been reported in GIT samples.56 
Renibacterium 1    
Unclassified 1    
Bifidobacteriales Bifidobacteriaceae Bifidobacterium 6 57–62  Majority of species belonging to the genus Bifidobacterium 
have been recovered exclusively from GIT specimens.56 
Coriobacteriales Coriobacteriaceae Collinsella 1 63  The order Coriobacteriales is frequently detected from the GIT 
with  Collinsella being the most dominant genus.56 
Bacteroidetes Bacteroidia Bacteroidales Porphyromonadaceae Porphyromonas 3 64,65  Majority of GIT Bacteroidetes spp. belong to the families 
Porphyromonodaceae, Prevotellaceae, Rikenellacea and 
Bacteroidaceae.56 
Unclassified 1   
Prevotellaceae Prevotella 1 58,61,62,66  
Rikenellaceae Alistipes 1 61,62,65  
Bacteroidaceae Bacteroides 4 54,58–62,65–67  
Sphingobacteria Sphingobacteriales Chitinophagaceae Sediminibacterium 1   Typically associated with ecosystems such as soil, however 
species belonging to the class Sphingobacteriales have 
occasionally been detected from GIT.56 
Proteobacteria Alphaproteobacteria Caulobacterales Caulobacteraceae Brevundimonas 3  55 The class Alphaproteobacteria is one the five GIT inhabiting 
classes of the Proteobacteria.56 
. 
Phenylobacterium 3   
Rhizobiales Bradyrhizobiaceae Bradyrhizobium 2 54 55 

68–70 
Unclassified 1   
Methylobacteriaceae Methylobacterium 3 54  55 

68 
Rhizobiaceae Rhizobium 1 54 55 

68 
Rhodobacterales Rhodobacteraceae Unclassified 1   
Rhodospirillales Rhodospirillaceae Rhodocista 1   
Sphingomonadales Sphingomonadaceae Sphingomonas 1 54,71 55 

68,69 






Table 3. Potential “contaminating genera” from our study assessed according to the genera frequently detected from faecal specimens and laboratory reagents (continued) 













Bacterial members belonging to the class Betaproteobacteria 
are common and diverse GIT colonizers.56 
Comamonadaceae Comamonas 3   
Pelomonas 2 54 55 

68  
Unclassified 1   
Oxalobacteraceae Massilia 1 73 55 
Undibacterium 1  55 
Unclassified 1   
Sutterellaceae Sutterella 1 65,74  
Neisseriales Neisseriaceae Neisseria 2 75  
Deltaproteobacteria Myxococcales Nannocystaceae Nannocystis 1    
Gammaproteobacteria Enterobacteriales Enterobacteriaceae Escherichia/Shigella 2 58 55 

76 
The family Enterobacteriaceae is the most prevalent and 
diverse of all nine families of Proteobacteria detected from 
the GIT.56 
Unclassified 2    
Aeromonadales Aeromonadaceae Aeromonas 1 77  Species of the genus Aeromonas are associated with 
gastroenteritis and diarrhea.56 
Succinivibrionaceae Succinivibrio 1   Succinivibrio is one of three genera from the family 
Succinivibrionaceae detected in the GIT.56 
Alteromonadales Shewanellaceae Shewanella 1 54   
Pasteurellales Pasteurellaceae Haemophilus 
 
2 58  Members from the genus Haemophilus are elevated in 
irritable bowel syndrome.56 
Pseudomonadales Moraxellaceae Acinetobacter 1 54,58,59 55 

76 
Frequent detection of members from the family 
Moraxellaceae from the GIT. Acinetobacter species are 
commonly detected from infants.56 
Moraxella 6 78   





Genus Pseudomonas constitute of eight species which have 
been detected in the GIT.56 





Genus Stenotrophomonas is one of two genera isolated from 
the family Xantohomonadaceae in the GIT.56 




Unclassified Unclassified Unclassified 1    




Table 3. Potential “contaminating genera” from our study assessed according to the genera frequently detected from faecal specimens and laboratory reagents (continued) 








Tenericutes Mollicutes Mycoplasmatales Mycoplasmataceae Mycoplasma 2   The phylum Tenericutes has not yet been cultured, however 
molecular assays have detected these bacteria from the GIT.56 
Firmicutes Bacilli Bacillales Staphylococcaceae Staphylococcus 2 54,58  Genus Staphylococcus is a typical skin colonizer, however also 
detected from the GIT. Early colonizers of the GIT.56 
Lactobacillales Carnobacteriaceae Granulicatella 1 80   
Enterococcaceae Enterococcus 1 58,60,61,81  Genus Enterococcus is dominant in the upper section of the 
small intestine. They can be detected from the GIT as early as 
the first day of life.56 
Lactobacillaceae Lactobacillus 4 54,58,59,61,82  Genus Lactobacilli are dominant in the upper GIT. They are 
ever-increasing in diversity as new species are still being 
reported from the GIT.56 
Leuconostocaceae Weissella 1 58 
 
 Genus Weissella is highly abundant in the GIT and also 
colonize the GIT of some newborns.56 
Streptococcaceae Streptococcus 8 54,58,59,61,83 55 Genus Streptococcus is dominant in the upper section of the 
small intestine. They can be detected from the GIT as early as 
the first day of life.56 
Clostridia Clostridiales Clostridiaceae Clostridium sensu 
stricto 
4 84  Thirty of the 72 Clostridium species detected from the GIT 
belong to the genus Clostridium sensu stricto 56. 
Lachnospiraceae Anaerostipes 2 62,85  The family Lachnospiraceae is most diverse and abundant, 
with 24 genera of which the majority can be detected from 
the GIT. Members from this family are also amongst the first 
colonizers of the GIT.56 
Blautia 3 54,60,67,86,87  
Clostridium XlVa 1 84  
Dorea 1 62,88  
Lachnospiracea 
incertae sedis 
3 89,90  
Roseburia 3 62,65,85  
Uncassified 4   
Peptococcaceae Peptococcus 1 84,91  
Peptostreptococcaceae Clostridium XI 2 92  
Ruminococcaceae Clostridium IV 1 56,61,84,92  The family Ruminococcaceae is another important group of 
GIT inhabiting bacteria.56 Faecalibacterium 5 62,65,67,93  
Ruminococcus 5 62,87  
Unclassified 3   
Erysipelotrichia Erysipelotrichales Erysipelotrichaceae Erysipelotrichaceae 
incertae sedis 
2    
Unclassified Unclassified Unclassified Unclassified 1    
 
 DNA extraction kits;  Ultrapure industrial water systems;  Molecular biology reagents 
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Figure 16A indicates that the 69 “contaminating genera” from the two non-template 
controls (summarised in Table 3) corresponded to genera found at high relative abundances 
(between 60 and 80%) within the faecal specimens from our study (n = 305). All “contaminating 
genera”, except for the genera Nannocystis, Renibacterium and an unclassified genus from the 
family Bradyrhizobium, were identified from faecal specimens processed in all four PCR plates during 
library preparation. Overall, we observed a relatively uniform distribution of the “contaminating 
genera” at phylum-level amongst faecal specimens across all four of the PCR plates. DNA from faecal 
specimens amplified in PCR plates no. 2 and 3 had a higher relative abundance of the phylum 
Firmicutes, whereas DNA from faecal specimens amplified in plates no. 3 and 4 had a higher relative 
abundance of the phylum Proteobacteria. PCR plates no. 1 and 2 contained 68% (62/91) and 64% 
(61/95) of infant faecal specimens, while PCR plates no. 3 and 4 contained 79% (67/85) and 73% 
(38/52) infant faecal specimens.  
Based on the actual number of OTUs classified from the two non-template controls, our 
findings indicated that the level of “contaminating genera” was very low in the non-template 
controls in comparison to the level of “contaminating genera” classified from faecal specimens 




Figure 16. “Contaminating genera” observed from two non-template controls and faecal specimens studied 
A) The relative abundance and B) number of OTUs representing “contaminating genera” from two non-template controls 
(NTC) and faecal specimens from the four PCR plates (P1 - P4) used during library preparation. Shades of red represent 
genera from the phylum Firmicutes, shades of blue from the phylum Proteobacteria, shades of green from the phylum 
Bacteroidetes and shades of yellow represent genera from the phylum Actinobacteria. “Other” represents genera not 
































Following the process of correction for the contaminant sequences, a significant reduction (p = 
0.011) in the total number of OTUs was evident with approximately 10% of the OTUs classified by 
the YAP workflow being removed (Figure 17). This resulted in a median number of 234 (IQR, 129 - 
447) OTUs available per faecal specimen for consecutive data analyses.  
 
Figure 17. OTUs classified by the YAP workflow prior to and following correction for contamination  
The number of OTUs are summarised for faecal specimens collected from mothers at birth (n=90), meconium specimens 
collected from infants at birth (n=107), faecal specimens collected from infants at 4 to 12 weeks of age (n=72) and 20 to 28 
weeks of age (n=36).The line within the box plot indicates the median values. The line within each box plot represents the 
median value. The median values of box plots are significantly different (at 5% significance level) in the event that their 




 percentile and whiskers show the minimum and maximum 
values. A) OTUs classified by the YAP workflow; and B) OTUs resulting from correcting for contamination. 
 
2.3.8 Variation between “technical repeats”  
The experimental reproducibility was determined at R2 = 0.85 based on the 17 “technical 
repeats”. When assessing the variation between “technical repeats” for each of the “groups under 
study”, we found that “technical repeats” for infant meconium specimens collected at birth were the 
least reproducible (R2 = 0.61); followed by infant faecal specimens collected at 4-12 weeks of age (R2 
= 0.83). Faecal specimens from infants collected at 20-28 weeks of age showed higher reproducibility 
between “technical repeats” (R2 = 0.92), while maternal faecal specimens collected at birth showed 
the highest reproducibility (R2 = 0.98). Interestingly, we also observed an increase in the 
reproducibility of “technical repeats” as the DNA concentration, used during library preparation, 
increased (Figure 18).  
OTUs prior to correcting 
for contamination 











































 Mothers at birth 
 Infants at birth 
 Infants at 4-12 weeks 





Figure 18. Reproducibility of “technical repeats”  
Scatter plots show the proportion of each OTU detected from the original specimens (first measurement) and their 
“technical repeats” (second measurement). The bigger the distance between the plot and the diagonal line, the bigger the 
variation. This increase in variation is also shown by the increase in size of the scatter plots. In addition, the DNA 
concentrations obtained from each of the specimens are indicated using a range of colours. Colours range from red, 
representing low DNA concentrations, to purple, representing high DNA concentrations. The mother-infant pair ID is shown 
in brackets for each of the specimens and their repeats. A) Meconium specimens collected from infants at birth; B) Faecal 
specimens collected from infants between 4 and 12 weeks of age; C) Faecal specimens collected from infants between 20 
and 28 weeks of age; and D) Faecal specimens collected from mothers at birth.   
 
2.3.9 Intra-individual bacterial diversity of faecal specimens under study 
The median Shannon diversity index for all “groups under study" (n = 305) was 3.4 (IQR, 3.2 - 
3.8). The lowest diversity index measured for a faecal specimen was 2.3 and the highest was 4.7. 
There was a significant difference (p < 0.0001) between the various “groups under study”; with 
infants at birth having the highest diversity measures (Figure 19).   
R2 = 0.61 R2 = 0.83 
R2 = 0.98 R2 = 0.92 
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Figure 19. Intra-individual bacterial diversity indices for “groups under study"  
The Shannon diversity indices are summarised for faecal specimens collected from mothers at birth (n=90), meconium 
specimens collected from infants at birth (n=107), faecal specimens collected from infants at 4 to 12 weeks of age (n=72) 
and 20 to 28 weeks of age (n=36). The line within each box plot represents the median value. The median values of box 





 percentile and whiskers show the minimum and maximum values. 
 
2.3.10 Correlations between DNA concentrations, reads sequenced, OTUs classified and 
intra-individual bacterial diversity 
 Overall, no strong correlations were seen between DNA concentrations, the number of 
reads sequenced, OTUs classified and intra-individual bacterial diversity indices for all “groups under 
study” (n = 305) (Table 4). Figure 20 visually highlights these correlations for the “groups under 
study”. We observed a very strong positive correlation between the number of reads sequenced and 
the number of OTUs classified for maternal faecal specimens. In addition, infants sampled at 4-12 
weeks also showed a strong positive correlation between the number of reads sequenced and the 
number of OTUs classified. Infants sampled at birth and 20-28 weeks of life showed a weak positive 
correlation between the number of reads sequenced and the number of OTUs classified. Another 
strong positive correlation was observed between the number of reads sequenced and the intra-
individual bacterial diversity measured from infant faecal specimens collected at 4-12 weeks of age. 
This positive correlation (moderate to strong) was found in all other sampling groups, except for 
maternal faecal specimens. Finally, we also observed a very strong positive correlation between the 
number of OTUs classified and the bacterial diversity within infant faecal specimens collected at 4-12 
weeks of age. A strong positive correlation was also observed between the number of OTUs 




























“Groups under study” 
 Mothers at birth 
 Infants at birth 
 Infants at 4-12 weeks 
 Infants at 20-28 weeks 
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Table 4. Correlations between DNA concentration, reads sequenced, OTUs classified and intra-individual  
bacterial diversity 
Correlations “Groups under study”               
(n = 305) 
Mothers at 
birth (n = 90) 
Infants at birth 
(n = 107) 
Infants at 4-12 
weeks (n = 72) 
Infants at 20-28 
weeks (n = 36) 
DNA concentration Reads sequenced -0.28 -0.09 0.09 -0.19 -0.18 
DNA concentration OTUs classified 0.29 0.09 0.35 -0.04 0.61 
DNA concentration Diversity -0.42 -0.36 -0.21 -0.20 -0.11 
Reads sequenced OTUs classified 0.05 0.71 0.27 0.69 0.23 
Reads sequenced Diversity
 
0.55 -0.14 0.41 0.69 0.38 
OTUs classified Diversity 0.02 -0.37 0.40 0.78 0.11 
 
Figure 20. Correlations between DNA concentrations, reads, OTUs and intra-individual bacterial diversity 
Correlations are summarised for faecal specimens collected from mothers at birth (n=90), meconium specimens collected 
from infants at birth (n=107), faecal specimens collected from infants at 4 to 12 weeks of age (n=72) and 20 to 28 weeks of 
age (n=36). Each of the sampling groups is indicated by a specific colour shown in the legend. Correlations between A) DNA 
concentrations and reads from the YAP workflow; B) DNA concentrations and OTUs corrected for contamination; C) DNA 
concentration and intra-individual diversity; D) reads from the YAP workflow and OTUs corrected for contamination; E) 




2.4  Discussion 
 
 High-throughput sequencing of the 16S rRNA gene, and in particular Illumina sequencing 
technology, 1–3 has been successfully used to sequence complex bacterial profiles from the human 
GIT. However, computational analysis of reads generated by high-throughput sequencing may be 
affected by a number of factors, such as the quality of the library prepared; the sequencing 
chemistry; as well as the bioinformatics workflow used to eliminate adapter sequences, chimeras, 
short reads and any sequencing artifacts.16 This discussion primarily focuses on i) describing the 
sequencing depth obtained during from our faecal specimens in relation to previous reports; ii) 
adressing the effect of quality control steps performed in addition to analysis conducted by CASAVA 
1.8.2 software; iii)  identifying the possible source for potential contamination observed in our 
sequencing data and discussing the importance of correcting for contaminants; iv) and to highlight 
the importance of the use of optimal DNA yields as starting material during library preparation.  
 One of the important elements of studying highly diverse microbiomes (such as the GIT 
microbiome) using high-throughput sequencing, is to sequence deep enough to obtain a ‘true’ 
representation of the complex microbiomes.89 Previously, studies targeting the V4, V6, and V2-V3 
regions, using Illumina MiSeq technology, concluded that a sequencing depth of about 40 000 reads 
per specimen is sufficient for studying the GIT microbiome.94,95 Our study successfully sequenced a 
median of 43 198 reads per faecal specimen, with the majority of reads ranging between 
approximately 28 000 to 73 000.  
In addition to the sequencing depth; the quality of the sequening data is as important. High 
quality sequencing data is crucial for various downstream analyses since errors in base calling, poor 
quality reads, adaptor/primer contamination, and sequencing artifacts such as chimeras may bias 
results.10 Overall, we generated high quality reads as indicated by more than 90% of the sequencing 
clusters passing sequencing filters. In addition, more than 80% of our bases sequenced had Q scores 
(or Phred scores) greater than 30, which are regarded as high quality scores according to Illumina 
Miseq technical team.35 In support of this; the Illumina Miseq performance specificiations indicate 
that > 70% of bases should have a Q score greater than 30 when using the 2 x 300 bp Miseq Reagent 
Kit V3, as per our study.96 Of note, however; the above-mentioned quality scores were generated 
using the Illumina sequencing software CASAVA 1.8.2 and it is known that machine-generated Q 
scores may over-estimate the accuracy of base calls.97 Therefore, in addition to Illumina’s 
sequencing software analysis; we included additional quality assessement steps by performing the 
YAP workflow. The YAP workflow consisted of a set of tools integrated into a computationally 
efficient workflow using a Python wrapper script to i) accurately filter erroneous reads by 
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overlapping paired-end reads;97 to ii) remove sequencing artifacts such as chimeras;10 and to iii) 
remove all reads not corresponding to the 16S rRNA reference gene which included overly long 
reads. Performing this quality control workflow, in addition to obtaining machine-assigned quality 
scores, was clearly of great importance since 25% of our reads sequenced were removed following 
the YAP workflow. These types of reductions in the number of reads sequenced are expected when 
utilising additional tools to filter high-quality reads produced by high-throughput platforms such as 
Illumina.10 The reduced number of reads available for downstream data analysis led us to construct 
an accumulation curve to determine whether we still had a sufficient number of reads to accurately 
assess bacterial diversity present within the faecal specimens under study. Characteristically, 
accumulation curves initially increase steeply, whereafter they gradually level off as an increase in 
number of reads no longer contribute to new species being detected.11 Although we did not reach 
the recommended sequencing depth of 40 000 reads per faecal specimen94,95 (after applying the YAP 
workflow to our sequencing output); we did observe a plateau in the accumulation curves for a 
number of our specimens under study. To the best of our knowledge, no studies have reported a 
recommended sequencing depth for meconium specimens; however we observed a plateau at 
approximately 20 000 reads sequenced per meconium specimen. Meconium specimens also 
plataued most prominently in comparison to the faecal specimens collected at later stages in life as 
well as the maternal faecal specimens. These findings indicate that less reads may be required to 
obtain a comprehensive insight into the genera colonizing meconium specimens when compared to 
faecal specimens sampled at later stages in life. Interestingly, the study by Mshvildadze and 
colleagues only had an average of 888 sequences per meconium specimen (and only 18-46 OTUs 
classified at 97% sequence similarity) available to characterise bacteria from meconium specimens 
of healthy premature infants and infants suffering from necrotizing enterocolitis.98 
 Another potential artifact of high-throughput sequencing is the introduction of a 
considerable number of contaminating sources which may result in erroneous conclusions.99 Several 
potential sources have been identified to contribute to sequence-based contamination from the 
time of specimen collection up until the final sequencing products are generated.100 Some of these 
include, for example, specimen collection, DNA extraction, PCR amplification steps and the 
sequencing process itself. In the event where a marker gene is targeted, as performed by our study, 
reagent contaminants may also be amplified during the library preparation step.100 Contamination 
was clearly evident from our sequencing run as we classified 67 and 77 OTUs at genus-level from our 
two non-template controls. However; determining the source of contamination for our sequencing 
data is not a straight forward process. Although studies have reported DNA extraction kits as 
possible sources for contamination,55 we do not suspect that this was the case for our study. One of 
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the reasons for this being that previous studies have reported the QIAsymphony nucleic acid 
extraction platform to be free of cross-contamination.101,102 Furthermore, we processed the 
contaminated non-template controls for the first time during library preparation in a different 
laboratory as to where the nucleic acid extractions took place. In addition to the potential role of 
DNA extraction kits in contamination; studies have also reported laboratory reagents such as PCR 
reagents and ultrapure water as potential sources for contamination.55 Despite the fact that we did 
not have a baseline established to determine the effect of reagents used during library preparation 
as sources for contamination; we did, however, observe that approximately 10% of the 
“contaminating genera” in our run have previously been reported from laboratory reagents (Table 
3). We suspect that the most influential factor for contamination in our study was the process of PCR 
amplification.20,76,103 Since all “sequencing reactions” in our study underwent repeated amplification 
of the same target sequence, and were possibly exposed to aerosolized amplicons with high copy 
numbers of the target genes;104 we suspect that contamination most likely resulted from cross-
contamination during library preparation.21 It has been reported that high copy numbers of the 
target sequences (evident for faecal specimens)105–108 may result in cross-contamination during 
amplicon generation.21 Moreover, studies have shown that the use of low template concentrations 
during amplification (evident for a number of our specimens) may result in contaminants being 
amplified instead of the desired template.109,16,110,22,111 We also observed DNA from our two non-
template controls after the process of amplification (as indicated in Section 2.3.3) which supports 
our suspicion of possible cross-contamination during library preparation. Furthermore, we also 
found that the majority of genera contaminating our non-template controls were in actual fact 
genera commonly found within the human GIT (Table 3). Another potential source for 
contamination is the use of contaminated laboratory equipment. This has been previously reported, 
for example, as carryover between consequtive MiSeq runs.112 In our study, however, it is highly 
unlikely for the latter to have occurred since we observed amplification of the 16S rDNA fragment in 
the two non-template controls prior to sequencing.  
 Salter and colleagues55 have provided a number of precautionary steps to minimize the 
impact of contaminants in high-througput sequencings studies. Some of these include minimising 
the risk of sample collection contamination; inclusion of technical controls (which may include 
storage, extraction kit, or PCR reagents) during each step of the laboratory workflow; treatment of 
reagents used for DNA extraction; using increased amounts of DNA yields as starting material during 
library preparation; treatment of reagents used for the process of PCR; quantification of negative 
controls and specimens of interest throughout the entire laboratory workflow in order to assess 
when contamination as it arises; and computationally controlling for negative controls when 
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analysing sequencing data. Since we were not in the position to repeat any experimental 
procedures, we decided to correct for the contaminants observed in our sequencing experiment by 
computationally removing OTUs representing “contaminating genera” from our faecal specimens. 
Following correction for contamination we noticed a 10% reduction in the number of OTUs classified 
from our faecal specimens. However, we do believe that it would be unlikely that this reduction 
would have any significant impact on downstream data analysis. The reason for this being that the 
OTUs present in our non-template controls were very low in numbers compared to their numbers in 
faecal specimens. In addition, the fact that these “contaminating genera” were highly abundant in 
our faecal specimens shows that the contaminants in our non-template controls represented genera 
naturally inhabiting the faecal specimens under study (supported by findings from the literature 
summarised in Table 3). In reality, exogenous microbial DNA representing contamination is to some 
extent a problem for every microbiome dataset;100 however, the steps used to control or remove 
these contaminants during sequencing or computational processes is what adds to the credibility of 
high-throughput sequencing results.  
 Also of concern when conducting 16S rRNA-based high-throughput sequencing studies is low 
template concentrations which may not only be highly susceptible to external contaminants,21 but 
may also result in less reproducible results.14 This is of great concern when performing diversity 
measurments.15 Since the poorest sequencing reproducibilities observed in our study were 
associated with meconium specimens which had the lowest DNA yields used during library 
preparation; our findings are in support of those from Kennedy et al. (2014) reporting a relationship 
between low DNA concentrations and low reproducibility.14 Interestingly, not only did the infant 
meconium specimens included in this study associate with less reproducible results, but these 
specimens also produced the lowest amplicon concentrations and quality scores compared to any of 
the other “groups under study”. This clearly highlight that low template concentrations incorporated 
during library preparation have a number of downstream effects on sequencing data. The low 
template concentrations extracted from meconium specimens in our study may be explained by the 
actual nature of the specimen rather than it resulting from the nucleic acid extraction process itself. 
The reason for this being that the faecal specimens included in this study provided significantly 
higher concentrations compared to the meconium specimens. In addition; we also used a nucleic 
acid extraction assay which have been reported to provide high quantities of DNA from faecal 
specimens.27 Despite these findings from the meconium specimens under study; we did in actual fact 
observe an increase in reproducibility as DNA concentrations increased. This again is in support of 
the findings by Kennedy and colleagues.14 We are, however, not in the position to compare our 
reproducibility measures with the literature, since we are not aware of any studies reporting on 
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reproducibility after conducting Illumina Miseq sequencing on faecal specimens. In addition, high-
throughput sequencing data may vary substantially across studies due to factors such as the number 
of repeats analysed,15 sampling methods and the type of specimen analysed,15 as well as a number 
of machine artifacts, such as sequencing errors.113 
 An interesting finding from this study was that the meconium specimens, from which the 
lowest DNA concentrations were extracted, also produced the highest number of reads and intra-
individual bacterial diversity, but the lowest numbers of OTUs. These dynamics are difficult to 
explain since we could not find any strong correlations between DNA yields, the number of reads 
sequenced, intra-individual bacterial diversities, nor the number of OTUs classified when assessing 
all “groups under study” (n = 305) (Table 4). We did, however, observe a weak positive correlation 
between the number of reads sequenced and the number of OTUs classified for infants sampled at 
birth; while maternal faecal specimens showed a very strong positive correlation. These interesting 
correlations, together with the summary statistics presented in Figures 14 and 17, indicate that   
infant meconium specimens produced more reads and less OTUs compared to maternal faecal 
specimens. A possible explanation for this may be that meconium specimens simply had more of the 
same reads (duplication of reads) sequenced which resulted in less OTUs being classified. These 
observations, however, does not necessarily suggest that meconium specimens are less diverse due 
to less OTUs being classified. This may be explained by the definition of the Shannon diversity index, 
used to calculate the bacterial diversity within a specimen (intra-individual diversity). Since the 
Shannon diversity index is based on both the number of OTUs (richness) and their distribution 
(evenness) within a specimen; intra-individual diversity does not necessarily suggest that high 
numbers of OTUs were classified from a specimen. This was clearly highlighted by the moderate 
negative correlation found when correlating the high number of OTUs classified from all maternal 
faecal specimens with their low intra-individual diversity indices. In addition, only faecal specimens 
sampled from infants at 4-12 weeks of age showed a very strong positive correlation when 
correlating their numbers of OTUs to their Shannon diversity indices.  
 Since DNA yields are commonly included when evaluating the DNA extraction methods for 
microbial community analyses;27,114–116 we decided to also determine the effect of DNA yields used 
during library preparation on the microbial diversity obtained from sequencing data. Interestingly, 
we found only weak negative correlations when determining the effect of DNA yield on bacterial 
diversity measures. These weak negative correlations, together with previous reports that maximal 
DNA yields are not a guarantee for maximal microbial diversity,117,118 emphasises that extraction 
protocols should be optimized for extracting the best representatives of the microbial community 
instead of aiming for high DNA yields only.118  
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 In contrast to the weak correlations between DNA yields and bacterial diversity indices; our 
study shows that the lower the DNA yields used during library preparation, the lower the 
reproducibility of the sequencing run. What’s more is that the reproducibility of a sequencing run 
has been reported to also affect diversity measures.15 Therefore, taking into account the low DNA 
yields, the low sequencing reproducibility, and the very high intra-individual diversity indices 
obtained for our meconium specimens; we are under the impression that diversity measures 
obtained from meconium specimens may have been skewed. In support of this, are the reports from 
previous studies indicating that intra-individual diversity is lowest during infancy and increases with 
age.88,119 In support of our opinion of a skewed intra-individual diversity for meconium and in 
agreement with previous studies88,119 we did observe an increasing trend in intra-individual diversity 
from our infant faecal specimens sampled from 4-12 to 20-28 weeks of age. Maternal faecal 
specimens also had higher intra-individual diversities compared to infant faecal specimens sampled 
at later stages in life. These findings suggest the importance of optimal DNA yields for library 
preparation, as it may not only affect sequencing reproducibility but may also subsequently 
influence bacterial diversity estimations.14 
 
2.5  Conclusion 
 
 We emphasize that microbiome studies, aiming to characterize bacterial communities from 
faecal specimens, first and foremostly need to ensure that optimal DNA extraction methods are 
used. We found that low DNA yields not only result in less reproducible results, but may in turn also 
impact on bacterial diversity measurements. Another critical step in high-throughput sequencing 
studies is to incorporate computational workflows in order to trim and select for good quality reads. 
This was clearly highlighted by the significant reduction in the number of reads resulting from quality 
control measures other than those performed by the sequencing platform’s software. Finally, 
findings from this study and previous reports reinforced the need for including non-template 
controls during the DNA extraction process, library preparation and sequencing steps. This will allow 
researchers to effectively trace the source of contamination and to repeat experimental procedures 
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A)  Preparation of Tris-HCl, pH 8.0 + 0.05% Tween-20 Solution 
1. Add 500 μL of the 1 M Tris-HCl, pH 8.0 buffer solution to 49.5 ml of Molecular Biology 
grade water. 
2. Measure out 49.25mL of 1X TE  
3. Using a genomic pipette tip, measure out 25 μL of Tween-20. 
4. Mix thoroughly. 
5. Label bottle with the name of the solution, date prepared, and preparer’s initials.   
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Bacterial colonization of the GIT in utero has recently become a topic of great interest. 
Meconium microbiota have been associated with health disorders (neonatal sepsis, mucus 
congestion and premature birth) and have also been suggested as potential contributors to GIT 
bacterial profiles later in life. To date, few studies, using high-throughput sequencing, have included 
meconium specimens in longitudinal studies of early life faecal bacterial profiles of healthy term 
infants. The aims of this chapter were i) to molecularly characterize the maternal and infant faecal 
microbiota up until seven months of life, ii) to assess whether maternal faecal microbiota is a 
possible source of the infant’s GIT bacteria, and iii) to study the dynamics of infant faecal bacterial 
profiles over time. 
We applied high-throughput sequencing of the 16S rRNA gene to study the microbiota from 
meconium specimens and maternal faecal specimens collected at birth; as well as a subset of infant 
faecal specimens up until seven months of age. Diversity measures used included Shannon diversity 
and Bray Curtis dissimilarity indices. We constructed lambda scaled log ratio biplots of specimens to 
determine differences between them based on significantly different operational taxonomic units 
(OTUs). We used generalized linear and mixed models to determine the effect of external factors on 
microbial profiles; and to determine significant differences in OTUs from mothers and their infants 
and from infants over time.   
Bacterial profiles were obtained from 90 maternal faecal specimens; 107 meconium; and 72 
and 36 infant faecal specimens sampled at 4-12 and 20-28 weeks, respectively. Meconium 
specimens harboured the most diverse bacterial profiles, and (based on relative abundances of 
OTUs) harboured mainly the phylum Proteobacteria (60%). The phylum Firmicutes was most 
abundant at 4-12 weeks (49%) and 20-28 weeks (64%) of life. The phylum Actinobacteria was at its 
highest at 4-12 weeks of age (26%), followed by 20-28 weeks (9%). Maternal faecal specimens were 
mainly colonized by the phylum Firmicutes (79%). Infant faecal bacterial profiles became more adult-
like over time; however no individual mother-infant pairs clustered at any timepoint studied. The 
most influential factor for changes in bacterial profiles was the increase in infant age.  
Altogether, our results indicate that meconium specimens are diversely colonized by 
bacteria and are influenced by factors such as maternal education and gender. An interesting finding 
in our study was the association between maternal HIV status and bacterial diversities from infant 
faecal specimens sampled at 4-12 weeks of age. In general, meconium and faecal bacterial profiles 
are distinct from maternal faecal bacterial profiles, but the infant’s microbiota do become more 
adult-like over time. 
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3.1  Introduction 
 
 The human GIT microbiota have been described as a ‘plastic’ entity with a number of 
environmental factors influencing its composition.1 Early life bacterial colonization has 
conventionally been reported to start at birth;2 and factors such as mode of delivery,3–6 feeding 
practices,6–8 weaning,9–11 geography12,13 as well as the use of antibiotics14 have been considered as 
key contributors to these profiles. However, recent studies suggest that bacterial colonization occurs 
prior to the process of birth by identifying microbes from the previously considered “sterile” 
womb15–19 as well as the newborn’s meconium.20–22 These findings raised questions on the origin of 
the bacteria found in the womb and meconium, and have also contributed to delineate different 
hypotheses. These hypotheses suggest either translocation of cervical and vaginal bacteria to 
amniotic fluid23–25 or dissemination of maternal (oral or GIT lumen) bacteria into the maternal 
bloodstream followed by transplacental invasion17,23,26–32 (described in Section 1.4.3 of Chapter 1). 
 Since our study focusses on characterising bacterial profiles from infant meconium and 
faecal specimens together with maternal faecal specimens; we found the hypothesis suggesting 
transfer from the maternal GIT lumen to the infant’s GIT most interesting.20,23 Despite the supporting 
data from the murine model study showing that bacterial strains orally administered to pregnant 
mice are indeed detected from the fetal meconium specimens;20 studies comparing human infant 
meconium bacterial profiles to those from parent faecal bacterial profiles have provided conflicting 
results.21,33 Despite these inconsistent findings, studies have not yet directly addressed this 
hypothesis by including a range of specimens such as meconium, amniotic fluid, umbilical cord 
blood, placental and maternal faecal specimens on large scale. In addition, factors influencing the 
meconium microbial profiles are still understudied.33 
 Bacterial colonization patterns early in life is a key determinant of microbial profiles34 as well 
as disease states in both early2,35–37 and in later stages of life.38–40 Of note, specific meconium 
microbiota profiles have been linked to early life disease states such as neonatal sepsis,41 infant 
mucus congestion,21 and premature birth.15 Meconium microbiota may also contribute to the 
development of GIT microbial profiles later in life. This concept is supported by the work of Gosalbes 
and colleagues21 which showed similarities between meconium and faecal specimens collected 
during the first few months of life. Other studies have also reported on the important role of early 
life colonizers in preparing the environment for successive bacterial colonization.42,43 
 To date, only a few studies have included meconium specimens when longitudinally studying 
changes in early life faecal bacterial profiles of healthy term infants.21,44 Therefore, the use of larger 
sample sizes may be very useful to determine what a healthy meconium microbiota looks like; to 
determine its roles in influencing successive faecal bacterial profiles; and to determine which 
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prenatal factors may influence the meconium microbiota. This chapter therefore aimed, using a 
larger sample size, to (i) characterise the maternal and infant faecal microbiota; (ii) to assess 
whether the maternal GIT microbiota is a possible source of the infant’s GIT inhabitants; iii) to 
investigate how infant bacterial profiles change during the first seven months of life; and iv) to 
determine factors that may influence the maternal and infant faecal bacterial communities in our 
study population.  
3.2   Materials and methods 
3.2.1  Ethics statement 
Both the DCHS and our pilot study received approval from the Faculty of Health Sciences, 
HREC of the University of Cape Town, South Africa. The HREC reference numbers assigned for these 
studies were 401/2009 (DCHS) and 742/2013 (this study). 
3.2.2  Study population and sample selection 
This pilot study was nested within the DCHS,45 as described in detail in Chapter 2 (Sections 
2.2.1 to 2.2.3). The aim of this pilot study was to include as many specimens as possible from 
mothers and their infants at birth. In addition, the study included a subset of longitudinal specimens 
from infants up to the age of seven months. The main criteria when selecting maternal and infant 
specimens from the DCHS database was that specimens were sampled at birth. The second criterion 
was that faecal specimens collected at later timepoints had to be from infants from which samples 
were collected at birth, and collections had to have taken place within the timeframes 4 and 12 
weeks or 20 and 28 weeks of age. The term “groups under study” will be used when referring 
collectively to infant and maternal specimens in subsequent sections. 
3.2.3 Laboratory processing of faecal specimens and16S ribosomal DNA sequencing 
A detailed description of the laboratory processing of faecal specimens and the approach to 
Illumina Miseq sequencing is summarised in Chapter 2 (Sections 2.2.4 to 2.2.7). Briefly, nucleic acid 
extractions took place from  50 mg of faecal specimen using the QIAsymphony DSP Virus/Pathogen 
Mini Kit® (Qiagen GmbH, Hilden, Germany) (Section 2.2.5). These extracts served as template during 
library preparation for 16S ribosomal DNA sequencing (Section 2.2.6). The V4 hypervariable region of 
the 16S rRNA gene was targeted using previously published primers 515F and 806R.46 Quantification 
of purified pooled PCR products took place using the KAPA Library Quantification Kit K4835 (KAPA 
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Biosystems, MA, USA) as per manufacturer’s instructions, with slight modifications. We prepared 
sequencing reagents and the DNA library using the MiSeq Reagent Kit v3, 600 Cycles (Illumina, CA, 
USA) as per manufacturer’s instructions (Section 2.2.7).47,48  
 
3.2.4 Bio-informatics workflow and data manipulation 
 The bioinformatics workflow used in this study to classify 16S rRNA sequences to bacterial 
taxonomies in this study is referred to as YAP49 and is described in detail in Section 2.2.8 of Chapter 
2. In addition to the YAP workflow, we also corrected for potential contamination, which is described 
in Section 2.2.9.3 of Chapter 2. 
 
3.2.5  Data analysis and statistics 
  We used R software version 3.1.150 together with RStudio version 0.98.50751 for all data 
analyses. The OTU table constructed at 97% sequence similarity (genus-level), and corrected for 
contamination (described in Section 2.2.9.3 of Chapter 2), was selected for data analysis. 
 
3.2.5.1  Demographic and clinical characteristics of participants 
 In order to describe participant characteristics we used the [summ] and [tab1] functions of 
the R package epicalc.52  
 
3.2.5.2  Calculating inter-individual (beta) diversity 
In order to determine the dissimilarity between faecal specimens, we used the Bray Curtis 
dissimilarity index53,54 (equation 4.1) due to its general suitability for ecological data.55,56 In order to 










Where,  𝑥𝑘1 = abundance of species 𝑘 in sampling unit 1 
𝑥𝑘2 = abundance of species 𝑘 in sampling unit 2, and 
𝑷 is the total number of species recorded across both units. 
 
In this study, the Bray Curtis dissimilarity index measured the distance between faecal specimens 
based on their OTU composition, as explained in Table 5. Measures ranged from 0 to 1, where 
dissimilarity measures closer to zero indicated that communities are more similar in their 










each OTU from 
specimen 1 (𝒙𝟏) 
Relative 
abundance of 
each OTU from 
specimen N (𝒙𝑵) 
Absolute difference between 
abundances of each OTU 
from specimen 1 and N  
|𝒙𝟏 − 𝒙𝑵| 
Sum of abundances of 
each OTU from 
specimen 1 and N 
(𝒙𝟏 + 𝒙𝑵) 
Bray-Curtis 
dissimilarity index 










OTU B  0.025 0.000 0.025 0.025 
OTU C 0.375 0.500 0.125 0.875 
OTU X 0.225 0.300 0.075 0.525 
OTU Z 0.125 0.200 0.075 0.325 
SUM 1.000 1.000 0.550 2.000 
 
3.2.5.3  Clustering of faecal specimens 
We used the [hclust] function from the built-in R package stats50 to perform agglomerative 
clustering using Complete Linkage (also referred to as furthest neighbour clustering).55 We made use 
of the Bray-Curtis dissimilarity index (calculated in Section 3.2.5.2) to calculate the matrix used 
during the agglomerative clustering. Clustering was performed on all OTUs with a relative 
abundance > 0.5%. The OTUs with a relative abundance of < 0.5% (referred to as “other”) are 
graphically represented according to the clustering of the OTUs with a relative abundance > 0.5%. 






























Figure 21. Clustering of faecal specimens based on their OTU compositions 
Each small filled circle which has a number allocated represents an OTU. Each of the bigger filled circles represents a 
specimen containing OTUs. A) The Bray Curtis dissimilarity index calculates the distance between specimens, based on 
their OTU composition. B) The dissimilarity matrix is used to assign specimens to clusters based on the distances between 
specimens. C) Complete linkage then uses the Bray Curtis dissimilarity index to compute distances between the furthest 
OTUs from each cluster. D) The first cluster is formed between the two original clusters with the smallest dissimilarity. E) 
The second cluster is formed between the next set of clusters with the smallest dissimilarity. F) The procedure continues 
until all clusters are linked and a G) dendogram can be drawn. 
 
3.2.5.4  Multidimensional scaling of clusters 
In the previous section, dendograms are drawn to avoid crossing of lines and do not provide 
information on the similarity between adjacent clusters. In order to determine how similar clusters 
were, we performed multidimensional scaling (MDS)58 on each of the clusters from the dendograms. 
Clusters were represented in MDS plots as pie charts summarising the proportions of OTUs within 
each of the clusters. We used the [smacofSym] function from the R package smacof59 to perform 
MDS, using the Bray-Curtis dissimilarity matrix as “input data”. The aim of MDS is to represent the 
clusters such that the ordinary Euclidean distances between clusters in the plot match as closely as 
possible the Bray-Curtis distances between the cluster means. 
 
3.2.5.5  Constructing biplots using sequencing data 
 Data output resulting from high throughput sequencing is in the form of count data.60 Due to 
the variation in the total number of reads sequenced across different specimens within a single 
run,61 count data needs to be transformed to compositional data by calculating the relative 
abundance of each OTU per specimen.61,62 
Since we were dealing with compositional data, we constructed log-ratio biplots,63 in which 




study” were used. We also made use of lambda scaling in our log-ratio biplots to ensure evenness in 
the “total spread” of each of the data sets (OTUs and specimens).64 Lambda scaling adjusted for 
plots where one set of data points are plotted on top of each other; and data points from the other 
set are plotted further apart.  
The use of log-ratio methodology, was made possible by first transforming count data to 
compositional data.61,62 We then adjusted the data in a Bayesian context65 to remove zeros.66 
Aitchinson and Greenacre (2002), shows that constructing a log ratio biplot is essentially equivalent 
to performing the central log ratio transformation.62,67 The first step was to replace zero-values with 
non-zero values. The second step was to correct for the added non-zero values across all specimens 
within the respective taxa. This ensured that the compositional total after adjustment did not 
change. The transformation of count data to compositional data and the adjustment for zeros are 
explained using one specimen with three taxa (X, Y, Z), outlined in Tables 6 and 7. The examplar 
table, Table 6, presents OTUs in the form of count data prior to adjustment for zeros, while the 



















Table 6. Example of a “count data” OTU table prior to adjustment for zeros 
Taxon Specimen 1 Specimen 2 Specimen 3 Specimen N 
X 4 0 2 5 
Y 5 10 0 0 
Z 0 12 4 5 
Total 9 22 6 10 
 
An example of adjustment for zeros (using Specimen 1 as example): 











Step 2: Calculate a non-zero value to replace the zero: 
 Fraction of zeros present in Specimen 1 =  
1 
3 
= 0.333  
 Non zero value for Specimen 1 =
Fraction of zeros present in Specimen 1




  =  0.033 =  
1
30
   
 











Step 4: Subtract the non-zero value added to Specimen 1 from the remaining taxa in Specimen 1: 






= 1    [i] 











 In order to obtain the new total we need to have: (𝑠𝑜𝑚𝑒𝑡ℎ𝑖𝑛𝑔 <
4
9






    [ii] 
 
Step 5: Multiplying all components of equation [i] with 
29
30


























We subtracted more from Taxon Y than from Taxon X since Taxon Y had a greater number of OTUs compared to Taxon X.  
 Start with: 0.4444 + 0.5556 + 0 = 1 
 End with: 0.4296 + 0.537 + 0.0333 ≅ 1 
This ensures that the reduction of the added non-zero value takes place in a proportionate manner. 
Table 7. Example of a “compositional data” OTU table resulting from adjustment for zeros  
Taxon Specimen 1 Specimen 2 Specimen 3 Specimen N 
X 0.43 0.15 0.32 0.48 
Y 0.54 0.45 0.05 0.03 
Z 0.03 0.52 0.63 0.48 
Total ~1.00 ~1.00 ~1.00 ~1.00 
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3.2.5.6  Fitting of generalized linear models  
 We performed hypothesis testing at a 5% significance level while controlling for the false 
discovery rate described by Benjamini & Hochberg.68 Generalized linear models (GLMs) tested the 
effect of risk factors on the composition and diversity of the maternal and infant faecal microbiota 
profiles, respectively. We tested GLMs on all OTUs sequenced; on OTUs with a relative abundance 
greater than 0.25%; and on OTUs with a relative abundance greater than 0.5%. Final models were 
based on OTUs with a relative abundance greater than 0.5%. 
 In general, the Poisson distribution model (equation 4.2) is used to model count data.69,70 
Modelling count data variance, using the Poisson distribution models, assumes that the variance in 
the data is equal to its mean (𝑣𝑎𝑟(𝑌𝑖) = 𝐸(𝑌𝑖)). However, the variance in count data obtained from 
high-throughput sequencing exceeds its mean (𝑣𝑎𝑟(𝑌𝑖) < 𝐸(𝑌𝑖)) and is referred to as being over-
dispersed.69,71 An alternative choice to Poisson modelling is the negative binomial distribution. This 
distribution provides a model (𝑣𝑎𝑟(𝑌𝑖) = 𝜙𝐸(𝑌𝑖)) which allows for over-dispersion, as 𝜙 > 1 is a 
parameter that can be estimated. We implemented the negative binomial model in RStudio51 
through the family function quasipoisson. To account for compositional data (instead of count 
data)62 in our model, we specified the offset as equal to “root OTU counts” during modelling.72 The 
parameters of a GLM are estimated by the iterative weighted least squares method, implemented in 
R in the function [glm] in the built in package stats.50 
 
log(𝑌) =  𝛽0 +  𝛽1𝑥1+ . . . . . + 𝛽𝑛𝑥𝑛 + 𝑒𝑟𝑟𝑜𝑟     
 
log(𝑌) = 𝜇 + log(𝑜𝑓𝑓𝑒𝑠𝑡) + 𝛽1(𝑏𝑖𝑟𝑡ℎ 𝑤𝑒𝑖𝑔ℎ𝑡) + 𝛽2(𝑏𝑖𝑟𝑡ℎ 𝑙𝑒𝑛𝑔𝑡ℎ) + 𝛼𝑔𝑒𝑛𝑑𝑒𝑟 + 𝛼𝑚𝑜𝑚−𝑒𝑑𝑢 + 𝛼𝑎𝑟𝑒𝑎
+ 𝛽3(𝑔𝑒𝑠𝑡𝑎𝑡𝑖𝑜𝑛 𝑎𝑔𝑒) + 𝛼𝑑𝑒𝑙𝑖𝑣𝑒𝑟𝑦 + 𝛼𝑚𝑜𝑚𝐻𝐼𝑉 + 𝜀𝑖𝑗 
 
Where, 𝑌 = OTU count for the taxon currently tested 
𝑜𝑓𝑓𝑒𝑠𝑡 = root OTU count 
𝜇 = overall mean effect 










 the parameters to be estimated for the mother’s education effect with 𝛼𝐺𝑟1−7 + 𝛼𝐺𝑟8−11 + 𝛼𝐺𝑟12 +












 the parameters to be estimated for the gender effect with 𝛼𝑝𝑜𝑠 + 𝛼𝑛𝑒𝑔 = 0 
 
3.2.5.7  Fitting of generalized linear mixed models 
We performed hypothesis testing at a 5% significance level while controlling for the false 
discovery rate described by Benjamini and Hochberg.68 Generalized linear mixed models (GLMMs) 




changes in an infant’s bacterial profile over time. It is shown in a paper by Cnaan and colleagues73 
that the model is formulated in a two-stage approach. The first stage models the mothers and their 
infants or infants followed over time and the second stage models the individuals at each time point. 
Cnaan and colleagues73 explains that all observations on the same pair will have the same between-
pair errors, but stage two allows for different within-pair errors. By fitting this model, the within-pair 
differences (differences between mother and infant or infants over time), can be tested without 
being confounded with between-pair differences.The models were fitted with the glmmPQL function 




3.3   Results 
 
3.3.1 Participant characteristics 
Table 8 summarises the clinical and demographical characteristics of the study participants. 
The study included faecal specimens from 90 mothers. The median age of mothers providing faecal 
specimens was 25 years (IQR; 22.2 - 32.1). The two residential areas were represented by similar 
numbers of mothers, with 9% more mothers residing in the area TC Newman. Most of the mothers 
included in this study had some form of secondary-level education, Grade 8-12 (84.5%), and were 
HIV negative (80%). Maternal faecal specimens sampled at birth were matched to 90 meconium 
specimens sampled from infants at birth; 72 infant faecal specimens sampled at 4-12 weeks of age; 
and 36 infant faecal specimens sampled at 20-28 weeks of age. The median age for the 107 infants 
providing meconium specimens at birth was 0 weeks (IQR; 0 - 0). The 72 infants providing faecal 
specimens at 4-12 weeks had a median age of 7 weeks (IQR; 6.8 - 8.3) and the 36 infants providing 
faecal specimens at 20-28 weeks had a median age of 24 weeks (IQR; 23 - 26). At all time-points, 
infant faecal specimen collections were slightly higher from the residential area Mbekweni, when 
compared to the residential area TC Newman. We also observed that the majority of infants had 
mothers with an secondary education level of Grade 8-12 at any of the three time points studied. 
The HIV status of infants is referred to as “HIV-exposed” if their mothers were tested HIV-positive or 
“HIV-unexposed” if their mothers were tested HIV-negative. The majority of infants were HIV-
unexposed, of which none tested positive for HIV infection. The median gestational age of infants 
participating in this study was 39 weeks (IQR; 38 - 40); the median birth weight was 3 kilogram (kg) 
(IQR; 2.7 - 3.3); and the median birth length was 51 centimeter (cm) (IQR; 48.5 - 53.0). At any of the 
timepoints under study, the majority of infants (80.5 - 83.3%) were delivered via vaginal delivery. We 
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also observed a relatively similar distribution for gender with 45 - 50% of infants being males across 
all timepoints. We found that breastfeeding at six to ten week of age was recorded for more than 
70% of the infants at 4-12 (72.5%) and 20-28 weeks of age (71.4%). Almost 80% of the infants 
studied at 20-28 weeks received breastfeeding at 14 weeks of life and 66% of these infants received 
breastfeeding at six months of life. Formula feeding was recorded for eight infants during the first 
week of life; for 13 infants during the first month of life; for 17 infants during the first two months of 
life; and for 20 infants during the first four months of life. The introduction of solid food was 
recorded for 18 infants studied at 4-12 weeks of age; for which three infants received solid food at 
one month of age, nine infants received solid food at two months of age and six infants received 
solid food at three months of age. With regards to the subset of infants studied at 20-28 weeks, 30 
infants had received solid foods at some point during the first six months of life. Two of the infants 
studied at 20-28 weeks received solid food at one month of age, five at two months, four at three 
months, two at four months, six at five months and 11 at six months of age. 
 
Table 8. Demographic and clinical characteristics of maternal and infant participants  
Participant characteristics Participants (%) Median (IQR) 
   
Mothers (n = 90)   
Age at which specimens were collected (years)  25.2 (22.2 - 32.1) 
Residential area   
TC Newman 49 (54.4)  
Mbekweni 41 (45.6)  
Maternal education   
Primary education (Grade 1 to 7) 8 (8.9)  
Secondary education (Grade 8 to 11) 43 (47.8)  
Secondary education (Grade 12) 33 (36.7)  
Tertiary education (enrolment/completion) 6 (6.7)  
Maternal HIV status at time of delivery   
HIV-positive 18 (20)  
   
Infants at birth (n = 107)   
Age at which specimens were collected (weeks)  0 (0 - 0) 
Residential area   
TC Newman 49 (45.8)  
Mbekweni 58 (54.2)  
Maternal education   
Primary education (Grade 1 to 7) 11 (10.3)  
Secondary education (Grade 8 to 11) 49 (45.8)  
Secondary education (Grade 12) 39 (36.5)  
Tertiary education (enrolment/completion) 8 (7.5)  
Maternal HIV status at time of delivery   
HIV-positive 26 (24.3)  
Gestational age (weeks)  39 (38 - 40) 
Birth weight (kg)  3 (2.7 - 3.3) 
Birth length (cm)  50 (48 - 53) 
Mode of delivery   
Vaginal delivery 87 (81.3)  
Gender    
Male 48 (44.9)  
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Table 8. Demographic and clinical characteristics of maternal and infant participants (continued) 
Participant characteristics Participants (%) Median (IQR) 
   
Infants at 4-12 weeks (n = 72)   
Age at which specimens were collected (weeks)  7 (6.8 - 8.3) Ϯ 
Residential area   
TC Newman 30 (41.7)  
Mbekweni 42 (58.3)  
Maternal education   
Primary education (Grade 1 to 7) 8 (11.1)  
Secondary education (Grade 8 to 11) 31 (43.0)  
Secondary education (Grade 12) 29 (40.3)  
Tertiary education (enrolment/completion) 4 (5.6)  
Maternal HIV status at time of delivery   
HIV-positive 19 (26.4)  
Gestational age (weeks)  39 (38 - 40) 
Birth weight (kg)  3.1 (2.7- 3.4) 
Birth length (cm)  51 (49 - 53) 
Mode of delivery   
Vaginal delivery 60 (83.3)  
Gender    
Male 33 (45.8)  
Breastfed at 6-10 weeks of age 50 (72.5) ǂ  
Formula feeding  16 (38.1) δ  
Introduction of solid food recorded from 1-3 months of age 18 (25)  
   
Infants at 20-28 weeks (n = 36)   
Age at which specimens were collected (weeks)  24 (23 - 26) 
Residential area   
TC Newman 16 (44.4)  
Mbekweni 20 (55.6)  
Maternal education   
Primary education (Grade 1 to 7) 7 (19.4)  
Secondary education (Grade 8 to 11) 14 (38.9)  
Secondary education (Grade 12) 13 (36.1)  
Tertiary education (enrolment/completion) 2 (5.6)  
Maternal HIV status at time of delivery   
HIV-positive 10 (27.8)  
Gestational age (weeks)  39 (38.8 - 40) 
Birth weight (kg)  3.0 (2.6 - 3.3) 
Birth length (cm)  50.5 (49 - 53) 
Mode of delivery   
Vaginal delivery 29 (80.5)  
Gender    
Male 18 (50.0)  
Breastfed at 6-10 weeks of age 25 (71.4) φ  
Breastfed at 14 weeks of age 23 (79.3) ψ  
Breastfed at 6 months of age 21 (65.6) ϴ  
Formula feeding  2 (10) ᵹ  
Introduction of solid food recorded from 1-6 months of age 30 (83.3)  
IQR: interquartile range;  
Number of observations recorded: Ϯ 71/72; ǂ 69/72; δ 42/72; φ 35/36; ψ 29/36; ϴ 32/36; ᵹ 20/36 
116 
 
3.3.2 Microbial profiles from all “groups under study” 
Most of the OTUs sequenced from all “groups under study” (n = 305) represented taxa from 
the domain Bacteria (99.88%). The remaining 0.12% of OTUs sequenced represented taxa from the 
domain Archaea (0.11%) as well as unclassifiable taxa (0.01%). Because the domain Bacteria is our 
main interest, the remainder of this section will focus on describing bacterial taxa sequenced from 
all “groups under study”.  
We classified 51 phyla from all “groups under study” (n =305) of which 28 phyla had relative 
abundances > 0.5% and 23 phyla had relative abundances < 0.5% (herein referred to as “other”). The 
most abundant phyla included the Firmicutes (50.44%), Proteobacteria (28.13%), Actinobacteria 
(13.54%), Bacteroidetes (5.39%) and an unclassified (1.33%) phylum. The remaining 23 phyla, which 
had relative abundances < 0.5%, constituted 1.17% of all OTUs classified at phylum-level. At class-
level, only 11 of the 55 bacterial classes obtained in this study had relative abundances > 0.5%. The 
most abundant bacterial classes were Clostridia (32.86%), followed by the class Actinobacteria 
(13.54%) and the class Gammaproteobacteria (12.75%). At order-level, 23 of the 97 orders 
successfully classified had relative abundances > 0.5%. Of these, the order Clostridiales (32.71%) was 
most abundant, followed by the order Lactobacillales (9.36%). At family-level, 39 of the 222 families 
had relative abundances > 0.5%. The most abundant families obtained in this study were the 
Lachnospiraceae (17.70%) and Ruminococcaceae (7.29%). At genus-level, 616 genera were obtained, 
of which 49 had relative abundances > 0.5%. The most abundant genera were an unclassified genus 
(6.95%) within the phylum Firmicutes, followed by the genus Bifidobacterium (6.61%). Relative 
abundances for all bacterial taxa from the faecal specimens under study are summarised in 
Supplementary table S1. 
 
3.3.3 Comparison of microbial profiles from infant and maternal faecal specimens 
sampled at birth 
The following section reports the relative abundance of bacterial OTUs classified from 107 
meconium specimens and 90 maternal faecal specimens sampled at birth. We also provide data 
comparing 90 meconium specimens, to their matched maternal faecal specimens sampled at birth. 
Descriptions are provided at both phylum- and genus-level for bacteria with proportions greater 
than 0.5% and those with less than 0.5%.  
 
3.3.3.1  Microbiota profiles at the phylum-level 
The most abundant phylum identified from infant meconium specimens (n = 107) was the 
phylum Proteobacteria (59.67%), followed by the phyla Firmicutes (22.91%), Actinobacteria (9.56%), 
and Bacteroidetes (4.31%) (Table S2). Overall, the phyla at abundances < 0.5% represented 2.38% of 
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all bacteria within infant meconium specimens. Of these, the phylum Cyanobacteria Chloroplast 
(0.46%) was most abundant, followed by Deinococcus Thermus (0.31%), Verrucomicrobia (0.18%), 
Chloroflexi (0.17%) and Fusobacteria (0.16%) (Table S3). In maternal faecal specimens collected at 
delivery (n = 90), the phylum Firmicutes (79.39%) was most abundant, followed by the phylum 
Bacteroidetes (7.06%), Actinobacteria (5.77%), Proteobacteria (4.71%) and unclassified phyla 
(2.44%) (Figure 22C and Table S2). The phyla at abundances < 0.5% represented 0.62% of all bacteria 
within maternal faecal specimens. Of these, the most abundant phyla were Euryarchaeota (0.23%) 
and Verrucomicrobia (0.17%) (Table S3 and Figure 22D). 
Based on the clustering analysis of OTUs with abundances > 0.5% from 90 mother-infant 
pairs, two primary clusters were identified at phylum-level, and tentatively named clusters M and B 
(Figure 22A). The primary cluster M consisted of three sub-clusters (sub-clusters no. 1, 2 and 3). Two 
of these sub-clusters (sub-clusters no. 1 and 2) consisted mainly of maternal faecal specimens, for 
which two infant meconium specimens (B_44 and B_106) clustered within sub-cluster no. 1. Sub-
cluster no. 3 consisted of 11 infant meconium specimens. The primary cluster B of Figure 22A also 
consisted of three sub-clusters (sub-clusters no. 4, 5 and 6). All three these sub-clusters consisted of 
infant meconium specimens, with the exception of one maternal faecal specimen (M_45) clustering 
within sub-cluster no. 6. The meconium specimen (B_67) clustered by itself within sub-cluster no. 5 
and contained only two phyla at abundances > 0.5%, of which the phylum Proteobacteria was most 
abundant (Figure 22C). Following the clustering analysis, we plotted the participant characteristics 
for each of the participants against the position of their specimen within the dendogram. Except for 
the sample type (maternal versus infant), we did not observe any pattern of participant 





























































Figure 22. Phylum-level bacterial profiles of infant meconium and maternal faecal specimens sampled at birth 
A) Dendogram of phylum-level bacterial profiles for infant meconium (n = 90) and maternal faecal (n = 90) specimens sampled at birth; B) Participant characteristics for each of the specimens under study; C) Relative abundance of bacteria with proportions > 0.5% at phylum-level; Relative 




Unclassified Spirochaetes Chloroflexi 
TM7 Planctomycetes Chlamydiae 




Cyanobacteria Chloroplast Gemmatimonadetes Acidobacteria 
Verrucomicrobia Fusobacteria Euryarchaeota 
Tenericutes Elusimicrobia Crenarchaeota 







Bacterial abundances > 0.5% (Figure C) 
Sampling group: Infants Mothers 
Birth weight  (g): 1000-1500  1500-2500  >2500  
Birth length (cm): <40  40-50 >50 
Female Male Infant gender:  
Mbekweni TC Newman Residential area: 
HIV negative HIV positive Maternal HIV status: 
Grade 1-7 Grade 8-11 Grade 12 Tertiary Maternal education: 
Participant characteristics (Figure B) 
>2-3 >3-4 >4-5 Shannon diversity index: 
Mode of delivery: Vaginal delivery C-section delivery 
































































































































































































































































































































































































































































































































































3.3.3.2  Microbiota profiles at the genus-level 
In infant meconium specimens (n = 107), the most abundant genus was Acinetobacter 
(6.28%), followed by the genera Aeromonas (3.56%), Shewanella (3.24%), an unclassified genus 
within the family Enterobacteriaceae (3.26%), and the genus Pseudomonas (2.65%) (Table S4). In 
this study, 14.95% of the genera with abundances > 0.5% were unclassifiable from meconium 
specimens. Genera with abundances of < 0.5% made up 35.96% of all bacteria within infant 
meconium specimens (Table S5). Unclassified genera within the families Lachnospiraceae (14.41%) 
and Ruminococcaceae (10.09%), followed by an unclassified genus within an unclassified family from 
the order Clostridiales (9.76%) were the most abundant genera from maternal faecal specimens (n = 
90) (Table S4 and Figure 23C). These were followed by the genera Blautia (5.95%) and 
Lachnospiraceae incertae sedis (4.41%). In total, 41.38% of the genera with abundances > 0.5% 
represented unclassifiable genera from maternal faecal specimens. Genera with abundances < 0.5% 
are summarised in Table S5 and made up 17.45% of all bacteria within maternal faecal specimens.  
Figure 23A summarises the two principle clusters (clusters M and B) evidenced at genus-
level for 90 mother-infant pairs sampled at birth. Cluster M in Figure 23A only consisted of a single 
sub-cluster (sub-cluster no. 1) which contained the majority of maternal faecal specimens. It also 
contained three meconium specimens, all of which clustered with maternal faecal specimens at 
phylum-level (Figure 22A). Cluster B in Figure 23A contained sub-clusters no. 2 to 6, which mainly 
consisted of meconium specimens. Only sub-cluster no. 3 contained two maternal faecal specimens. 
The maternal faecal specimen M_45 (from sub-cluster no. 3) also clustered with meconium 
specimens at phylum-level (Figure 22A). The meconium specimen, B_67, which previously clustered 
by itself at phylum-level now clustered with other meconium specimens. Meconium specimen B_31 
formed its own sub-cluster (sub-cluster no. 4) at genus-level. As observed for the phylum-level, plots 
of participant characteristics against the dendogram did not provide any interesting patterns for any 























































Figure 23. Genus-level bacterial profiles of infant meconium and maternal faecal specimens sampled at birth 














Clostridium XlVa Acidovorax 
Dorea Naxibacter Rothia 
Coprococcus Unclassified Blastococcus 
Blautia Unclassified Other 
Clostridium sensu stricto Sphingomonas Unclassified 
Unclassified Unclassified Unclassified 
Streptococcus Rhizobium Veillonella 
Weissella Aurantimonas Erysipelotrichaceae incertae sedis 
Lactobacillus Phenylobacterium Catenibacterium 
Enterococcus Caulobacter Unclassified 
Lysobacter Brevundimonas Unclassified 
Pseudomonas Bacteroides Ruminococcus 
Acinetobacter Prevotella Faecalibacterium 
Shewanella Unclassified Clostridium XI 
Aeromonas Olsenella Unclassified 
Unclassified Collinsella Roseburia 
Escherichia/Shigella Bifidobacterium Lachnospiracea incertae sedis 





























































































































































































































































































































































































































































































































































Sampling group: Infants Mothers 
Birth weight  (g): 1000-1500  1500-2500  >2500  
Birth length (cm): <40  40-50 >50 
Female Male Infant gender:  
Mbekweni TC Newman Residential area: 
HIV negative HIV positive Maternal HIV status: 
Grade 1-7 Grade 8-11 Grade 12 Tertiary Maternal education: 
Participant characteristics (Figure B) 
>2-3 >3-4 >4-5 Shannon diversity index: 
Mode of delivery: Vaginal delivery C-section delivery 





3.3.3.3  Similarities between sub-clusters consisting of infant and maternal faecal specimens 
The MDS plots (Figures 24A and B) represent sub-clusters from the 90 mother-infant pairs 
(Figures 22 and 23) in the form of pie charts. These plots provide information on the similarity of 
sub-clusters (based on their bacterial composition), which are not provided by the clustering 
analysis. Meconium specimens (n = 90) clustered at greater distances over a bigger area compared 
to maternal faecal specimens (n = 90), at both phylum- and genus-level. Meconium specimens are 
more diverse and less stable, as indicated by the number of clusters, the distance between them as 
well as their composition. 
 
Figure 24. Multi-dimensional scaling (MDS) plots of infant meconium and maternal faecal specimens sampled at birth 
A) MDS plots at phylum-level based on bacterial proportions > 0.5%; B) MDS plots at genus-level based on bacterial 
proportions > 0.5%. 
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3.3.3.4  Comparing infant and maternal faecal specimens based on significant bacterial genera 
 Log ratio biplots of genera with abundances > 0.5%, which were also statistically significant 
(at 5% significance) for infant (n = 107) and maternal (n = 90) faecal specimens, showed that infant 
and maternal specimens formed two distinct clusters (Figure 25). Maternal faecal specimens 
clustered tightly around genera within the phyla Firmicutes, Actinobacteria, Bacteroidetes and an 
unclassified phylum. Meconium specimens formed a less compact cluster, and clustered mainly 




Figure 25. Log ratio biplot of infant meconium and maternal faecal specimens sampled at birth in relation to statistically 
significant genera 
Meconium specimens are shown in yellow and maternal faecal specimens are shown in pink. Genera significantly 
associated with meconium and maternal faecal specimens range from 1 to 37 and their colours correspond to the class 
(and phyla) to which they belong. 
 
3.3.3.5  Significant differences in bacterial abundances from infant and maternal faecal specimens 
Table S6 summarises rate ratios for all bacterial OTUs which differed significantly (at 5% 
significance level) between infant (n = 107) and maternal (n = 90) faecal specimens.  Meconium 
specimens sampled at birth had significantly higher proportions of the phyla Actinobacteria and 
Proteobacteria (rate ratios > 1.00). The maternal faecal specimens sampled at birth had significantly 
higher proportions of the phyla Firmicutes, Bacteroidetes as well as an unclassified phylum (rate 
ratios < 1.00). In total, 106 bacterial OTUs (ranging from phylum to genus-level) differed significantly 





3.3.3.6  “Participant characteristics” influencing bacterial profiles in infant and maternal faecal 
specimens 
Table 9 summarises the association between participant characteristics (which included 
maternal education, residential area, maternal HIV status, infant’s gestational age, gender, birth 
weight, birth length and mode of delivery) and meconium bacterial profiles (n = 107). None of the 
above-mentioned maternal characteristics had any significant association with maternal faecal (n = 
90) bacterial taxa. In infants, only male gender and maternal education were significantly associated 
with meconium bacterial profiles. Gender was significantly associated with taxa from the class 
Clostridia. Females only had 60% of the proportions of the class Clostridia which were observed in 
males. This pattern was also observed down to genus-level for the families Lachnospiraceae and 
Ruminococcaceae (Table 9). The effect of maternal education on meconium bacterial profiles was 
clear for an unclassified family within the class Clostridia as well as an unclassified class within the 
phylum Firmicutes. We observed an increase in the proportions of both the unclassified family 
within the class Clostridia and the unclassified class within the phylum Firmicutes from meconium 
specimens as the maternal education levels increased from primary (Grades 1-7) to secondary 
(Grade 12) education level. A decrease in the bacterial proportions observed for the unclassified 
family within the class Clostridia and the unclassified class within the phylum Firmicutes was evident 
for infants with mothers having a tertiary eduction level. Finally, the intra- and inter-individual 
bacterial diversities of meconium specimens sampled at birth were not significantly associated with 






Table 9. Participant characteristics with significant effects on bacterial OTUs from meconium specimens (n = 107) 
Taxon level Bacterial OTUs Gender (male: RR=1) Maternal education (Grade 12: RR=1) 




  Rate ratio p-value Rate ratio Rate ratio Rate ratio p-value 
Phylum Firmicutes       
Class Clostridia 0.6 0.0461 - - - - 
Order Clostridiales 0.6 0.0461 - - - - 
Family Lachnospiraceae 0.5 0.0079 - - - - 
Genus Blautia 0.6 0.0369 - - - - 
Genus Unclassified 0.3 0.0018 - - - - 
Family Ruminococcaceae 0.4 0.0254 - - - - 
Genus Faecalibacterium 0.4 0.0254 - - - - 
Genus Ruminococcus 0.3 0.0183 - - - - 
Family Unclassified - - 0.2 0.5 0.3 0.0400 
Genus Unclassified - - 0.2 0.5 0.3 0.0400 
Class Unclassified - - 0.2 0.5 0.1 0.0200 
Order Unclassified - - 0.2 0.5 0.1 0.0200 
Family Unclassified - - 0.2 0.5 0.1 0.0200 
Genus Unclassified - - 0.2 0.5 0.1 0.0200 
OTU: Operational taxonomic unit 
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3.3.4 Comparison of microbial profiles from infant faecal specimens sampled at 4 to 12 
weeks of age to those of maternal faecal specimens sampled at birth 
The following section reports the relative abundance of bacterial OTUs classified from faecal 
specimens of 72 infants sampled at 4-12 weeks. We also provide data comparing 55 infant faecal 
specimens sampled at 4-12 weeks, to their matched maternal faecal specimens sampled at birth. 
Descriptions are provided at both phylum- and genus-level for bacteria with proportions greater 
than 0.5% and those with less than 0.5%.  
 
3.3.4.1  Microbiota profiles at the phylum-level 
The phylum Firmicutes (48.53%) was the most abundant phylum identified from infant faecal 
specimens collected at 4-12 weeks of age (n = 72); followed by the phylum Actinobacteria (26.27%), 
Proteobacteria (18.72%) and Bacteroidetes (5.42%). In total, 0.60% of the phyla with abundances > 
0.5% were unclassifiable (Table S2). We observed a decrease in the proportions of phyla with 
abundances < 0.5% for infants at 4-12 weeks of age (0.45%) compared to infants sampled at birth 
(2.38%). Of the phyla with abundances < 0.5%; the phyla Verrucomicrobia (0.14%) and TM7 (0.14%) 
were most abundant, followed by the phylum Fusobacteria (0.06%) (Table S3). The 55 maternal 
faecal specimens (paired with the subset of infants studied at 4-12 weeks of age) had similar 
bacterial profiles at phylum-level when compared to the “main maternal cohort” of 90 mothers 
(Figures 22C-D and 26C-D).  
The cluster analysis at phylum-level identified two principle clusters (clusters M and B) for 
the 55 mother-infant pairs based on OTUs with abundances > 0.5% (Figure 26A). Principle cluster M 
(sub-clusters no. 1 to 3) consisted of 36 infant faecal specimens sampled at 4-12 weeks of age, 
clustering with maternal faecal specimens collected at birth. Sub-cluster no. 1 mainly contained 
maternal faecal specimens, but also included two infant faecal specimens. Sub-clusters no. 2 and 3 
consisted of 34 infant faecal specimens. Principle cluster B mainly grouped 19 infant faecal 
specimens into two sub-clusters (sub-clusters no. 4 and 6), while sub-cluster no. 5 contained a single 
maternal faecal specimen (M_45). This maternal faecal specimen, M_45, had high proportions of the 
phylum Proteobacteria and also clustered with infant meconium specimens studied at birth (Figures 
22A and 23A). No interesting patterns, except for the sample type (maternal versus infant), were 
visible when plotting the participant characteristics against the order of the dendogram (Figures 26A 



































































Figure 26. Phylum-level bacterial profiles of infant faecal specimens sampled at 4-12 weeks of age and maternal faecal specimens sampled at birth  
A) Dendogram of phylum-level bacterial profiles for infant (n = 55) and maternal (n = 55) faecal specimens; B) Participant characteristics for each of the specimens under study; C) Relative abundance of bacteria with proportions > 0.5% at phylum-level; D) Relative abundance of bacteria with 















































































































































































































































































































































































Bacterial abundances > 0.5% (Figure C) 
Sampling group: Infants Mothers 
Birth weight  (g): 1000-1500  1500-2500  >2500  
Birth length (cm): <40  40-50 >50 
Female Male Infant gender:  
Mbekweni TC Newman Residential area: 
HIV negative HIV positive Maternal HIV status: 
Grade 1-7 Grade 8-11 Grade 12 Tertiary Maternal 
education: 
Participant characteristics (Figure B) 
>2-3 >3-4 >4-5 Shannon diversity 
index: 
Mode of delivery: Vaginal delivery C-section delivery 
Gestational age: <32 weeks 33-36 weeks >37 weeks 
No Yes Breast-fed at 6-10 weeks: 






3.3.4.2  Microbiota profiles at the genus-level 
The genus Bifidobacterium (16.88%) was the most abundant in the infant faecal specimens 
(n = 72), followed by the genera Streptococcus (7.83%), Lactobacillus (5.73%), as well as unclassified 
genera from the families Enterobacteriaceae (3.84%) and Lachnospiraceae (3.24%). Overall, 15.25% 
of the phyla with abundances > 0.5% were unclassifiable (Table S4). Genera with abundances < 0.5% 
were reduced by half (17.61%) when compared to the proportions observed from meconium 
specimens (35.96%) (Table S5). The 55 maternal faecal specimens (paired with the subset of infants 
studied at 4-12 weeks of age) had similar bacterial profiles at the genus-level when compared to the 
“main maternal cohort” of 90 maternal faecal specimens (Figures 23C and 27C).  
As at the phylum-level, two primary clusters (M and B) were observed for the 55 mother-
infant pairs at genus-level when performing clustering analysis on OTUs with abundances > 0.5% 
(Figure 27 A). The main difference observed when compared to the phylum-level analysis is that at 
genus-level the principle cluster M mainly consisted of maternal faecal specimens (Figures 26A and 
27A). In addition, primary cluster B (consisting of mainly infant faecal specimens) contained a single 
maternal faecal specimen (M_45) within sub-cluster no. 4 (Figure 27A). This maternal faecal 
specimen formed its own sub-cluster during phylum-level analysis at 4-12 weeks (Figure 26A). This 
maternal faecal specimen, M_45, also clustered with meconium specimens at both phylum- and 
genus-level. Once again the only pattern visible in relation to the clusters in the dendogram was the 
























Figure 27. Genus-level bacterial profiles of infant faecal specimens sampled at 4-12 weeks of age and maternal faecal specimens sampled at birth  








































































































































































































































































































































































































































































Sampling group: Infants Mothers 
Birth weight  (g): 1000-1500  1500-2500  >2500  
Birth length (cm): <40  40-50 >50 
Female Male Infant gender:  
Mbekweni TC Newman Residential area: 
HIV negative HIV positive Maternal HIV status: 
Grade 1-7 Grade 8-11 Grade 12 Tertiary Maternal education: 
Participant characteristics (Figure B) 
>2-3 >3-4 >4-5 Shannon diversity index: 
Mode of delivery: Vaginal delivery C-section delivery 
Gestational age: <32 weeks 33-36 weeks >37 weeks 
No Yes Breast-fed at 6-10 weeks: 
0-4 weeks 4-8 weeks 8-12 weeks >12 weeks Formula feeding started: 
Clostridium XlVa Acidovorax 
Dorea Naxibacter Rothia 
Coprococcus Unclassified Blastococcus 
Blautia Unclassified Other 
Clostridium sensu stricto Sphingomonas Unclassified 
Unclassified Unclassified Unclassified 
Streptococcus Rhizobium Veillonella 
Weissella Aurantimonas Erysipelotrichaceae incertae sedis 
Lactobacillus Phenylobacterium Catenibacterium 
Enterococcus Caulobacter Unclassified 
Lysobacter Brevundimonas Unclassified 
Pseudomonas Bacteroides Ruminococcus 
Acinetobacter Prevotella Faecalibacterium 
Shewanella Unclassified Clostridium XI 
Aeromonas Olsenella Unclassified 
Unclassified Collinsella Roseburia 
Escherichia/Shigella Bifidobacterium Lachnospiracea incertae sedis 





3.3.4.3  Similarities between sub-clusters consisting of infant and maternal faecal specimen 
At both phylum- and genus-level, infant faecal specimens sampled at 4-12 weeks of age (n = 
55) clustered at greater distances over bigger areas compared to their matched maternal faecal 
specimens (n = 55) (Figure 28). As observed for meconium specimens in this study (Figure 24), infant 
faecal specimens at 4-12 weeks are more diverse and less stable compared to maternal faecal 
specimens (Figure 28). This is clearly indicated by the number of sub-clusters, the area in which they 
are plotted, and their composition. 
 
Figure 28. Multi-dimensional scaling (MDS) plots of infant faecal specimens sampled at 4-12 weeks of age and maternal 
faecal specimens sampled at birth 
A) MDS plots at phylum-level based on bacterial proportions > 0.5%; B) MDS plots at genus-level based on bacterial 
proportions > 0.5%. 
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3.3.4.4  Comparing infant and maternal faecal specimens based on significant bacterial genera 
Log ratio biplots of statistically significant genera (at 5% significance) showed that infant 
faecal specimens sampled at 4-12 weeks of age (n = 72) and maternal faecal specimens sampled at 
birth (n = 90) formed two distinct clusters (Figure 29). A notable difference for this biplot, compared 
to the one for specimens sampled at birth, is the reduced number of statistically different genera 
between maternal and infant faecal specimens. The number of genera that differed statistically 
between infants and mothers was reduced from 37 (Figure 25) to 28 (Figure 29). As with meconium 
specimens (Figure 25), infant faecal specimens sampled at 4-12 weeks of age formed a less compact 
cluster when compared to maternal faecal specimens and clustered around genera from the phylum 
Proteobacteria (Figure 29). In addition, these infant faecal specimens now also clustered more 












Figure 29. Log ratio biplot of infant faecal specimens sampled at 4-12 weeks of age and maternal faecal specimens 
sampled at birth in relation to statistically significant genera  
Infant specimens are shown in light orange and maternal faecal specimens are shown in pink. Genera significantly 
associated with infant and maternal faecal specimens range from 1 to 28 and their colours correspond to the class (and 
phyla) to which they belong. 
 
3.3.4.5  Significant differences in bacterial abundances from infant and maternal faecal specimens 
Table S7 summarises the rate ratios for all bacterial OTUs which differed significantly (at 5% 
significance) between infant (n =72) and maternal faecal specimens (n = 90). Our results clearly 
showed that infant faecal specimens sampled at 4-12 weeks of age had statistically significantly 
higher proportions of the phyla Actinobacteria and Proteobacteria (rate ratios > 1.00). In total, 74 
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bacterial OTUs differed significantly in their proportions, as opposed to the 106 differing OTUs for 
mother-infant pairs sampled at birth.  
 
3.3.4.6  “Participant characteristics” influencing bacterial profiles in infant faecal specimens 
sampled at 4-12 weeks of age 
Table 10 summarises the association of participant characteristics (tested for meconium 
specimens with the addition of breastfeeding at 6-10 weeks and the effect of formula feeding) with 
bacterial profiles from infant faecal specimens collected at 4-12 weeks of age (n = 72). We found 
that gestational age was significantly associated with taxa from the order Coriobacteriales within the 
phylum Actinobacteria. A 20% reduction was seen for the order Coriobacteriales for every one week 
increase in gestational age. This pattern was evident down to the genus-level as shown for the genus 
Collinsella (Table 10). We also observed that HIV-unexposed infants only had 50% of the proportions 
of the genus Leuconostoc when compared to infants exposed to HIV. In addition, we observed a 
significant difference in the proportions of the phylum Actinobacteria for infants according to the 
residential areas. Infants residing in Mbekweni only had 20% of the proportions of the phylum 
Actinobacteria when compared to infants from TC Newman. This significant difference was clear 
down to the genus-level, as shown for the genus Bifidobacterium (Table 10). Conversely, at the 
phylum-level, infants from Mbekweni had 120% of the bacterial proportions for the phylum 
Firmicutes when compared to the bacterial proportions from infants residing in TC Newman. With 
regards to the feeding practices, infants breastfed at 6-10 weeks of age had 160% of the bacterial 
proportions belonging to the class Actinobacteria, compared to the proportions measured from 
infants not being breastfed. Moreover, breastfed infants also only had 50% of the bacterial 
proportions belonging to the class Clostridia, when compared to those not receiving breastfeeding. 
Among the characteristics tested against the intra- and inter-individual bacterial diversities 
observed at 4-12 weeks of age, only maternal HIV status was significantly associated with both intra- 
(p = 0.0073) and inter- (p = 0.0002) individual bacterial diversity measures. HIV-unexposed infants 
only had around 80% of the intra-individual bacterial diversity found in HIV-exposed infants at 4-12 
weeks of age (RR = 0.78). For inter-individual bacterial diversity, HIV-unexposed infants had even less 
diverse bacterial profiles with approximately 1% of the diversity found in infants exposed to HIV        
(RR = 0.01). 
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Table 10. Participant characteristics with significant effects on bacterial OTUs from infant faecal specimens at 4-12 weeks of life (n =72) 
Taxon level Taxa 
Gestational age (Weekly 
increase in ageϮ) 
Maternal HIV status  
(HIV positive: RR=1.00) 
Residential area  
(TC Newman: RR=1.00) 
Breastfeeding  
(Not breastfed at 6-10 
weeks: RR=1.00) 
Rate ratio p-value Rate ratio p-value Rate ratio p-value Rate ratio p-value 
Phylum Actinobacteria - - - - 0.8 0.0183 1.6 0.0351 
Class Actinobacteria - - - - 0.8 0.0183 1.6 0.0351 
Order Bifidobacteriales - - - - 0.8 0.0263 - - 
Family Bifidobacteriaceae - - - - 0.8 0.0263 - - 
Genus Bifidobacterium - - - - 0.8 0.0255 - - 
Order Coriobacteriales 0.8 0.0309 - - - - - - 
Family Coriobacteriaceae 0.8 0.0309 - - - - - - 
Genus Collinsella 0.8 0.0309 - - - - - - 
Phylum Firmicutes - - - - 1.2 0.0340 0.8 0.0351 
Genus Leuconostoc - - 0.5 0.0309 - - - - 
Class Clostridia - - - - - - 0.5 0.0076 
Order Clostridiales - - - - - - 0.5 0.0076 
Family Clostridiaceae - - - - - - 0.3 0.0488 
Genus Clostridium sensu stricto - - - - - - 0.3 0.0464 
Family Lachnospiraceae - - - - - - 0.5 0.0256 
Ϯ Rate ratios increase or decrease at a constant rate for every one week increase in gestational age 
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3.3.5 Comparison of microbial profiles from infant faecal specimens sampled at 20 to 
28 weeks of age with those of maternal faecal sampled at birth 
The following section reports the relative abundance of bacterial OTUs classified from faecal 
specimens of 36 infants sampled at 20-28 weeks. We also provide data comparing 28 infant faecal 
specimens sampled at 20-28 weeks, to their matched maternal faecal specimens sampled at birth. 
Descriptions are provided at both phylum- and genus-level for bacteria with proportions greater 
than 0.5% and those with less than 0.5%.  
 
3.3.5.1  Microbiota profiles at the phylum-level 
The most abundant phylum identified for infant faecal specimens collected at 20-28 weeks 
of age (n = 36) was the phylum Firmicutes (63.72%), followed by the phylum Actinobacteria 
(19.29%), Proteobacteria (11.76%), Bacteroidetes (4.38%). Of the phyla with abundances > 0.5%; 
0.46% were unclassifiable (Table S2). Phyla with abundances < 0.5% were similar to those from 
infants at 4-12 weeks of age and made up 0.39% of all bacteria within infant faecal specimens. Of 
these, the phylum Verrucomicrobia (0.29%) was most abundant, followed by the phylum TM7 
(0.0.03%) (Table S3). Similar phylum-level bacterial profiles were observed for the 28 maternal faecal 
specimens (used to match with infant faecal specimens), when compared to the bacterial profiles of 
the “main maternal cohort” of 90 mothers (Figures 22C-D and 30C-D). The only exception for this 
subset of 28 maternal faecal specimens was that the phylum Proteobacteria was slightly more 
abundant than the phyla Bacteroidetes and Actinobacteria.  
With the exception of a single maternal faecal specimen (M_45), containing high proportions 
of the phylum Proteobacteria, we observed two primary clusters (clusters M and B) for the 28 
mother-infant pair specimens based on their OTUs with abundances > 0.5% (Figure 30A). Primary 
cluster M contained maternal faecal specimens, together with seven infant faecal specimens. Four of 
these seven infant faecal specimens (B_1, B_6, B_8, B_40) also clustered with maternal faecal 
specimens at phylum-level during analysis of infant faecal specimens at 4-12 weeks of age (Figure 
26A). The remainder of the infant faecal specimens sampled at 20-28 weeks of age, clustered in 
primary cluster B which consisted of sub-clusters no. 2 to 5. As shown for all prior analyses, the only 
participant characteristics which grouped with clusters from the dendogram was the sample types 


































































Figure 30. Phylum-level bacterial profiles of infant faecal specimens sampled at 20-28 weeks of age and maternal faecal specimens sampled at birth  
A) Dendogram of phylum-level bacterial profiles for infant (n = 28) and maternal (n = 28) faecal specimens; B) Participant characteristics for each of the specimens under study; C) Relative abundance of bacteria with proportions > 0.5% at phylum-level; D) Relative abundance of bacteria with 
proportions < 0.5% at phylum-level. 
Sampling group: Infants Mothers 
Birth weight  (g): 1000-1500  1500-2500  >2500  
Birth length (cm): <40  40-50 >50 
Female Male Infant gender:  
Mbekweni TC Newman Residential area: 
HIV negative HIV positive Maternal HIV status: 
Grade 1-7 Grade 8-11 Grade 12 Tertiary Maternal education: 
Participant characteristics (Figure B) 
>2-3 >3-4 >4-5 Shannon diversity index: 
Mode of delivery: Vaginal delivery C-section delivery 
Gestational age: <32 weeks 33-36 weeks >37 weeks 
No Yes Breast-fed at 6-10 weeks: 
No Yes Breast-fed at 14 weeks: 
No Yes Breast-fed at 6 months: 


























































































































Bacterial abundances > 0.5% (Figure C) 
Synergistetes Deinococcus Thermus 
Unclassified Spirochaetes Chloroflexi 
TM7 Planctomycetes Chlamydiae 




Cyanobacteria Chloroplast Gemmatimonadetes Acidobacteria 
Verrucomicrobia Fusobacteria Euryarchaeota 
Tenericutes Elusimicrobia Crenarchaeota 





3.3.5.2  Microbiota profiles at the genus-level 
The genus Bifidobacterium (12.66%) was the most abundant in infant faecal specimens (n = 
36), followed by an unclassified genus within the family Lachnospiraceaea (11.10%), as well as the 
genera Lachnospiraceae incertae sedis (6.67%), Streptococcus (5.06%) and Dorea (3.76%). Of the 
genera with abundances > 0.5%; 20.66% of the taxa were unclassifiable (Table S4). Genera with 
abundances < 0.5% were very similar to those found in faecal specimens sampled at 4-12 weeks of 
age and represented 17.65% of all bacteria within infant faecal specimens collected at 20-28 weeks 
of life (Table S5). The 28 maternal faecal specimens (paired with the subset of infants analysed at 20-
28 weeks of age) had similar bacterial profiles at the genus-level compared to the “main maternal 
cohort” of 90 mothers (Figures 23C and 31C).  
We observed two primary clusters (clusters M and B) of the 28 mother-infant pair specimens 
based on clustering of OTUs with abundances > 0.5% at genus-level (Figure 31A). Cluster M 
comprised of three sub-clusters which included 14/28 infant faecal specimens together with 35/28 
maternal faecal specimens. Nine and six of these infant faecal specimens also clustered with 
maternal faecal specimens at phylum-level during analyses performed at 4-12 weeks of age (Figure 
26A) and 20-28 weeks of age (Figure 30A), respectively. Cluster B (sub-clusters no. 4 to 6) consisted 
of the other 14 infant faecal specimens and a single maternal faecal specimen. Sub-cluster no. 6 
contained the maternal faecal specimen (M_45) which clustered with infant faecal specimens for all 
clustering analyses performed in this study (Figures 22, 23, 26, 27, 30 and 31). With the exception of 
only the sample type analysed (maternal versus infant); no patterns were observed when plotting 



























































Figure 31. Genus-level bacterial profiles of infant faecal specimens sampled at 20-28 weeks of age and maternal faecal specimens sampled at birth  































































































































































Sampling group: Infants Mothers 
Birth weight  (g): 1000-1500  1500-2500  >2500  
Birth length (cm): <40  40-50 >50 
Female Male Infant gender:  
Mbekweni TC Newman Residential area: 
HIV negative HIV positive Maternal HIV status: 
Grade 1-7 Grade 8-11 Grade 12 Tertiary Maternal education: 
Participant characteristics (Figure B) 
>2-3 >3-4 >4-5 Shannon diversity index: 
Mode of delivery: Vaginal delivery C-section delivery 
Gestational age: <32 weeks 33-36 weeks >37 weeks 
No Yes Breast-fed at 6-10 weeks: 
No Yes Breast-fed at 14 weeks: 
No Yes Breast-fed at 6 months: 
0-4 weeks 4-8 weeks 8-12 weeks >12 weeks Formula feeding started: 
Clostridium XlVa Acidovorax 
Dorea Naxibacter Rothia 
Coprococcus Unclassified Blastococcus 
Blautia Unclassified Other 
Clostridium sensu stricto Sphingomonas Unclassified 
Unclassified Unclassified Unclassified 
Streptococcus Rhizobium Veillonella 
Weissella Aurantimonas Erysipelotrichaceae incertae sedis 
Lactobacillus Phenylobacterium Catenibacterium 
Enterococcus Caulobacter Unclassified 
Lysobacter Brevundimonas Unclassified 
Pseudomonas Bacteroides Ruminococcus 
Acinetobacter Prevotella Faecalibacterium 
Shewanella Unclassified Clostridium XI 
Aeromonas Olsenella Unclassified 
Unclassified Collinsella Roseburia 
Escherichia/Shigella Bifidobacterium Lachnospiracea incertae sedis 





3.3.5.3  Similarities between sub-clusters consisting of infant and maternal faecal specimen 
We observed that infant faecal specimens clustered at greater distances over a bigger area 
compared to maternal faecal specimens at both phylum- and genus-level when comparing 28 
mother-infant pairs (Figure 28). As observed for meconium specimens and infant faecal specimens 
sampled at 4-12 weeks of age (Figures 24 and 28); infant faecal specimens collected at 20-28 weeks 
are more diverse and less stable (Figure 32). We did observe that the distances between infant 
faecal specimen sub-clusters sampled at 20-28 weeks are smaller compared to the sub-clusters 
observed for specimens collected earlier in life. At genus-level more sub-clusters consisted of both 










































Figure 32. Multi-dimensional scaling (MDS) plots of infant faecal specimens sampled at 20-28 weeks of age and maternal 
faecal specimens sampled at birth  
A) MDS plots at phylum-level based on bacterial proportions > 0.5%; B) MDS plots at genus-level based on bacterial 
proportions > 0.5%. 
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3.3.5.4  Comparing infant and maternal faecal specimens based on significant bacterial genera 
Analysis at 20-28 weeks of age still showed two distinct clusters when constructing log-ratio 
biplots of statistically significant genera for infant (n = 36) and maternal (n = 90) faecal specimens. Of 
note, we observed a reduction in the number of genera which differed significantly between infant 
and maternal faecal specimens, compared to the analysis at 4-12 weeks of age (Figure 29). Infant 
faecal specimens sampled at 20-28 weeks of age formed a less compact cluster compared to 
maternal faecal specimens. This pattern was also observed for meconium and faecal specimens 
sampled earlier in life. In contrast to earlier specimens (and in agreement with maternal faecal 
specimens); infant faecal specimens sampled at 20-28 weeks of age clustered around genera from 
the phylum Firmicutes (Figure 33). Infant faecal specimens also clustered around genera from the 
phylum Actinobacteria (Figure 33), which was previously seen for specimens collected at 4-12 weeks 
of age (Figure 29). 
 
Figure 33. Log ratio biplot of infant faecal specimens sampled at 20-28 weeks of age and maternal faecal specimens 
sampled at birth in relation to statistically significant genera 
Infant specimens are shown in light orange and maternal faecal specimens are shown in pink. Genera significantly 
associated with infant and maternal faecal specimens range from 1 to 21 and their colours correspond to the class (and 
phyla) to which they belong. 
 
3.3.5.5  Significant differences in bacterial abundances from infant and maternal faecal specimens 
Rate ratios for bacterial OTUs which differed significantly (at 5% significance) between infant 
(n = 36) and maternal (n = 90) faecal specimens are summarised in Table S8. As with infants studied 
at 4-12 weeks of age, infants studied at 20-28 weeks also had statistically significantly higher 
proportions of the phyla Actinobacteria and Proteobactera (rate ratios > 1.00). In total, 60 bacterial 
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OTUs differed significantly in proportions as opposed to 74 statistically different OTUs for mother-
infant pairs studied at 4-12 weeks of age. 
 
3.3.5.6  “Participant characteristics” influencing bacterial profiles in infant faecal specimens 
sampled at 20-28 weeks of age 
The association of participant characteristics (tested for infants at 4-12 weeks with the 
addition of breastfeeding at 14 weeks and six months of age) with bacterial profiles from infant 
faecal specimens collected at 20-28 weeks of age (n = 36) are summarised in Table 11. We found 
that for every one kilogram increase in birth weight, a significant increase of 20% was evident for the 
phylum Proteobacteria. Conversely; a significant decrease of 10% was observed for the phylum 
Firmicutes with every one kilogram increase in birth weight. Increased proportions of bacterial taxa 
were also seen for lower taxonomic levels from the classes Betaproteobacteria and 
Gammaproteobacteria; while decreased proportions for lower taxonomic levels from the class 
Clostridia were also evident. Females had 140% of the proportions of the family Leuconostocaceae 
observed in males. These high proportions were observed for females down to genus-level, shown 
by the high proportions of the genera Leuconostoc and Weissella when compared to males (Table 
11). We also observed that females had almost four times greater proportions of OTUs representing 
the genus Lactococcus from the family Streptococcaceae when compared to males. Conversely, 
females only had had 30% of the proportions of the family Lactobacillaceae observed in males. 
Caesarean section delivered infants only had 20% of the proportions of the genus Lactococcus when 
compared to vaginal delivered infants. Infants born via caesarean section delivery had more than 
four times greater proportions of the genus Faecalibacterium compared to vaginal delivered infants. 
Infants receiving breastfeeding at 6-10 weeks of life had three times higher proportions of the order 
Bifidobacteriales at 20-28 weeks when compared to infants not receiving breastfeeding. This pattern 
was evident down to genus-level as shown for the genus Bifidobacterium (Table 11). Infants 
receiving breastfeeding only had 20% of the proportions of the genera Leuconostoc and Weissella; 
30% of the proportions of the genus Lactococcus; and 40% of the proportions of the genus 
Clostridium XIVa at 20-28 weeks of life when compared to those not receiving breastfeeding.  
None of the participant characteristics tested against intra- and inter-individual bacterial 




Table 11. Participant characteristics with significant effects on bacterial OTUs from infant faecal specimens at 20-28 weeks of life (n =36) 
Taxon level Bacterial OTUs 
Birth weight (Per kilogram 
increase in weightϮ) 
Gender(Male: RR=1.00) 
Mode of delivery 
(Vaginal delivery: RR=1.00) 
Breastfeeding (Not 
breastfed at 6-10 weeks: 
RR=1.00) 
Rate ratio p-value Rate ratio p-value Rate ratio p-value Rate ratio p-value 
Phylum Actinobacteria         
Order Bifidobacteriales - - - - - - 2.5 0.0307 
Family Bifidobacteriaceae - - - - - - 2.5 0.0307 
Genus Bifidobacterium - - - - - - 2.5 0.0307 
Phylum Proteobacteria 1.2 0.0085 - - - -   
Class Betaproteobacteria 1.6 0.0485 - - - -   
Order Burkholderiales 1.6 0.0485 - - - -   
Class Gammaproteobacteria 1.1 0.0485 - - - -   
Phylum Firmicutes 0.9 0.0087 - - - - - - 
Family Lactobacillaceae - - 0.3 0.0485 - - - - 
Family Leuconostocaceae - - 1.4 0.0076 - - 0.2 <0.0001 
Genus Leuconostoc - - 2.2 0.0223 - - 0.2 0.0485 
Genus Weissella - - 1.2 0.0485 - - 0.2 <0.0001 
Family Streptococcaceae         
Genus Lactococcus - - 3.7 0.0019 0.2 0.0485 0.3 0.0485 
Class Clostridia         
Family Lachnospiraceae         
Genus Clostridium XIVa - - - - - - 0.4 0.0380 
Family Ruminococcaceae 0.8 <0.0001 - - - - - - 
Genus Faecalibacterium 0.6 <0.0001 - - 4.3 0.0485 - - 
Genus Ruminococcus 0.1 <0.0001 - - - - - - 
Genus Unclassified 0.5 <0.0001 - - - - - - 
Family Unclassified 0.9 <0.0001 - - - - - - 
Genus Unclassified 0.9 <0.0001 - - - - - - 
Ϯ Rate ratios increase or decrease at a constant rate for every one kilogram increase in infant birth weight
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3.3.6 Dynamics of infant faecal bacterial profiles from birth throughout the first seven 
months of life 
3.3.6.1  Changes in infant faecal bacterial proportions over time 
At birth (Figure 34A), meconium specimens (n = 107) had a high abundance of the phylum 
Proteobacteria (60%), followed by Firmicutes (23%). As infants grew older, the phylum 
Proteobacteria decreased dramatically by approximately 40% around 4-12 weeks (n = 72) (Figure 
34B) and a further 7% by 20-28 weeks of age (n = 36) (Figure 34C). The phylum Firmicutes almost 
doubled in abundance by 4-12 weeks (Figure 34 B) and increased even further by 15% at 20-28 
weeks of age (Figure 34C). The phylum Actinobacteria was at its highest abundance (26%) around 4-
12 weeks (Figure 34B), and 20-28 weeks (19%) (Figure 34C). The phylum Bacteroidetes remained 




Figure 34. Pie charts summarising the changes in bacterial proportions for infant meconium and faecal specimens over time  
The outer circles represent bacterial proportions at phylum-level while the inner circle represents class-level. A) Bacterial proportions from meconium specimens sampled at birth (n = 107); B) 
from infant faecal specimens sampled at 4-12 weeks of age (n = 72); C) from infant faecal specimens sampled at 20-28 weeks of age (n =36) ; and D) from maternal faecal specimens sampled 





3.3.6.2  The significance of change over time on bacterial OTUs from infant faecal specimens 
When testing the effect of a weekly increase in infant age on the infant’s faecal (n = 215) 
bacterial OTUs with proportions > 0.5%, we found significant changes in proportions of 87 OTUs 
(Table S9). At phylum-level, we observed a significant (p < 0.0001) decrease in the phylum 
Proteobacteria of approximately 10% for every one week increase in infant age. The phylum 
Firmicutes significantly (p < 0.0001) increased by 4% with every one week increase in infant age and 
the phylum Actinobacteria significantly (p = 0.0274) increased by 2% with every one week increase in 
infant age. A significant (p = 0.0274) reduction of 2% was observed for the unclassified phylum with 
every one week increase in infant age. No significant differences were observed for the phylum 
Bacteroidetes over time. 
 
3.3.6.3 Significant genera representing infant faecal specimens over time 
Log ratio biplots of statistically different genera for meconium and infant faecal specimens 
sampled shows a distinct profile for meconium (n = 90) when compared to infant faecal specimens 
sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of life (Figure 35). The meconium specimens 
(shown in yellow in Figure 35) formed a distinct cluster around genera from the phylum 
Proteobacteria. The other prominent cluster comprised of infant faecal specimens sampled at 4-12 
and 20-28 weeks of age. The faecal specimens sampled at 4-12 weeks (Figure 35; light orange) 
mainly clustered around genera from the phylum Firmicutes and Actinobacteria, while infant faecal 
specimens sampled at 20-28 weeks (Figure 35; dark orange) mainly clustered around genera from 



















Figure 35. Faecal specimens sampled at birth, 4-12 and 20-28 weeks of age in relation to statistically significant genera  
Infant meconium specimens are shown yellow, infant faecal specimens sampled at 4-12 weeks of age are shown in light 
orange and faecal specimens sampled at 20-28 weeks of age are shown in dark orange. Genera significantly associated with 




3.3.6.4  Relating longitudinal infant faecal bacterial profiles to maternal faecal bacterial profiles 
Figure 34 showed the meconium and faecal bacterial profiles in comparison to the maternal 
faecal specimens. It is clear that infant bacterial profiles became more like the maternal profile as 
the infants grew older (Figure 34). At phylum-level, the phylum Proteobacteria was significantly (p < 
0.0001) decreased from 60% at birth to 12% at 20-28 weeks of life. The proportion of Proteobacteria 
found within maternal faecal specimens sampled at birth was 5%. In contrast, the phylum Firmicutes 
signicantly (p < 0.0001) increased from 23% at birth to 64% at 20-28 weeks of life. The proportion of 
Firmicutes found within maternal faecal specimens sampled at birth was 79%. At class-level, the 
class Clostridia was the most abundant class classified from maternal faecal specimens (69%). This 
was also one of the classes which increased the most (from 12 to 37%) as the infants grew older. At 
genus-level, Table 12 shows a reduction in the number of genera present in meconium specimens 
when compared to other infant faecal specimens sampled at later timepoints.  
 
Table 12. Number of genera from meconium specimens compared to other infant faecal specimens at later 
time points, as well as maternal faecal specimens 
 Genera from infants at 4-12 
weeks (n = 72) 
Genera from infants at 20-28 
weeks (n = 36) 
Genera from maternal 
specimens (n = 90) 
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In addition to Table 12, the log ratio biplot of the 616 genera identified from infant and 
maternal faecal specimens, shows three distinct clusters (Figure 36). Meconium specimens formed 
an overlap with the cluster consisting of other infant faecal specimens at 4-12 and 20-28 weeks of 
age. Maternal faecal specimens also formed a compact cluster detached from specimens sampled 
from infants (Figure 36). In addition, Figure 36 shows that the changes occurring in infant faecal 
bacterial profiles up until seven months of life are still of infant-like composition when compare to 




Figure 36. Log ratio biplot of infant meconium specimens sampled at birth (n = 107), infant faecal specimens sampled at 
4-12 (n = 72) and 20-28 (n = 36) weeks of age and maternal faecal specimens sampled at birth (n = 90) 
Biplots represent faecal specimens in relation to the most abundant genera identified from them. 
 
 
3.3.6.5  “Participant characteristics” influencing infant faecal bacterial profiles during the first 28 
weeks of life 
Table 13 summarises the association of participant characteristics with changes in infant 
bacterial profiles measured from birth up until 28 weeks of life (n = 215). In addition, we also 
determined if any of the participant characteristics had an effect on bacterial proportions as a 
function of a weekly increase in infant age (which is denoted by an asterisk in Table 13).  
Mode of delivery was the only participant characteristic significantly associated with changes 
in bacterial profiles during the first 28 weeks of life as a function of a weekly increase in infant age. 
We observed changes in abundances of the families Burkholderiaceae and Ruminococcaceae for 
every one week increase in infant age. The family Burkolderiaceae decreased with every one week 
increase in age for both vaginal and caesarean sectional delivered infants, but the effect was 
greatest for vaginal delivered infants. In contrast to the family Burkholderiaceae, we observed a 
weekly increase in abundance for the family Ruminococcaceae from both vaginal and caesarean 
sectional delivered infants. This effect was again greatest for vaginally delivered infants. At genus-
level, a per-week increase in abundance was evident for three genera (Faecalibacterium, 
Ruminococcus and an unclassified genus within the family Ruminococcaceae) from vaginally 
delivered infants. For caesarean sectional delivered infants, the genus Faecalibacterium also 
increased with every one week increase in age, but Ruminococcus and the unclassified genus 
decreased with every one week increase in age. Not all changes in bacterial profiles from vaginally 
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and caesarean sectionally delivered infants were associated with a “per-week increase” in infant 
age. We observed changes in the proportions of the genera Massilia and Escherichia/Shigella during 
the first 28 weeks of life, but these were not due to the effect of a weekly increase in infant age. We 
observed that infants born via vaginal delivery had 180% of proportions of the genus 
Escherichia/Shigella during the first 28 weeks of life compared to caesarean section delivered 
infants. On the other had,  caesarean section delivered infants had 129% of the proportions of the 
genus Masillia observed for vaginal delivered infants during the first 28 weeks of life.  
As seen for mode of delivery, significant changes in bacterial profiles during the first 28 
weeks life were not due to a “per week increase” in infant. Participant characteristics which 
influenced bacterial profiles at some stage during the first 28 weeks of life, but not resulting from a 
“per week increase” in infant age were birth weight, gestational age, gender and maternal HIV status 
(Table 13). The two participant characteristics birth weight and gestational age were significantly 
associated with changes in the order Coriobacteriales, down to genus-level, during the first 28 weeks 
of life. The genus Collinsella increased by 76% with every one kilogram increase in birth weight 
during the first 28 weeks of life. The genera Collinsella and Olsenella were reduced by 13% and 12%, 
respectively, with every one week increase in gestational age. In this study, gender was significantly 
associated with changes in bacteria from the phylum Bacteroidetes. During the first 28 weeks of life 
lower proportions of the class Bacteroidia were observed for female infants when compared to 
males. The proportions of the class Bacteroidia (down to the genus Prevotella) observed for females 
were only around 68% of the proportions observed from males. Conversely, the class Flavobacteria, 
down to the family Flavobacteriaceae, was significantly more abundant in female infants when 
compared to males. Maternal HIV status was significantly associated with changes in the infant 
faecal bacterial genera Weissella and Lactococcus within the phylum Firmicutes. We observed that 
HIV-unexposed infants only had 37% and 45% of the proportions of the genera Weissella and 









Table 13. Participant characteristics with significant effects on bacterial OTUs from infant faecal specimens over time during the first 20-28 weeks of life (n = 215) 
Taxon level Bacterial OTUs 
Birth weight (Weekly 
increase in kilogramsϮ) 
Gestational age  
(Weekly increase in ageϮ) 
Gender (Male: RR=1.00) Vaginal deliveryϮ Caesarean sectionϮ  
Maternal HIV status 
(HIV positive: RR=1.00) 
Rate ratio p-value Rate ratio p-value Rate ratio p-value Rate ratio Rate ratio p-value Rate ratio p-value 
Phylum Actinobacteria            
Order Coriobacteriales - - 0.88 0.0123 - - - - - - - 
Family Coriobacteriaceae - - 0.88 0.0123 - - - - - - - 
Genus Collinsella 1.76 0.0250 0.87 0.0133 - - - - - - - 
Genus Olsenella - - 0.88 0.0251 - - - - - - - 
Phylum Bacteroidetes            
Class Bacteroidia - - - - 0.68 0.0279 - - - - - 
Order Bacteroidales - - - - 0.68 0.0279 - - - - - 
Family Prevotellaceae - - - - 0.66 0.0328 - - - - - 
Genus Prevotella - - - - 0.65 0.0328 - - - - - 
Class Flavobacteria - - - - 1.65 0.0466 - - - - - 
Order Flavobacteriales - - - - 1.65 0.0466 - - - - - 
Family Flavobacteriaceae - - - - 1.64 0.0495 - - - - - 
Phylum Proteobacteria            
Family Burkholderiaceae - - - - - - 0.84* 0.95* 0.0033* - - 
Genus Massilia - - - - - - 0.77 1.29 0.0233 - - 
Genus Escherichia/Shigella - - - - - - 1.80 0.55 0.0233 - - 
Phylum Firmicutes            
Family Leuconostocaceae - - - - - - - - - 0.37 0.0001 
Genus Weissella - - - - - - - - - 0.37 0.0002 
Genus Lactococcus - - - - - - - - - 0.45 0.0155 
Family Ruminococcaceae - - - - - - 1.06* 1.02* 0.0014* - - 
Genus Faecalibacterium - - - - - - 1.05* 1.03* 0.0001* - - 
Genus Ruminococcus - - - - - - 1.39* 0.68* 0.0050* - - 
Genus Unclassified - - - - - - 1.09* 0.97* 0.0055* - - 
* Characteristics associated with changes in infant faecal bacterial profiles during the first 28 week s of life also having an interaction with a weekly increase in infant age. 
Ϯ Rate ratios increase or decrease at a constant rate over time based on the initial proportions of OTUs from faecal specimens collected at birth  
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3.3.6.6  Changes in infant faecal bacterial diversity as a function of a weekly increase in infant age 
Our GLMs showed a significant decrease (p < 0.0001) in both the diversity within faecal 
specimens (intra-individual diversity) and the diversity between faecal specimens (inter-individual 
diversity) as an effect of a per-week increase in infant age (data not shown). The intra-individual 
bacterial diversities from infant faecal specimens decreased significantly by 3% with every one week 
increase in infant age. We also found that the intra-individual bacterial diversities in infant 
specimens differed significantly (p < 0.0001) from maternal faecal specimens (Figure 37A). 
Meconium specimens had much greater (80% higher) intra-individual bacterial diversity compared 
to maternal specimens, while infant faecal specimens at 4-12 and 20-28 weeks had less diverse (20% 
and 15% less) bacterial profiles compared to their mothers. The inter-individual bacterial diversities 
decreased by 62% with every one week increase in infant age (data not shown). When comparing 
inter-individual bacterial diversities of infant faecal specimens to maternal faecal specimens, we 
found that infant faecal bacterial diversities differed significantly from maternal faecal specimens 
(Figure 37B). This significant difference in bacterial diversities was observed at all timepoints studied 
(infant specimens collected at birth (p < 0.0001), at 4-12 weeks (p = 0.027) and at 20-28 weeks (p = 
0.028)). Meconium specimens had 100% greater inter-individual bacterial diversity compared to 
maternal faecal specimens, while infant faecal specimens at 4-12 weeks and 20-28 weeks had much 
less diverse (99% and 80% less) bacterial profiles compared to mothers. Of the participant 
characteristics tested, only maternal HIV status was significantly associated with the two bacterial 
diversity measures.  
 
 
Figure 37. Intra- and inter-individual bacterial diversity measures of faecal specimens from the “groups under study”  
A) Shannon diversity (intra-individual diversity) and B) Bray Curtis dissimilarity (inter-individual diversity) measures are 
shown for faecal specimens collected from mothers at birth (n=90), meconium specimens collected from infants (n=107), 
faecal specimens collected from infants at 4 to 12 (n=72) and at 20 to 28 weeks of age (n=36). The line within each box plot 
represents the median value. The median values of box plots are significantly different (at 5% significance level) in the 
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3.4   Discussion 
 
Meconium consists of amniotic fluid, metabolites such as pancreatic secretions and bile 
acids, intestinal epithelial cells, and mucus.75 Remarkably, studies have recently also reported 
bacterial components from these specimens;15,20–22,41 however the exact mechanisms of how the 
fetus acquires these bacterial components in-utero still remains unclear.76 
Our study supports the notion that meconium is not sterile as we identified a number of 
genera previously reported from meconium specimens (Table S10).15,20–22,41 The most abundant 
colonizers of meconium specimens were bacteria from the phylum Proteobacteria, followed by the 
phylum Firmicutes; which has also been reported from previous studies on meconium 
microbiota.15,21,33 In contrast to this, two studies conducted on preterm infants15,22 reported inverse 
bacterial proportions of these two phyla identified from infants born at gestational ages of less than 
33 weeks. Interestingly, the study by Ardissone and colleagues15 reported higher proportions of the 
phylum Proteobacteria in comparison to the phylum Firmicutes, as shown by our study, in infants 
born at gestational ages greater than 33 weeks. Of note, infants providing meconium specimens in 
our study had a median gestational age of 39 weeks (IQR, 38 – 40). In support of the high 
proportions of the phyla Proteobacteria and Firmicutes found in our study; studies have shown that 
select facultative anaerobes42 belonging to these two phyla2 are essential for successive GIT 
colonization by strict anaerobes around the first week of life.42,77 One explanation for these 
colonization patterns is that facultative anaerobes prepare the environment for strict aerobes by 
consuming oxygen during growth and thereby reducing the positive redox potential of the infant’s 
GIT.42,77,78 Corroborating the above-mentioned “colonization dogma”; we observed a significant 
reduction in some facultative anaerobes (including Acinetobacter, Aeromonas, Shewanella, 
Pseudomonas and Aurantimonas) and a significant increase in strict anaerobes (including 
Bifidobacterium, Clostridium, Lactobacillus, Bacteroides and Veillonella) when studying infant faecal 
bacterial profiles over time. Despite the findings from our study, as well as the widely accepted 
“colonization dogma”; it is not set in stone that strictly anaerobic bacteria are completely absent 
very early on in life.79 Tsuji et al. (2012) reported that 95% of the meconium specimens from 166 
Japanese newborns were colonised by both facultative and strict anaerobes.44 This is in agreement 
with what we observed in our study as we detected both facultative and strict anaerobic bacteria 
from meconium specimens sampled at birth.  
Our study did not aim to address the mechanisms behind the meconium colonization 
process, as we did not analyse amniotic fluid, cord blood or placenta. Among several hypotheses; it 
has been suggested that bacteria may translocate from the maternal GIT lumen to placenta via 
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maternal systemic circulation.23 Although we observed some overlap between bacterial profiles of 
infant and maternal samples, our study showed that meconium and maternal faecal bacterial 
profiles forms distinct clusters. This suggests that the in-utero translocation may have only a modest 
effect on the overall bacterial composition of the meconium at the time of birth. Our finding is in 
agreement with what has been reported in the study by Gosalbes and colleagues,21 also showing 
separate clustering of meconium and maternal faecal specimens from two mother-infant pairs 
during early life using high-throughput sequencing. One possible reason for this may be that the 
anaerobic fetal/newborn GIT is not a suitable environment for adult-like microbiota which colonizes 
an aerobic GIT environment.43,80–82 This is clearly emphasised by our study showing a significant 
increase in the number of strictly anaerobic Clostridia over time.9 Furthermore, the murine model 
used to report on in-utero bacterial translocations of bacterial strains from the maternal to fetal 
GIT20 studied facultative anaerobic Enterococcus species, which have been suggested as one of the 
early colonizers of the newborn’s GIT. Considering that our meconium specimens were not sterile 
we do suggest the occurrence of in-utero colonization; however we also suspect that specific 
maternal GIT bacteria, such as anaerobes and facultative anaerobes belonging to the phyla 
Proteobacteria and Firmicutes,2,42,77 may be better colonizers of the fetal GIT. Moreover, we did not 
observe direct clustering of bacterial profiles from any of the respective mother-infant pairs up until 
seven months of age, which supports previous reports of an adult-like microbiota only appearing 
between one to two and a half years of life.83–85 Despite the fact that we did not detect direct 
clustering between respective mother-infant pairs; we did however note a changing trend in the 
infant faecal bacterial profiles over time. We noted that even though no mother-infant pair 
clustering was observed, infant faecal bacterial profiles became more adult-like during the first 
seven months of life. These observations are in line with those from Gosalbes et al. (2012) reporting 
closer clustering of infant faecal specimens with maternal faecal specimens as the infant’s age 
increased.21 We therefore suggest that faecal bacterial profiles from infants converge to profiles 
characteristic of the adult GIT during the first seven months of life and should be considered as an 
ongoing process starting from early infancy. 
Our study and others86–88 showed that changes in healthy infant faecal bacterial profiles 
during the first few months of life, are characterized by increased proportions of Actinobacteria and 
Firmicutes, with reduced proportions of the phylum Proteobacteria. These changes over time may 
be attributed to the introduction of milk feeding (breast or formula) during infancy.79,89 The genus 
Bifidobacterium, from the phylum Actinobacteria, has been shown to increase in particular for 
breastfed infants.6,7,12,87,89 In support of this, we found that the phylum Actinobacteria was most 
abundant around 4-12 weeks of age, and that the class Actinobacteria increased significantly with 
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the introduction of breastfeeding at 6-10 weeks of life. Moreover, the genus Bifidobacterium was 
most abundant within the phylum Actinobacteria from specimens sampled at 4-12 and 20-28 weeks 
(Figure S1), also reported by a Ringel-Kulka and co-workers.90 In addition, our study also showed that 
the genus Bifidobacterium were the most abundant genus when compared to all other genera at 4-
12 and 20-28 weeks of life (Table S4).81,86,89,91–94 Interestingly, not only was breastfeeding associated 
with a significant increase in bacterial taxa from the class Actinobacteria at 4-12 and 20-28 weeks of 
age, but we also observed a significant reduction in bacterial taxa from the families 
Leuconostocaceae and Streptococcaceae, as well as the class Clostridia within the phylum Firmicutes 
for breastfed infants. This suggests that the introduction of formula feeding may contribute to the 
proliferation of bacteria within the families Leuconostocaceae and Streptococcaecae as well as the 
class Clostridia. In support of the latter, studies have shown that Bifidobacteria and Lactobacilli were 
dominant in breastfed infants, while formula fed infants contained higher proportions of 
Bacteroides, Staphylococci, Enterobacteria, Veillonella and Clostridia.2,89 
In addition to breast- and formula feeding, weaning has also been associated with changes in 
infant faecal bacterial profiles, mainly contributing to shifts from infant-like bacterial profiles to 
adult-like profiles.9,85,95 Bergstrom and colleagues11 showed that solid foods dramatically impacted 
on infant GIT bacterial profiles between nine and 18 months of age. They reported an increase in 
Bacteroidetes species and a decrease in Bifidobacterium, Lactobacillus and Enterobacteriaceae.11 In 
contrast, we did not find any significant association between the introduction of solid foods and any 
of our bacterial profiles; however our sample size was small. Of note, the Danish study by Bergstrom 
and colleagues11 investigated a cohort of 330 infants, while we only studied faecal specimens of 30 
infants who received solid food. The age at which solid foods were introduced to the 30 infants 
studied at 20-28 weeks of age, also varied across the first six months of life. More than half (17/30) 
of the infants only started to receive solid foods at five months of age of which seven provided 
samples after a short weaning period of less than two weeks. Bergstrom et al’s study reported 
changes as from nine months of age, while our cohort only investigated infants up until seven 
months of age.11  
Despite the fact that we did not observe significant changes in bacterial profiles associated 
with the introduction of solid food, which is in contrast with reports from previous studies, 9,84,85,95,96 
we did observe that infant faecal bacterial profiles from our cohort are becoming more adult-like 
(Figure 34  and Table S9).97 This is clearly highlighted by our study as we observed i) less distinct 
clustering of infant and maternal faecal specimens as infants grew older, ii) a reduction in 
significantly different genera between infant and maternal faecal specimens with increased age; iii)  
a significant increase in the phylum Firmicutes from our infant faecal specimens during the first 
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seven months of life; and iv) that the strictly anaerobic class Clostridia was the most abundant class 
from infant faecal specimens at 20-28 weeks of life. The latter being reported for adult faecal 
specimens from previous studies9,11 as well as maternal faecal specimens in our cohort. Since our 
cohort was only studied up until seven months of age, these findings may be reflective of the effect 
of external factors, other than weaning,9,84,89 on changes in the infant faecal bacterial profiles. In 
support of this, weaning seems to be associated with a significant increase in the proportions of 
Bacteroidetes.84,96 Koenig and colleagues84 found that the increase in Bacteroidetes only became 
apparent around six months of age; which too is in agreement with the findings from our study. Our 
results, and those from previous studies,83–85 therefore suggest additional sampling points at later 
stages of infancy and early childhood in order to optimally address shifts towards adult-like bacterial 
profiles.  
Adult faecal bacterial profiles are characterised by high proportions of the phylum 
Firmicutes; and when combined with the phylum Bacteroidetes, together consisted of approximately 
90% of the bacteria found in the adult GIT.98–105 In agreement with this, we found that the phyla 
Firmicutes and Bacteroidetes represented 86% of the bacteria identified from maternal faecal 
specimens under study. These were followed by the phylum Actinobacteria, Proteobacteria and 
other, which has also been reported by other studies.86,102,103,105,106 This pattern of most abundant 
phyla was observed for all maternal faecal specimens; however the subset at 20-28 week of life had 
slightly higher abundances of the phylum Proteobacteria compared to the phyla Bacteroidetes and 
Actinobacteria. This may be explained by a sample-size effect since only 36 maternal samples were 
profiled of which one maternal faecal specimen, M_45, had a very high abundance of 
Proteobacteria. These findings highlight the importance of using large sample sizes when performing 
microbiota analyses in order to minimize the effect of outlier data. 
In addition to feeding practices (i.e., breastfeeding, formula feeding and weaning), other 
external factors may act as potential “risk factors” for changes in both infant and maternal faecal 
bacterial profiles. Previous studies have reported an influence of maternal factors such as eczema 
and diabetes on infant meconium microbiota profiles.21,33 We observed that the two maternal 
characteristics, maternal education and maternal HIV status, impacted infant faecal bacterial profiles 
early in life. An increase in maternal education levels was associated with higher proportions of an 
unclassified family within the class Clostridia, as well as an unclassified class within the phylum 
Firmicutes. Despite these increasing proportions, we surprisingly observed a reduction in these 
bacterial proportions from infants whose mothers had tertiary education levels. This does not seem 
biologically plausible since our findings up until the Grade 12 education level suggests that the 
higher the maternal education level, the higher the proportions of these unclassified bacteria. 
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Therefore, we suspect that our finding of an association with eduction levels may be ambiguous. 
However, our findings suggesting a potential role of maternal education in shaping meconium 
bacterial profiles are in keeping with those of Gosalbes et al. (2012) who reported two distinct 
bacterial profiles from infants whose mothers had either a low or a high level of education.21   
When testing the effect of maternal HIV status on infant faecal bacterial profiles we found 
that HIV-exposed infants had increased bacterial diversities at 4-12 weeks of age and also had higher 
proportions of bacteria from the family Leuconostocaceae. Although the majority of children in this 
study were not exposed to HIV nor HIV-infected, our finding is in line with studies reporting 
increased bacterial diversities from faecal specimens of HIV positive participants.107 Our observation, 
suggesting the role of maternal HIV status in altering infant faecal bacterial profiles, may be 
explained by a possible influence from breastfeeding. This is supported by the interesting findings 
from Gonzáles and colleagues108 showing that the presence of HIV RNA in breast milk was associated 
with increased bacterial diversity from breastmilk specimens.108  
Participant characteristics having a long-term effect on bacterial profiles from the time of 
birth up until the first 28 weeks of life were infant birth weight, gestational age, mode of delivery, 
gender and HIV status. Interestingly, we observed an increase in the proportions of the order 
Coriobacteriales with decreased gestational ages. Lower gestational ages have been shown to be 
associated with increased formula milk supplementation.109–111 In addition, formula feeding has been 
associated with increased proportions of the order Coriobacteriales.112 Therefore, we suggest that 
infants born to lower gestational ages may be exposed to increased supplementation with formula, 
which may in turn result in increased levels of Order Coriobacteriales. However; since we had a small 
number of infants being formula fed, and an even smaller number being born at low gestational ages 
we could not statistically determine whether low gestational ages were associated with increased 
formula feeding. Mode of delivery on the other hand was associated with changes in the genera 
Massilia and Escherichia/Shigella in this study. Although we could not find any literature reporting 
on the genus Massilia and its associations with mode of delivery, the higher abundances of 
Escherichia/Shigella observed for vaginal delivered infants are in agreement with findings from a 
previous study.87 Besides measuring the effect of a number of participant characteristics on bacterial 
profiles throughout the first seven months of life; we also tested the effect of a per-week increase in 
infant age on these profiles. Interestingly, we only observed a significant association for the 
characteristic mode of delivery. Both vaginal and caesarean sectional delivered infants had a 
significant decrease in the proportions of bacteria within the phylum Proteobacteria, and conversely 
had a significant increase in bacteria within the phylum Firmicutes with every one week increase in 
infant age. However, the effects seen for vaginal delivered infants were much greater. This may be 
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supported by the findings of Grönlund et al.;113 reporting that caesarean sectional delivered infants 
have delayed bacterial colonization rates.  
 
3.5   Conclusion 
 
Our results indicate colonization of meconium specimens by highly diverse bacterial profiles. 
We did not observe direct clustering of any of the respective mother-infant pairs when comparing 
their faecal bacterial profiles. Our study also emphasizes that a number of external factors, such as 
maternal education and HIV status, infant gestational age and birth weight, the infant’s mode of 
delivery, the residential area in which the infant resides and whether the infant received 
breastfeeding or not, influence colonization of the GIT during early infancy. An interesting finding, 
not previously reported, was the association between HIV-exposed infants and increased bacterial 
diversities from infant faecal specimens. Furthermore, among the number of participant 
characteristics influencing bacterial profiles during early life, the most influential factor was the 
increase in infant age. Finally our study provides information on the shifts from an infant- to an 
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Supplementary data  
A)  Supplementary tables 
Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% 
Phylum-level (> 0.5%) Phylum-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
Actinobacteria 13.54 Crenarchaeota 0.006 Chloroflexi 0.061 Nitrospira 0.007 Cyanobacteria Chloroplast 0.163 
Bacteroidetes 5.39 Euryarchaeota 0.106 Deinococcus Thermus 0.125 Planctomycetes 0.008 OD1 0.001 
Proteobacteria 28.13 Acidobacteria 0.017 Elusimicrobia 0.025 Spirochaetes 0.025 OP11 0.001 
Firmicutes 50.44 Aquificae 0.003 Fusobacteria 0.083 Synergistetes 0.010 TM7 0.318 
Unclassified 1.33 Armatimonadetes 0.007 Gemmatimonadetes 0.007 Tenericutes 0.006 Unclassified 0.005 
Other 1.17 Chlamydiae 0.003 Lentisphaerae 0.003 Verrucomicrobia 0.180   
Class-level (> 0.5%) Class-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
Actinobacteria 13.54 Thermoprotei 0.006 
Bacteroidetes incertae sedis class 
incertae sedis 
0.001 Lentisphaeria 0.003 Verrucomicrobiae 0.163 
Bacteroidia 4.48 Halobacteria 0.001 Sphingobacteria 0.332 Nitrospira 0.007 Unclassified 0.003 
Alphaproteobacteria 9.53 Methanobacteria 0.104 Flavobacteria 0.313 Planctomycetacia 0.007 Chloroplast 0.149 
Betaproteobacteria 5.02 Thermoplasmata 0.001 Unclassified 0.265 Unclassified 0.001 Cyanobacteria 0.014 
Gammaproteobacteria 12.75 Acidobacteria Gp10 0.004 Chlamydiae 0.003 Deltaproteobacteria 0.404 OD1 class incertae sedis 0.001 
Bacilli 10.65 Acidobacteria Gp16 0.001 Chloroflexi 0.000 Epsilonproteobacteria 0.075 OP11 class incertae sedis 0.001 
Clostridia 32.86 Acidobacteria Gp3 0.000 Thermomicrobia 0.059 Unclassified 0.356 TM7 class incertae sedis 0.318 
Erysipelotrichia 3.61 Acidobacteria Gp4 0.006 Unclassified 0.003 Spirochaetes 0.025 Unclassified 0.005 
Negativicutes 2.18 Acidobacteria Gp6 0.005 Deinococci 0.125 Synergistia 0.010   
Unclassified 1.14 Acidobacteria Gp7 0.001 Elusimicrobia 0.025 Mollicutes 0.006   
Unclassified 1.33 Aquificae 0.003 Fusobacteria 0.083 Opitutae 0.009   




Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Order-level (> 0.5%) Order-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
Actinomycetales 2.99 Fervidicoccales 0.006 Unclassified 0.003 Cardiobacteriales 0.005 TM7 order incertae sedis 0.318 
Bifidobacteriales 6.82 Halobacteriales 0.001 Deinococcales 0.123 Chromatiales 0.175 Unclassified 0.005 
Coriobacteriales 3.49 Methanobacteriales 0.104 Thermales 0.002 
Gammaproteobacteria order incertae 
sedis 
0.005   
Bacteroidales 4.48 Thermoplasmatales 0.001 Elusimicrobiales 0.025 Legionellales 0.016   
Caulobacterales 2.16 Acidobacteria Gp10 order incertae sedis 0.004 Fusobacteriales 0.083 Oceanospirillales 0.030   
Rhizobiales 3.74 Acidobacteria Gp16 order incertae sedis 0.001 Gemmatimonadales 0.007 Pasteurellales 0.217   
Rhodobacterales 1.02 Acidobacteria Gp3 order incertae sedis 0.000 Victivallales 0.002 Thiotrichales 0.002   
Rhodospirillales 0.65 Acidobacteria Gp4 order incertae sedis 0.006 Unclassified 0.000 Unclassified 0.238   
Sphingomonadales 1.36 Acidobacteria Gp6 order incertae sedis 0.005 Nitrospirales 0.007 Unclassified 0.356   
Unclassified 0.55 Acidobacteria Gp7 order incertae sedis 0.001 Planctomycetales 0.007 Spirochaetales 0.025   
Burkholderiales 4.77 Acidimicrobiales 0.007 Unclassified 0.001 Synergistales 0.010   
Enterobacteriales 3.31 Solirubrobacterales 0.080 Rickettsiales 0.044 Anaeroplasmatales 0.002   
Aeromonadales 1.68 Thermoleophilales 0.003 Hydrogenophilales 0.005 Mycoplasmatales 0.005   
Alteromonadales 1.60 Unclassified 0.147 Methylophilales 0.002 Opitutales 0.002   
Pseudomonadales 4.81 Aquificales 0.003 Neisseriales 0.188 Puniceicoccales 0.007   
Xanthomonadales 0.65 Armatimonadetes gp5 order incetae sedis 0.007 Nitrosomonadales 0.001 Subdivision5 order incertae sedis 0.004   
Bacillales 1.07 
Bacteroidetes incertae sedis order incertae 
sedis 
0.001 Rhodocyclales 0.027 Verrucomicrobiales 0.163   
Lactobacillales 9.36 Sphingobacteriales 0.332 Unclassified 0.029 Unclassified 0.003   
Clostridiales 32.71 Flavobacteriales 0.313 Bdellovibrionales 0.186 Chloroplast order incertae sedis 0.149   
Erysipelotrichales 3.61 Unclassified 0.265 Desulfovibrionales 0.200 Cyanobacteria order incertae sedis 0.014   
Selenomonadales 2.18 Chlamydiales 0.003 Myxococcales 0.011 Unclassified 0.220   
Unclassified 1.14 Herpetosiphonales 0.000 Unclassified 0.006 Unclassified 0.141   
Unclassified 1.33 Sphaerobacterales 0.058 Campylobacterales 0.075 OD1 order incertae sedis 0.001   




Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Family-level (> 0.5%) Family-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
Geodermatophilaceae 0.61 Fervidicoccaceae 0.006 Bacteroidales incertae sedis 0.000 Unclassified 0.001 Bacillales Incertae Sedis XI 0.077 
Micrococcaceae 0.82 Halobacteriaceae 0.001 Marinilabiaceae 0.057 Erythrobacteraceae 0.030 Bacillales Incertae Sedis XII 0.030 
Nocardioidaceae 0.53 Methanobacteriaceae 0.104 Rikenellaceae 0.174 Unclassified 0.101 Anaeroplasmataceae 0.002 
Bifidobacteriaceae 6.82 Unclassified 0.001 Unclassified 0.241 Alcaligenaceae 0.002 Mycoplasmataceae 0.005 
Coriobacteriaceae 3.49 Acidobacteria Gp10 family incertae sedis 0.004 Cyclobacteriaceae 0.011 Burkholderiales incertae sedis 0.350 Opitutaceae 0.002 
Porphyromonadaceae 0.64 Acidobacteria Gp16 family incertae sedis 0.001 Saprospiraceae 0.002 Sutterellaceae 0.175 Puniceicoccaceae 0.007 
Prevotellaceae 2.32 Acidobacteria Gp3 family incertae sedis 0.000 Chitinophagaceae 0.132 Unclassified 0.432 Subdivision5 family incertae sedis 0.004 
Bacteroidaceae 1.05 Acidobacteria Gp4 family incertae sedis 0.006 Cytophagaceae 0.107 Hydrogenophilaceae 0.005 Verrucomicrobiaceae 0.163 
Caulobacteraceae 2.16 Acidobacteria Gp6 family incertae sedis 0.005 Sphingobacteriaceae 0.009 Methylophilaceae 0.002 Unclassified 0.003 
Aurantimonadaceae 1.01 Acidobacteria Gp7 family incertae sedis 0.001 Unclassified 0.071 Neisseriaceae 0.188 Chloroplast 0.149 
Hyphomicrobiaceae 0.60 Acidimicrobineae incertae sedis 0.001 Flavobacteriaceae 0.312 Nitrosomonadaceae 0.001 Family II 0.005 
Rhizobiaceae 0.72 Acidimicrobiaceae 0.004 Unclassified 0.001 Rhodocyclaceae 0.027 Family IV 0.002 
Unclassified 0.82 Unclassified 0.002 Unclassified 0.265 Unclassified 0.029 Family V 0.001 
Rhodobacteraceae 1.02 Actinomycetaceae 0.300 Chlamydiaceae 0.000 Bacteriovoracaceae 0.114 Unclassified 0.006 
Sphingomonadaceae 1.23 Beutenbergiaceae 0.001 Parachlamydiaceae 0.002 Bdellovibrionaceae 0.072 Alicyclobacillaceae 0.001 
Unclassified 0.55 Bogoriellaceae 0.001 Herpetosiphonaceae 0.000 Desulfomicrobiaceae 0.002 Hahellaceae 0.001 
Burkholderiaceae 0.52 Brevibacteriaceae 0.007 Sphaerobacteraceae 0.058 Desulfovibrionaceae 0.180 Halomonadaceae 0.028 
Comamonadaceae 1.76 Cellulomonadaceae 0.017 Unclassified 0.001 Unclassified 0.019 Pasteurellaceae 0.217 
Oxalobacteraceae 1.53 Corynebacteriaceae 0.104 Unclassified 0.003 Cystobacteraceae 0.002 Unclassified 0.001 
Enterobacteriaceae 3.31 Demequinaceae 0.001 Deinococcaceae 0.121 Nannocystaceae 0.003 Bacillales incertae sedis 0.001 
Aeromonadaceae 1.51 Dermabacteraceae 0.025 Trueperaceae 0.002 Phaselicystidaceae 0.004 Listeriaceae 0.002 
Shewanellaceae 1.53 Dermacoccaceae 0.001 Thermaceae 0.002 Polyangiaceae 0.000 Paenibacillaceae 1 0.008 
Moraxellaceae 3.27 Dermatophilaceae 0.007 Elusimicrobiaceae 0.025 Unclassified 0.002 Paenibacillaceae 2 0.003 
Pseudomonadaceae 1.54 Dietziaceae 0.058 Fusobacteriaceae 0.060 Unclassified 0.006 Planococcaceae 0.254 
Xanthomonadaceae 0.65 Intrasporangiaceae 0.044 Leptotrichiaceae 0.023 Campylobacteraceae 0.050 Sporolactobacillaceae 0.026 
Enterococcaceae 1.27 Kineosporiaceae 0.003 Gemmatimonadaceae 0.007 Helicobacteraceae 0.025 Staphylococcaceae 0.413 
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Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Family-level (> 0.5%) Family-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
Lactobacillaceae 2.29 Microbacteriaceae 0.107 Victivallaceae 0.002 Vibrionaceae 0.031 Unclassified 0.096 
Leuconostocaceae 1.09 Micromonosporaceae 0.005 Unclassified 0.000 Succinivibrionaceae 0.161 Aerococcaceae 0.022 
Streptococcaceae 3.58 Mycobacteriaceae 0.028 Nitrospiraceae 0.007 Unclassified 0.000 Carnobacteriaceae 0.153 
Unclassified 0.95 Nocardiaceae 0.055 Planctomycetaceae 0.007 Alteromonadaceae 0.012 Unclassified 0.220 
Clostridiaceae 1.21 Nocardiopsaceae 0.005 Unclassified 0.001 Unclassified 0.055 Clostridiaceae 2 0.058 
Lachnospiraceae 17.7 Promicromonosporaceae 0.005 Hyphomonadaceae 0.001 Cardiobacteriaceae 0.005 Clostridiales Incertae Sedis XI 0.287 
Peptostreptococcaceae 1.94 Propionibacteriaceae 0.055 Unclassified 0.005 Chromatiaceae 0.175 Clostridiales Incertae Sedis XIII 0.156 
Ruminococcaceae 7.29 Pseudonocardiaceae 0.043 Bartonellaceae 0.002 
Gammaproteobacteria family 
incertae sedis 
0.005 Eubacteriaceae 0.084 
Unclassified 3.70 Sporichthyaceae 0.001 Beijerinckiaceae 0.074 Coxiellaceae 0.005 Gracilibacteraceae 0.001 
Erysipelotrichaceae 3.61 Streptomycetaceae 0.015 Bradyrhizobiaceae 0.216 Legionellaceae 0.011 Incertae Sedis XI 0.006 
Veillonellaceae 2.02 Thermomonosporaceae 0.002 Brucellaceae 0.006 Alcanivoracaceae 0.001 Peptococcaceae 1 0.282 
Unclassified 1.14 Unclassified 0.148 Methylobacteriaceae 0.179 Piscirickettsiaceae 0.002 Syntrophomonadaceae 0.002 
Unclassified 1.33 Conexibacteraceae 0.070 Phyllobacteriaceae 0.004 Unclassified 0.238 Unclassified 0.141 
Other 10.89 Solirubrobacteraceae 0.005 Rhodobiaceae 0.004 Unclassified 0.356 Acidaminococcaceae 0.151 
  Unclassified 0.005 Xanthobacteraceae 0.113 Spirochaetaceae 0.025 Unclassified 0.006 
  Thermoleophilaceae 0.003 Acetobacteraceae 0.174 Unclassified 0.000 OD1 family incertae sedis 0.001 
  Unclassified 0.147 Rhodospirillaceae 0.469 Synergistaceae 0.010 OP11 family incertae sedis 0.001 
  Aquificaceae 0.003 Unclassified 0.007 Bacillaceae 1 0.113 TM7 family incertae sedis 0.318 
  Armatimonadetes gp5 family incetae sedis 0.007 Mitochondria 0.043 Bacillaceae 2 0.042 Unclassified 0.005 
  
Bacteroidetes incertae sedis family incertae 
sedis 







Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Genus-level (> 0.5%) Genus-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
Blastococcus 0.54 Fervidicoccus 0.006 Sediminibacterium 0.062 Variovorax 0.003 Paenibacillus 0.007 
Rothia 0.61 Unclassified 0.001 Unclassified 0.040 Duganella 0.004 Ammoniphilus 0.001 
Bifidobacterium 6.61 Methanobrevibacter 0.074 Adhaeribacter 0.015 Herbaspirillum 0.018 Oxalophagus 0.002 
Collinsella 0.89 Methanosphaera 0.026 Dyadobacter 0.031 Herminiimonas 0.001 Jeotgalibacillus 0.002 
Olsenella 0.75 Methanothermobacter 0.002 Hymenobacter 0.004 Janthinobacterium 0.013 Lysinibacillus 0.001 
Unclassified 1.32 Unclassified 0.002 Litoribacter 0.003 Massilia 0.325 Planomicrobium 0.051 
Prevotella 2.08 Unclassified 0.001 Pontibacter 0.046 Oxalicibacterium 0.144 Ureibacillus 0.002 
Bacteroides 1.05 Gp10 0.004 Unclassified 0.009 Oxalobacter 0.001 Unclassified 0.199 




Caulobacter 0.63 Gp3 0.000 Sphingobacterium 0.003 Unclassified 0.210 Jeotgalicoccus 0.024 
Phenylobacterium 0.50 Gp4 0.006 Unclassified 0.071 Parasutterella 0.026 Macrococcus 0.000 
Aurantimonas 1.00 Gp6 0.005 Capnocytophaga 0.003 Sutterella 0.149 Nosocomiicoccus 0.002 
Rhizobium 0.72 Gp7 0.001 Chryseobacterium 0.008 Unclassified 0.000 Staphylococcus 0.298 
Unclassified 0.82 Aciditerrimonas 0.001 Cloacibacterium 0.095 Unclassified 0.432 Unclassified 0.089 
Sphingomonas 0.91 Ilumatobacter 0.002 Flavobacterium 0.189 Hydrogenophilus 0.001 Unclassified 0.096 
Unclassified 0.55 Unclassified 0.002 Riemerella 0.008 Petrobacter 0.004 Aerococcus 0.005 
Acidovorax 0.63 Unclassified 0.002 Unclassified 0.009 Unclassified 0.002 Facklamia 0.006 
Unclassified 0.87 Actinobaculum 0.002 Unclassified 0.001 Iodobacter 0.000 Globicatella 0.008 
Naxibacter 0.72 Actinomyces 0.257 Unclassified 0.265 Neisseria 0.062 Unclassified 0.003 
Escherichia/Shigella 0.58 Arcanobacterium 0.003 Chlamydia 0.000 Vogesella 0.115 Atopostipes 0.020 
Unclassified 2.44 Mobiluncus 0.003 Neochlamydia 0.001 Unclassified 0.011 Carnobacterium 0.003 
Aeromonas 1.51 Trueperella 0.001 Parachlamydia 0.001 Unclassified 0.001 Desemzia 0.003 
Shewanella 1.53 Varibaculum 0.034 Herpetosiphon 0.000 Azoarcus 0.006 Dolosigranulum 0.056 
Acinetobacter 2.96 Unclassified 0.001 Sphaerobacter 0.058 Azospira 0.007 Granulicatella 0.042 
Pseudomonas 1.30 Georgenia 0.001 Unclassified 0.001 Shinella 0.001 Isobaculum 0.002 
Lysobacter 0.52 Brevibacterium 0.007 Unclassified 0.003 Zoogloea 0.001 Trichococcus 0.002 
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Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Genus-level (> 0.5%) Genus-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
Enterococcus 1.13 Cellulomonas 0.009 Deinococcus 0.121 Unclassified 0.012 Unclassified 0.025 
Lactobacillus 2.03 Unclassified 0.007 Truepera 0.002 Unclassified 0.029 Vagococcus 0.002 
Weissella 0.80 Corynebacterium 0.104 Thermus 0.002 Bacteriovorax 0.011 Unclassified 0.140 
Streptococcus 3.09 Demequina 0.001 Elusimicrobium 0.025 Peredibacter 0.103 Paralactobacillus 0.005 
Unclassified 0.95 Brachybacterium 0.017 Cetobacterium 0.002 Bdellovibrio 0.070 Pediococcus 0.002 
Clostridium sensu 
stricto 
0.78 Dermabacter 0.007 Fusobacterium 0.059 Vampirovibrio 0.002 Unclassified 0.158 
Blautia 3.01 Helcobacillus 0.001 Leptotrichia 0.011 Desulfomicrobium 0.002 Leuconostoc 0.250 
Clostridium XlVa 0.86 Unclassified 0.000 Sneathia 0.007 Bilophila 0.049 Unclassified 0.041 
Coprococcus 0.62 Unclassified 0.001 Streptobacillus 0.001 Desulfovibrio 0.128 Lactococcus 0.452 
Dorea 2.17 Piscicoccus 0.007 Unclassified 0.004 Unclassified 0.002 Unclassified 0.041 
Lachnospiracea 
incertae sedis 
2.99 Dietzia 0.058 Gemmatimonas 0.007 Unclassified 0.019 Unclassified 0.220 
Roseburia 0.52 Geodermatophilus 0.040 Victivallis 0.002 Cystobacter 0.001 Anaerosporobacter 0.009 
Unclassified 6.95 Modestobacter 0.007 Unclassified 0.000 Unclassified 0.001 Proteiniclasticum 0.004 
Clostridium XI 1.80 Unclassified 0.020 Nitrospira 0.007 Nannocystis 0.003 Sarcina 0.236 
Faecalibacterium 1.17 Arsenicicoccus 0.000 Blastopirellula 0.002 Phaselicystis 0.004 Unclassified 0.180 
Ruminococcus 1.19 Janibacter 0.018 Gemmata 0.001 Byssovorax 0.000 Natronincola 0.002 
Unclassified 3.44 Ornithinimicrobium 0.018 Planctomyces 0.001 Unclassified 0.002 Unclassified 0.056 
Unclassified 3.70 Unclassified 0.008 Singulisphaera 0.001 Unclassified 0.006 Anaerococcus 0.127 
Catenibacterium 0.76 Kineococcus 0.000 Unclassified 0.002 Arcobacter 0.002 Finegoldia 0.069 
Erysipelotrichaceae 
incertae sedis 
1.90 Kineosporia 0.000 Unclassified 0.001 Campylobacter 0.049 Helcococcus 0.003 
Veillonella 0.77 Quadrisphaera 0.001 Asticcacaulis 0.002 Helicobacter 0.025 Parvimonas 0.009 
Unclassified 1.14 Unclassified 0.002 Unclassified 0.245 Buttiauxella 0.001 Peptoniphilus 0.066 
Unclassified 1.33 Agrococcus 0.051 Hyphomonas 0.001 Citrobacter 0.073 Sedimentibacter 0.000 
Other 24.00 Agromyces 0.001 Unclassified 0.005 Cosenzaea 0.000 Tissierella 0.002 




Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Genus-level (> 0.5%) Genus-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
  Leucobacter 0.004 Bartonella 0.002 Enterobacter 0.001 Mogibacterium 0.087 
  Microbacterium 0.004 Camelimonas 0.006 Klebsiella 0.013 Unclassified 0.069 
  Rathayibacter 0.003 Chelatococcus 0.058 Morganella 0.009 Anaerofustis 0.004 
  Unclassified 0.043 Unclassified 0.011 Pectobacterium 0.003 Eubacterium 0.063 
  Arthrobacter 0.025 Afipia 0.001 Proteus 0.025 Pseudoramibacter 0.005 
  Kocuria 0.089 Balneimonas 0.022 Providencia 0.003 Unclassified 0.013 
  Micrococcus 0.059 Bosea 0.013 Raoultella 0.000 Gracilibacter 0.001 
  Nesterenkonia 0.006 Bradyrhizobium 0.026 Salmonella 0.033 Anaerosphaera 0.001 
  Renibacterium 0.001 Salinarimonas 0.127 Serratia 0.118 Murdochiella 0.005 
  Yaniella 0.001 Unclassified 0.027 Photobacterium 0.003 Acetitomaculum 0.013 
  Unclassified 0.029 Mycoplana 0.000 Vibrio 0.028 Anaerostipes 0.327 
  Micromonospora 0.004 Unclassified 0.006 Succinatimonas 0.001 Catonella 0.003 
  Unclassified 0.001 Devosia 0.344 Succinivibrio 0.161 Cellulosilyticum 0.003 
  Mycobacterium 0.028 Gemmiger 0.246 Unclassified 0.000 Clostridium XlVb 0.085 
  Gordonia 0.046 Hyphomicrobium 0.004 Alishewanella 0.009 Hespellia 0.009 
  Millisia 0.000 Pedomicrobium 0.002 Haliea 0.001 Howardella 0.025 
  Nocardia 0.002 Rhodoplanes 0.001 Marinobacter 0.003 Lachnobacterium 0.001 
  Rhodococcus 0.004 Unclassified 0.001 Unclassified 0.055 Lactonifactor 0.014 
  Williamsia 0.003 Methylobacterium 0.023 Cardiobacterium 0.005 Marvinbryantia 0.008 
  Unclassified 0.000 Microvirga 0.127 Rheinheimera 0.175 Moryella 0.019 
  Aeromicrobium 0.033 Unclassified 0.029 Methylonatrum 0.001 Oribacterium 0.064 
  Kribbella 0.001 Aminobacter 0.001 Orbus 0.003 Parasporobacterium 0.000 
  Marmoricola 0.018 Mesorhizobium 0.001 Thiohalorhabdus 0.001 Pseudobutyrivibrio 0.014 
  Nocardioides 0.461 Unclassified 0.003 Aquicella 0.005 Robinsoniella 0.002 
  Unclassified 0.013 Anderseniella 0.001 Legionella 0.011 Shuttleworthia 0.001 
  Nocardiopsis 0.005 Parvibaculum 0.003 Alcanivorax 0.001 Syntrophococcus 0.002 
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Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Genus-level (> 0.5%) Genus-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
  Cellulosimicrobium 0.001 Ancylobacter 0.004 Hahella 0.001 Peptococcus 0.279 
  Isoptericola 0.002 Azorhizobium 0.003 Halomonas 0.028 Unclassified 0.003 
  Promicromonospora 0.002 Xanthobacter 0.063 Actinobacillus 0.015 Peptostreptococcus 0.040 
  Unclassified 0.000 Unclassified 0.043 Haemophilus 0.069 Sporacetigenium 0.000 
  Friedmanniella 0.001 Amaricoccus 0.000 Unclassified 0.132 Unclassified 0.099 
  Microlunatus 0.001 Catellibacterium 0.028 Alkanindiges 0.175 Acetanaerobacterium 0.004 
  Propionibacterium 0.049 Haematobacter 0.000 Enhydrobacter 0.124 Acetivibrio 0.007 
  Tessaracoccus 0.000 Pannonibacter 0.002 Moraxella 0.000 Anaerofilum 0.004 
  Unclassified 0.004 Paracoccus 0.292 Perlucidibaca 0.003 Anaerotruncus 0.034 
  Actinoalloteichus 0.001 Rhodobacter 0.055 Psychrobacter 0.006 Butyricicoccus 0.102 
  Actinomycetospora 0.002 Rubellimicrobium 0.179 Unclassified 0.008 Clostridium III 0.030 
  Prauserella 0.000 Unclassified 0.465 Azotobacter 0.002 Clostridium IV 0.469 
  Pseudonocardia 0.008 Acetobacter 0.003 Cellvibrio 0.004 Fastidiosipila 0.001 
  Saccharopolyspora 0.008 Craurococcus 0.005 Serpens 0.011 Flavonifractor 0.152 
  Unclassified 0.024 Paracraurococcus 0.001 Unclassified 0.216 Hydrogenoanaerobacterium 0.003 
  Sporichthya 0.001 Roseococcus 0.002 Unclassified 0.001 Oscillibacter 0.174 
  Streptacidiphilus 0.002 Roseomonas 0.142 Methylophaga 0.002 Papillibacter 0.018 
  Streptomyces 0.013 Rubritepida 0.002 Aquimonas 0.001 Pseudoflavonifractor 0.015 
  Unclassified 0.002 Unclassified 0.017 Arenimonas 0.004 Saccharofermentans 0.001 
  Unclassified 0.148 Azospirillum 0.145 Luteibacter 0.005 Sporobacter 0.239 
  Alloscardovia 0.010 Caenispirillum 0.001 Luteimonas 0.002 Subdoligranulum 0.233 
  Gardnerella 0.134 Desertibacter 0.020 Pseudoxanthomonas 0.026 Pelospora 0.000 
  Parascardovia 0.000 Novispirillum 0.050 Silanimonas 0.004 Thermohydrogenium 0.002 
  Scardovia 0.008 Rhodocista 0.156 Stenotrophomonas 0.004 Unclassified 0.000 
  Unclassified 0.063 Skermanella 0.037 Thermomonas 0.001 Unclassified 0.141 
  Asaccharobacter 0.014 Thalassospira 0.001 Xanthomonas 0.045 Allobaculum 0.000 
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Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Genus-level (> 0.5%) Genus-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
  Atopobium 0.115 Unclassified 0.058 Unclassified 0.029 Bulleidia 0.022 
  Cryptobacterium 0.000 Unclassified 0.007 Unclassified 0.238 Clostridium XVIII 0.338 
  Eggerthella 0.142 Mitochondria genus incertae sedis 0.043 Unclassified 0.356 Coprobacillus 0.011 
  Enterorhabdus 0.123 Rickettsia 0.000 Treponema 0.025 Erysipelothrix 0.004 
  Gordonibacter 0.013 Unclassified 0.001 Unclassified 0.000 Holdemania 0.016 
  Paraeggerthella 0.001 Altererythrobacter 0.004 Cloacibacillus 0.008 Solobacterium 0.022 
  Slackia 0.124 Erythrobacter 0.001 Jonquetella 0.001 Turicibacter 0.279 
  Conexibacter 0.070 Porphyrobacter 0.024 Pyramidobacter 0.000 Unclassified 0.266 
  Solirubrobacter 0.005 Unclassified 0.001 Unclassified 0.001 Acidaminococcus 0.102 
  Unclassified 0.005 Blastomonas 0.043 Asteroleplasma 0.002 Phascolarctobacterium 0.008 
  Thermoleophilum 0.003 Novosphingobium 0.078 Mycoplasma 0.001 Succiniclasticum 0.002 
  Unclassified 0.147 Sandaracinobacter 0.001 Ureaplasma 0.004 Unclassified 0.039 
  Hydrogenobacter 0.003 Sphingobium 0.017 Unclassified 0.002 Allisonella 0.068 
  Armatimonadetes gp5 0.007 Sphingopyxis 0.042 Cerasicoccus 0.005 Anaeroglobus 0.001 
  Unclassified 0.001 Sphingosinicella 0.007 Unclassified 0.002 Anaerosinus 0.005 
  Phocaeicola 0.000 Unclassified 0.130 5 genus incertae sedis 0.004 Centipeda 0.000 
  Anaerophaga 0.026 Unclassified 0.101 Akkermansia 0.161 Dialister 0.341 
  Unclassified 0.031 Alcaligenes 0.001 Prosthecobacter 0.002 Megamonas 0.197 
  Barnesiella 0.048 Pusillimonas 0.001 Unclassified 0.003 Megasphaera 0.406 
  Butyricimonas 0.062 Burkholderia 0.013 Chlorophyta 0.002 Mitsuokella 0.070 
  Dysgonomonas 0.002 Chitinimonas 0.021 Streptophyta 0.145 Negativicoccus 0.024 
  Odoribacter 0.029 Cupriavidus 0.177 Unclassified 0.003 Selenomonas 0.005 
  Paludibacter 0.003 Limnobacter 0.051 GpIIa 0.005 Sporomusa 0.001 
  Parabacteroides 0.376 Paucimonas 0.012 GpIV 0.002 Unclassified 0.127 
  Porphyromonas 0.008 Polynucleobacter 0.006 GpV 0.001 Unclassified 0.006 
  Tannerella 0.001 Ralstonia 0.143 Unclassified 0.006 OD1 genus incertae sedis 0.001 
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Table S1. Bacterial taxa sequenced from all faecal and meconium specimens (n = 305) with relative abundances > 0.5% and < 0.5% (continued) 
Genus-level (> 0.5%) Genus-level (< 0.5%) 
Taxon % Taxon % Taxon % Taxon % Taxon % 
  Unclassified 0.111 Unclassified 0.100 Tumebacillus 0.001 OP11 genus incertae sedis 0.001 
  Hallella 0.005 Aquabacterium 0.333 Anoxybacillus 0.005 TM7 genus incertae sedis 0.318 
  Paraprevotella 0.097 Inhella 0.004 Bacillus 0.078 Unclassified 0.005 
  Xylanibacter 0.001 Sphaerotilus 0.002 Geobacillus 0.003   
  Unclassified 0.137 Tepidimonas 0.006 Unclassified 0.028   
  Alistipes 0.172 Unclassified 0.006 Alkalibacillus 0.001   
  Unclassified 0.002 Albidiferax 0.009 Marinococcus 0.001   
  Anaerorhabdus 0.002 Caldimonas 0.004 Terribacillus 0.002   
  Unclassified 0.241 Comamonas 0.006 Unclassified 0.039   
  Algoriphagus 0.011 Curvibacter 0.012 Thermicanus 0.005   
  Haliscomenobacter 0.002 Delftia 0.019 Gemella 0.077   
  XChitinophaga 0.001 Hydrogenophaga 0.202 Exiguobacterium 0.030   
  Ferruginibacter 0.001 Pelomonas 0.001 Caldalkalibacillus 0.001   
  Flavihumibacter 0.003 Polaromonas 0.005 Listeria 0.002   
  Flavisolibacter 0.007 Schlegelella 0.004 Unclassified 0.000   
  Parasegetibacter 0.017 Simplicispira 0.001 Cohnella 0.002   
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Table S2. Phylum-level proportions of bacterial taxa with relative abundances > 0.5% sequenced from infant 
meconium specimens (n = 107) and maternal faecal specimens (n = 90) sampled at birth, infant faecal 
specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age 
Phyla (> 0.5%) 
Relative abundance (%) 
Infants at birth  Infants at 4 to 12 weeks Infants at 20 to 28 weeks Maternal at birth 
Actinobacteria 9.560 26.273 19.286 5.772 
Bacteroidetes 4.310 5.425 4.384 7.064 
Proteobacteria 59.671 18.721 11.759 4.714 
Firmicutes 22.909 48.528 63.716 79.385 
Unclassified 1.174 0.604 0.465 2.445 
Other 2.376 0.450 0.391 0.621 
 
Table S3. Phylum-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant 
meconium specimens (n = 107) and maternal faecal specimens (n = 90) sampled at birth, infant faecal 
specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age 
Phyla (< 0.5%) 
Relative abundance (%) 
Infants at birth Infants at 4 to 12 weeks Infants at 20 to 28 weeks Maternal at birth 
Crenarchaeota 0.020 0.000 0.000 0.000 
Euryarchaeota 0.080 0.030 0.010 0.230 
Acidobacteria 0.040 0.000 0.020 0.000 
Aquificae 0.010 0.000 0.000 0.000 
Armatimonadetes 0.020 0.000 0.000 0.000 
Chlamydiae 0.010 0.000 0.000 0.000 
Chloroflexi 0.170 0.000 0.000 0.000 
Deinococcus Thermus 0.310 0.030 0.020 0.020 
Elusimicrobia 0.020 0.010 0.000 0.050 
Fusobacteria 0.160 0.060 0.020 0.040 
Gemmatimonadetes 0.020 0.000 0.000 0.000 
Lentisphaerae 0.000 0.000 0.000 0.010 
Nitrospira 0.020 0.000 0.000 0.000 
Planctomycetes 0.020 0.000 0.000 0.000 
Spirochaetes 0.040 0.020 0.000 0.020 
Synergistetes 0.010 0.000 0.000 0.030 
Tenericutes 0.010 0.010 0.000 0.000 
Verrucomicrobia 0.180 0.140 0.290 0.170 
Cyanobacteria Chloroplast 0.450 0.010 0.000 0.000 
OD1 0.000 0.000 0.000 0.000 
OP11 0.000 0.000 0.000 0.000 
TM7 0.770 0.140 0.030 0.030 






Table S4. Genus-level proportions of bacterial taxa with relative abundances > 0.5% sequenced from infant 
meconium specimens (n = 107) and maternal faecal specimens (n = 90) sampled at birth, infant faecal 
specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age 
Genera (> 0.5%) 
Relative abundance (%) 
Infants at birth Infants at 4 to 12 weeks Infants at 20 to 28 weeks Maternal at birth 
Blastococcus 1.010 0.480 0.360 0.100 
Rothia 0.430 1.220 0.990 0.180 
Bifidobacterium 1.710 16.880 12.660 1.790 
Collinsella 0.490 1.700 1.200 0.570 
Olsenella 0.510 1.210 0.440 0.800 
Unclassified 0.640 2.270 1.320 1.350 
Prevotella 1.280 2.540 1.500 2.890 
Bacteroides 0.520 1.420 1.820 1.060 
Brevundimonas 2.130 0.070 0.090 0.010 
Caulobacter 1.060 0.700 0.490 0.110 
Phenylobacterium 1.390 0.040 0.050 0.010 
Aurantimonas 2.360 0.530 0.240 0.070 
Rhizobium 1.510 0.530 0.340 0.070 
Unclassified 1.940 0.340 0.300 0.090 
Sphingomonas 2.030 0.560 0.300 0.100 
Unclassified 1.340 0.140 0.200 0.070 
Acidovorax 1.100 0.670 0.400 0.120 
Unclassified 2.060 0.400 0.200 0.090 
Naxibacter 1.530 0.520 0.350 0.080 
Escherichia/Shigella 0.910 0.760 0.490 0.080 
Unclassified 3.260 3.840 2.410 0.360 
Aeromonas 3.560 0.760 0.400 0.130 
Shewanella 3.240 1.060 0.660 0.210 
Acinetobacter 6.280 1.980 0.980 0.580 
Pseudomonas 2.650 1.040 0.560 0.210 
Lysobacter 1.290 0.200 0.080 0.050 
Enterococcus 1.010 2.160 1.740 0.200 
Lactobacillus 0.720 5.730 3.280 0.460 
Weissella 0.480 1.680 1.640 0.160 
Streptococcus 1.420 7.830 5.060 0.500 
Unclassified 0.360 2.480 1.540 0.180 
Clostridium sensu stricto 0.850 0.600 0.890 0.790 
Blautia 1.220 1.720 3.560 5.950 
Clostridium XlVa 0.390 0.940 1.810 0.970 
Coprococcus 0.350 0.360 0.500 1.210 
Dorea 1.020 1.820 3.760 3.180 
Lachnospiracea incertae sedis 0.650 2.850 6.670 4.410 
Roseburia 0.140 0.020 0.210 1.500 
Unclassified 1.770 3.240 11.100 14.410 




Table S4. Genus-level proportions of bacterial taxa with relative abundances > 0.5% sequenced from infant 
meconium specimens (n = 107) and maternal faecal specimens (n = 90) sampled at birth, infant faecal 
specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (> 0.5%) 
Relative abundance (%) 
Infants at birth Infants at 4 to 12 weeks Infants at 20 to 28 weeks Maternal at birth 
Faecalibacterium 0.350 0.400 0.470 3.040 
Ruminococcus 0.340 0.030 0.210 3.510 
Unclassified 0.880 0.220 0.870 10.090 
Unclassified 1.130 1.010 1.520 9.760 
Catenibacterium 0.630 0.800 0.700 0.900 
Erysipelotrichaceae incertae 
sedis 
0.900 2.200 2.840 2.460 
Veillonella 0.280 1.940 1.540 0.120 
Unclassified 0.400 0.690 0.720 2.530 
Unclassified 1.170 0.600 0.460 2.440 




















Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Fervidicoccus 0.020 0.000 0.000 0.000 Brevibacterium 0.020 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Cellulomonas 0.030 0.000 0.000 0.000 
Methanobrevibacter 0.070 0.030 0.000 0.140 Unclassified 0.020 0.000 0.000 0.000 
Methanosphaera 0.010 0.000 0.000 0.080 Corynebacterium 0.280 0.000 0.030 0.000 
Methanothermobacter 0.000 0.000 0.000 0.000 Demequina 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.010 Brachybacterium 0.050 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Dermabacter 0.010 0.000 0.040 0.000 
Gp10 0.010 0.000 0.000 0.000 Helcobacillus 0.000 0.000 0.000 0.000 
Gp16 0.000 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Gp3 0.000 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Gp4 0.010 0.000 0.020 0.000 Piscicoccus 0.010 0.000 0.020 0.000 
Gp6 0.010 0.000 0.000 0.000 Dietzia 0.110 0.060 0.020 0.010 
Gp7 0.000 0.000 0.000 0.000 Geodermatophilus 0.100 0.010 0.000 0.010 
Aciditerrimonas 0.000 0.000 0.000 0.000 Modestobacter 0.020 0.000 0.000 0.000 
Ilumatobacter 0.010 0.000 0.000 0.000 Unclassified 0.060 0.000 0.000 0.000 
Unclassified 0.010 0.000 0.000 0.000 Arsenicicoccus 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Janibacter 0.040 0.010 0.000 0.000 
Actinobaculum 0.000 0.010 0.000 0.000 Ornithinimicrobium 0.050 0.000 0.000 0.000 
Actinomyces 0.100 0.480 0.470 0.180 Unclassified 0.020 0.000 0.000 0.000 
Arcanobacterium 0.000 0.000 0.000 0.000 Kineococcus 0.000 0.000 0.000 0.000 
Mobiluncus 0.000 0.000 0.000 0.010 Kineosporia 0.000 0.000 0.000 0.000 
Trueperella 0.000 0.000 0.000 0.000 Quadrisphaera 0.000 0.000 0.000 0.000 
Varibaculum 0.000 0.110 0.050 0.010 Unclassified 0.010 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Agrococcus 0.130 0.020 0.020 0.000 
Georgenia 0.000 0.000 0.000 0.000 Agromyces 0.000 0.000 0.000 0.000 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Frondihabitans 0.000 0.000 0.000 0.000 Unclassified 0.040 0.000 0.000 0.000 
Leucobacter 0.010 0.000 0.000 0.000 Nocardiopsis 0.010 0.010 0.000 0.000 
Microbacterium 0.010 0.000 0.000 0.000 Cellulosimicrobium 0.000 0.000 0.000 0.000 
Rathayibacter 0.010 0.000 0.000 0.000 Isoptericola 0.000 0.000 0.000 0.000 
Unclassified 0.120 0.000 0.000 0.000 Promicromonospora 0.010 0.000 0.000 0.000 
Arthrobacter 0.070 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Kocuria 0.140 0.100 0.120 0.010 Friedmanniella 0.000 0.000 0.000 0.000 
Micrococcus 0.130 0.030 0.000 0.020 Microlunatus 0.000 0.000 0.000 0.000 
Nesterenkonia 0.020 0.000 0.000 0.000 Propionibacterium 0.130 0.010 0.020 0.000 
Renibacterium 0.000 0.000 0.000 0.000 Tessaracoccus 0.000 0.000 0.000 0.000 
Yaniella 0.000 0.000 0.000 0.000 Unclassified 0.010 0.000 0.000 0.000 
Unclassified 0.060 0.030 0.010 0.000 Actinoalloteichus 0.000 0.000 0.000 0.000 
Micromonospora 0.010 0.000 0.000 0.000 Actinomycetospora 0.010 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Prauserella 0.000 0.000 0.000 0.000 
Mycobacterium 0.080 0.000 0.000 0.000 Pseudonocardia 0.020 0.000 0.000 0.000 
Gordonia 0.120 0.010 0.000 0.000 Saccharopolyspora 0.020 0.010 0.000 0.000 
Millisia 0.000 0.000 0.000 0.000 Unclassified 0.060 0.020 0.000 0.000 
Nocardia 0.000 0.000 0.020 0.000 Sporichthya 0.000 0.000 0.000 0.000 
Rhodococcus 0.010 0.000 0.000 0.000 Streptacidiphilus 0.010 0.000 0.000 0.000 
Williamsia 0.000 0.010 0.000 0.000 Streptomyces 0.040 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Aeromicrobium 0.090 0.000 0.020 0.000 Unclassified 0.270 0.140 0.070 0.040 
Kribbella 0.000 0.000 0.000 0.000 Alloscardovia 0.000 0.030 0.000 0.010 
Marmoricola 0.040 0.010 0.000 0.000 Gardnerella 0.300 0.070 0.020 0.030 
Nocardioides 1.180 0.120 0.060 0.040 Parascardovia 0.000 0.000 0.000 0.000 
175 
 
Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Scardovia 0.000 0.020 0.000 0.010 Paludibacter 0.010 0.000 0.000 0.000 
Unclassified 0.000 0.180 0.110 0.020 Parabacteroides 0.280 0.600 0.430 0.290 
Asaccharobacter 0.000 0.000 0.030 0.030 Porphyromonas 0.020 0.000 0.000 0.000 
Atopobium 0.050 0.290 0.180 0.020 Tannerella 0.000 0.000 0.000 0.000 
Cryptobacterium 0.000 0.000 0.000 0.000 Unclassified 0.120 0.040 0.040 0.180 
Eggerthella 0.040 0.240 0.570 0.020 Hallella 0.010 0.000 0.000 0.000 
Enterorhabdus 0.070 0.080 0.120 0.210 Paraprevotella 0.040 0.000 0.020 0.270 
Gordonibacter 0.020 0.010 0.020 0.010 Xylanibacter 0.000 0.000 0.000 0.000 
Paraeggerthella 0.000 0.000 0.000 0.000 Unclassified 0.110 0.100 0.030 0.240 
Slackia 0.030 0.160 0.170 0.180 Alistipes 0.090 0.100 0.190 0.320 
Conexibacter 0.180 0.000 0.040 0.000 Unclassified 0.000 0.000 0.000 0.000 
Solirubrobacter 0.010 0.000 0.000 0.000 Anaerorhabdus 0.000 0.000 0.000 0.010 
Unclassified 0.010 0.000 0.000 0.000 Unclassified 0.090 0.150 0.100 0.540 
Thermoleophilum 0.010 0.000 0.000 0.000 Algoriphagus 0.020 0.000 0.020 0.000 
Unclassified 0.180 0.230 0.080 0.070 Haliscomenobacter 0.010 0.000 0.000 0.000 
Hydrogenobacter 0.010 0.000 0.000 0.000 Chitinophaga 0.000 0.000 0.000 0.000 
Armatimonadetes gp5 0.020 0.000 0.000 0.000 Ferruginibacter 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Flavihumibacter 0.010 0.000 0.000 0.000 
Phocaeicola 0.000 0.000 0.000 0.000 Flavisolibacter 0.020 0.000 0.000 0.000 
Anaerophaga 0.020 0.030 0.000 0.040 Parasegetibacter 0.050 0.000 0.000 0.000 
Unclassified 0.020 0.010 0.000 0.070 Sediminibacterium 0.160 0.000 0.030 0.000 
Barnesiella 0.010 0.020 0.010 0.140 Unclassified 0.090 0.020 0.020 0.000 
Butyricimonas 0.010 0.020 0.040 0.160 Adhaeribacter 0.020 0.030 0.000 0.000 
Dysgonomonas 0.000 0.010 0.000 0.000 Dyadobacter 0.080 0.000 0.030 0.000 
Odoribacter 0.010 0.020 0.030 0.060 Hymenobacter 0.010 0.000 0.000 0.000 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Litoribacter 0.010 0.000 0.000 0.000 Cetobacterium 0.000 0.000 0.000 0.010 
Pontibacter 0.120 0.020 0.000 0.000 Fusobacterium 0.110 0.040 0.020 0.030 
Unclassified 0.030 0.000 0.000 0.000 Leptotrichia 0.030 0.010 0.000 0.000 
Pedobacter 0.020 0.000 0.000 0.000 Sneathia 0.010 0.020 0.000 0.000 
Sphingobacterium 0.010 0.000 0.000 0.000 Streptobacillus 0.000 0.000 0.000 0.000 
Unclassified 0.100 0.020 0.000 0.100 Unclassified 0.010 0.000 0.000 0.000 
Capnocytophaga 0.010 0.000 0.000 0.000 Gemmatimonas 0.020 0.000 0.000 0.000 
Chryseobacterium 0.020 0.000 0.000 0.000 Victivallis 0.000 0.000 0.000 0.010 
Cloacibacterium 0.220 0.050 0.030 0.010 Unclassified 0.000 0.000 0.000 0.000 
Flavobacterium 0.450 0.100 0.030 0.020 Nitrospira 0.020 0.000 0.000 0.000 
Riemerella 0.020 0.000 0.000 0.000 Blastopirellula 0.010 0.000 0.000 0.000 
Unclassified 0.020 0.010 0.000 0.000 Gemmata 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Planctomyces 0.000 0.000 0.000 0.000 
Unclassified 0.140 0.120 0.020 0.630 Singulisphaera 0.000 0.000 0.000 0.000 
Chlamydia 0.000 0.000 0.000 0.000 Unclassified 0.010 0.000 0.000 0.000 
Neochlamydia 0.000 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Parachlamydia 0.000 0.000 0.000 0.000 Asticcacaulis 0.000 0.000 0.000 0.000 
Herpetosiphon 0.000 0.000 0.000 0.000 Unclassified 0.630 0.070 0.040 0.010 
Sphaerobacter 0.160 0.000 0.000 0.000 Hyphomonas 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Unclassified 0.010 0.000 0.000 0.000 
Unclassified 0.010 0.000 0.000 0.000 Unclassified 0.010 0.000 0.000 0.000 
Deinococcus 0.300 0.030 0.020 0.020 Bartonella 0.010 0.000 0.000 0.000 
Truepera 0.000 0.000 0.000 0.000 Camelimonas 0.020 0.000 0.000 0.000 
Thermus 0.010 0.000 0.000 0.000 Chelatococcus 0.140 0.020 0.000 0.020 
Elusimicrobium 0.020 0.010 0.000 0.050 Unclassified 0.030 0.000 0.000 0.000 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Afipia 0.000 0.000 0.000 0.000 Unclassified 0.110 0.020 0.010 0.000 
Balneimonas 0.050 0.010 0.000 0.000 Amaricoccus 0.000 0.000 0.000 0.000 
Bosea 0.040 0.000 0.000 0.000 Catellibacterium 0.080 0.000 0.000 0.000 
Bradyrhizobium 0.080 0.000 0.000 0.000 Haematobacter 0.000 0.000 0.000 0.000 
Salinarimonas 0.270 0.100 0.040 0.010 Pannonibacter 0.010 0.000 0.000 0.000 
Unclassified 0.080 0.000 0.000 0.000 Paracoccus 0.730 0.090 0.060 0.030 
Mycoplana 0.000 0.000 0.000 0.000 Rhodobacter 0.150 0.000 0.000 0.010 
Unclassified 0.010 0.000 0.000 0.000 Rubellimicrobium 0.470 0.040 0.000 0.010 
Devosia 0.710 0.230 0.210 0.060 Unclassified 0.930 0.360 0.260 0.080 
Gemmiger 0.160 0.200 0.190 0.410 Acetobacter 0.000 0.010 0.000 0.000 
Hyphomicrobium 0.010 0.010 0.000 0.000 Craurococcus 0.010 0.000 0.000 0.000 
Pedomicrobium 0.000 0.000 0.000 0.000 Paracraurococcus 0.000 0.000 0.000 0.000 
Rhodoplanes 0.000 0.000 0.000 0.000 Roseococcus 0.010 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Roseomonas 0.330 0.070 0.050 0.020 
Methylobacterium 0.070 0.000 0.000 0.000 Rubritepida 0.010 0.000 0.000 0.000 
Microvirga 0.290 0.050 0.030 0.040 Unclassified 0.040 0.000 0.020 0.000 
Unclassified 0.070 0.020 0.000 0.000 Azospirillum 0.360 0.070 0.020 0.000 
Aminobacter 0.000 0.000 0.000 0.000 Caenispirillum 0.000 0.000 0.000 0.000 
Mesorhizobium 0.000 0.000 0.000 0.000 Desertibacter 0.040 0.030 0.000 0.000 
Unclassified 0.010 0.000 0.000 0.000 Novispirillum 0.140 0.000 0.000 0.000 
Anderseniella 0.000 0.000 0.000 0.000 Rhodocista 0.410 0.040 0.010 0.010 
Parvibaculum 0.010 0.000 0.000 0.000 Skermanella 0.070 0.030 0.020 0.000 
Ancylobacter 0.000 0.010 0.000 0.000 Thalassospira 0.000 0.000 0.000 0.000 
Azorhizobium 0.010 0.000 0.000 0.000 Unclassified 0.140 0.030 0.000 0.010 
Xanthobacter 0.160 0.030 0.000 0.000 Unclassified 0.020 0.000 0.000 0.000 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Mitochondria genus incertae 
sedis 
0.110 0.000 0.040 0.000 Unclassified 0.210 0.080 0.030 0.010 
Rickettsia 0.000 0.000 0.000 0.000 Aquabacterium 0.780 0.170 0.090 0.030 
Unclassified 0.000 0.000 0.000 0.000 Inhella 0.010 0.000 0.000 0.000 
Altererythrobacter 0.010 0.000 0.000 0.000 Sphaerotilus 0.000 0.000 0.000 0.000 
Erythrobacter 0.000 0.000 0.000 0.000 Tepidimonas 0.020 0.000 0.000 0.000 
Porphyrobacter 0.070 0.000 0.000 0.000 Unclassified 0.010 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Albidiferax 0.020 0.000 0.000 0.000 
Blastomonas 0.120 0.010 0.000 0.000 Caldimonas 0.010 0.000 0.000 0.000 
Novosphingobium 0.190 0.030 0.020 0.010 Comamonas 0.020 0.000 0.000 0.000 
Sandaracinobacter 0.000 0.000 0.000 0.000 Curvibacter 0.030 0.000 0.000 0.000 
Sphingobium 0.050 0.000 0.000 0.000 Delftia 0.060 0.000 0.000 0.000 
Sphingopyxis 0.110 0.010 0.000 0.000 Hydrogenophaga 0.480 0.120 0.030 0.010 
Sphingosinicella 0.020 0.000 0.000 0.000 Pelomonas 0.000 0.000 0.000 0.000 
Unclassified 0.320 0.040 0.020 0.020 Polaromonas 0.010 0.010 0.000 0.000 
Unclassified 0.200 0.110 0.020 0.010 Schlegelella 0.010 0.000 0.000 0.000 
Alcaligenes 0.000 0.000 0.000 0.000 Simplicispira 0.000 0.000 0.000 0.000 
Pusillimonas 0.000 0.000 0.000 0.000 Variovorax 0.010 0.000 0.000 0.000 
Burkholderia 0.040 0.000 0.000 0.000 Duganella 0.010 0.000 0.000 0.000 
Chitinimonas 0.050 0.010 0.000 0.010 Herbaspirillum 0.050 0.000 0.000 0.000 
Cupriavidus 0.420 0.050 0.060 0.030 Herminiimonas 0.000 0.000 0.000 0.000 
Limnobacter 0.120 0.020 0.020 0.000 Janthinobacterium 0.040 0.000 0.000 0.000 
Paucimonas 0.020 0.010 0.020 0.010 Massilia 0.770 0.170 0.030 0.040 
Polynucleobacter 0.020 0.000 0.000 0.000 Oxalicibacterium 0.270 0.090 0.070 0.060 
Ralstonia 0.380 0.030 0.020 0.000 Oxalobacter 0.000 0.000 0.000 0.000 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Undibacterium 0.220 0.020 0.000 0.000 Bilophila 0.020 0.050 0.020 0.090 
Unclassified 0.510 0.040 0.050 0.050 Desulfovibrio 0.090 0.110 0.080 0.200 
Parasutterella 0.020 0.010 0.050 0.030 Unclassified 0.000 0.000 0.000 0.010 
Sutterella 0.110 0.190 0.240 0.130 Unclassified 0.010 0.000 0.000 0.050 
Unclassified 0.000 0.000 0.000 0.000 Cystobacter 0.000 0.000 0.000 0.000 
Unclassified 0.980 0.210 0.130 0.080 Unclassified 0.000 0.000 0.000 0.000 
Hydrogenophilus 0.000 0.000 0.000 0.000 Nannocystis 0.000 0.010 0.000 0.000 
Petrobacter 0.010 0.000 0.000 0.000 Phaselicystis 0.010 0.000 0.000 0.000 
Unclassified 0.010 0.000 0.000 0.000 Byssovorax 0.000 0.000 0.000 0.000 
Iodobacter 0.000 0.000 0.000 0.000 Unclassified 0.010 0.000 0.000 0.000 
Vogesella 0.300 0.020 0.000 0.020 Unclassified 0.000 0.000 0.000 0.020 
Unclassified 0.020 0.010 0.000 0.000 Arcobacter 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Campylobacter 0.050 0.080 0.060 0.010 
Azoarcus 0.020 0.000 0.000 0.000 Helicobacter 0.040 0.010 0.070 0.000 
Azospira 0.020 0.000 0.000 0.000 Buttiauxella 0.000 0.000 0.000 0.000 
Shinella 0.000 0.000 0.000 0.000 Citrobacter 0.130 0.100 0.030 0.000 
Zoogloea 0.000 0.000 0.000 0.000 Cosenzaea 0.000 0.000 0.000 0.000 
Unclassified 0.030 0.000 0.000 0.000 Cronobacter 0.010 0.000 0.010 0.000 
Unclassified 0.050 0.020 0.000 0.030 Enterobacter 0.000 0.000 0.000 0.000 
Bacteriovorax 0.020 0.000 0.010 0.000 Klebsiella 0.030 0.000 0.010 0.000 
Peredibacter 0.290 0.000 0.000 0.010 Morganella 0.000 0.000 0.070 0.000 
Bdellovibrio 0.180 0.030 0.000 0.000 Pectobacterium 0.010 0.000 0.000 0.000 
Vampirovibrio 0.000 0.000 0.000 0.010 Proteus 0.020 0.040 0.060 0.000 
Desulfomicrobium 0.000 0.000 0.000 0.000 Providencia 0.010 0.000 0.000 0.000 
Neisseria 0.180 0.000 0.000 0.000 Raoultella 0.000 0.000 0.000 0.000 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Salmonella 0.070 0.020 0.040 0.000 Unclassified 0.240 0.070 0.150 0.050 
Serratia 0.230 0.100 0.100 0.010 Alkanindiges 0.400 0.090 0.040 0.020 
Photobacterium 0.010 0.000 0.000 0.000 Enhydrobacter 0.290 0.050 0.040 0.020 
Vibrio 0.080 0.000 0.000 0.000 Moraxella 0.000 0.000 0.000 0.000 
Succinatimonas 0.000 0.000 0.000 0.000 Perlucidibaca 0.010 0.000 0.000 0.000 
Succinivibrio 0.200 0.130 0.160 0.140 Psychrobacter 0.020 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Unclassified 0.010 0.020 0.000 0.000 
Alishewanella 0.020 0.000 0.000 0.000 Azotobacter 0.010 0.000 0.000 0.000 
Haliea 0.000 0.000 0.000 0.000 Cellvibrio 0.010 0.000 0.000 0.000 
Marinobacter 0.010 0.000 0.000 0.000 Serpens 0.030 0.000 0.000 0.000 
Unclassified 0.130 0.020 0.020 0.000 Unclassified 0.590 0.010 0.040 0.000 
Cardiobacterium 0.020 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Rheinheimera 0.440 0.070 0.020 0.010 Methylophaga 0.010 0.000 0.000 0.000 
Methylonatrum 0.000 0.000 0.000 0.000 Aquimonas 0.000 0.000 0.000 0.000 
Orbus 0.010 0.000 0.000 0.000 Arenimonas 0.000 0.010 0.000 0.000 
Thiohalorhabdus 0.000 0.000 0.000 0.000 Luteibacter 0.010 0.000 0.010 0.000 
Aquicella 0.010 0.000 0.000 0.000 Luteimonas 0.010 0.000 0.000 0.000 
Legionella 0.030 0.000 0.000 0.000 Pseudoxanthomonas 0.050 0.010 0.030 0.000 
Alcanivorax 0.000 0.000 0.000 0.000 Silanimonas 0.010 0.000 0.000 0.000 
Hahella 0.000 0.000 0.000 0.000 Stenotrophomonas 0.010 0.000 0.000 0.000 
Halomonas 0.080 0.000 0.000 0.000 Thermomonas 0.000 0.000 0.000 0.000 
Actinobacillus 0.040 0.000 0.000 0.000 Xanthomonas 0.090 0.040 0.010 0.010 




Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Unclassified 0.470 0.210 0.120 0.020 Tumebacillus 0.000 0.000 0.000 0.000 
Unclassified 0.640 0.220 0.140 0.210 Anoxybacillus 0.010 0.000 0.000 0.000 
Treponema 0.040 0.020 0.000 0.020 Bacillus 0.190 0.040 0.000 0.010 
Unclassified 0.000 0.000 0.000 0.000 Geobacillus 0.000 0.010 0.000 0.000 
Cloacibacillus 0.000 0.000 0.000 0.020 Unclassified 0.060 0.020 0.000 0.010 
Jonquetella 0.000 0.000 0.000 0.000 Alkalibacillus 0.000 0.000 0.000 0.000 
Pyramidobacter 0.000 0.000 0.000 0.000 Marinococcus 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.000 Terribacillus 0.000 0.000 0.000 0.000 
Asteroleplasma 0.000 0.010 0.000 0.000 Unclassified 0.090 0.010 0.020 0.000 
Mycoplasma 0.000 0.000 0.000 0.000 Thermicanus 0.010 0.000 0.000 0.000 
Ureaplasma 0.010 0.000 0.000 0.000 Gemella 0.130 0.060 0.090 0.020 
Unclassified 0.000 0.000 0.000 0.000 Exiguobacterium 0.090 0.000 0.000 0.000 
Cerasicoccus 0.000 0.000 0.000 0.020 Caldalkalibacillus 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.010 Listeria 0.010 0.000 0.000 0.000 
5 genus incertae sedis 0.010 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Akkermansia 0.150 0.140 0.290 0.140 Cohnella 0.000 0.000 0.000 0.000 
Prosthecobacter 0.010 0.000 0.000 0.000 Paenibacillus 0.020 0.000 0.000 0.000 
Unclassified 0.010 0.000 0.000 0.000 Ammoniphilus 0.000 0.000 0.000 0.000 
Chlorophyta 0.000 0.000 0.000 0.000 Oxalophagus 0.010 0.000 0.000 0.000 
Streptophyta 0.400 0.010 0.000 0.000 Jeotgalibacillus 0.000 0.000 0.000 0.000 
Unclassified 0.010 0.000 0.000 0.000 Lysinibacillus 0.000 0.000 0.000 0.000 
GpIIa 0.010 0.000 0.000 0.000 Planomicrobium 0.150 0.000 0.000 0.000 
GpIV 0.010 0.000 0.000 0.000 Ureibacillus 0.000 0.000 0.000 0.000 
GpV 0.000 0.000 0.000 0.000 Unclassified 0.360 0.170 0.150 0.050 
Unclassified 0.020 0.000 0.000 0.000 Sporolactobacillaceae incertae sedis 0.050 0.000 0.040 0.010 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Jeotgalicoccus 0.070 0.000 0.000 0.000 Lactococcus 0.200 0.990 1.070 0.070 
Macrococcus 0.000 0.000 0.000 0.000 Unclassified 0.010 0.110 0.080 0.010 
Nosocomiicoccus 0.000 0.000 0.010 0.000 Unclassified 0.220 0.390 0.320 0.040 
Staphylococcus 0.530 0.330 0.220 0.020 Anaerosporobacter 0.000 0.000 0.000 0.030 
Unclassified 0.160 0.110 0.060 0.000 Proteiniclasticum 0.010 0.000 0.020 0.000 
Unclassified 0.230 0.040 0.000 0.010 Sarcina 0.230 0.270 0.160 0.250 
Aerococcus 0.010 0.000 0.000 0.000 Unclassified 0.150 0.130 0.090 0.290 
Facklamia 0.020 0.000 0.000 0.000 Natronincola 0.000 0.010 0.000 0.000 
Globicatella 0.010 0.000 0.020 0.010 Unclassified 0.020 0.030 0.010 0.140 
Unclassified 0.010 0.000 0.000 0.000 Anaerococcus 0.200 0.140 0.130 0.030 
Atopostipes 0.060 0.000 0.000 0.000 Finegoldia 0.060 0.130 0.080 0.020 
Carnobacterium 0.010 0.000 0.000 0.000 Helcococcus 0.010 0.000 0.000 0.000 
Desemzia 0.010 0.000 0.000 0.000 Parvimonas 0.010 0.010 0.000 0.010 
Dolosigranulum 0.100 0.050 0.060 0.010 Peptoniphilus 0.020 0.170 0.090 0.020 
Granulicatella 0.030 0.050 0.100 0.020 Sedimentibacter 0.000 0.000 0.000 0.000 
Isobaculum 0.000 0.000 0.000 0.000 Tissierella 0.000 0.000 0.000 0.000 
Trichococcus 0.010 0.000 0.000 0.000 Unclassified 0.010 0.010 0.010 0.010 
Unclassified 0.000 0.070 0.030 0.010 Mogibacterium 0.070 0.030 0.080 0.160 
Vagococcus 0.010 0.000 0.000 0.000 Unclassified 0.020 0.020 0.000 0.200 
Unclassified 0.080 0.320 0.260 0.010 Anaerofustis 0.000 0.000 0.000 0.010 
Paralactobacillus 0.000 0.020 0.010 0.000 Eubacterium 0.010 0.100 0.070 0.090 
Pediococcus 0.000 0.000 0.000 0.000 Pseudoramibacter 0.000 0.000 0.040 0.000 
Unclassified 0.030 0.360 0.260 0.110 Unclassified 0.000 0.000 0.090 0.010 
Leuconostoc 0.140 0.440 0.700 0.040 Gracilibacter 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.090 0.150 0.000 Anaerosphaera 0.000 0.000 0.000 0.000 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Murdochiella 0.000 0.010 0.000 0.010 Anaerofilum 0.000 0.000 0.000 0.010 
Acetitomaculum 0.000 0.000 0.010 0.040 Anaerotruncus 0.010 0.020 0.020 0.080 
Anaerostipes 0.080 0.020 0.700 0.720 Butyricicoccus 0.020 0.010 0.220 0.230 
Catonella 0.010 0.000 0.000 0.000 Clostridium III 0.020 0.000 0.020 0.070 
Cellulosilyticum 0.010 0.000 0.000 0.000 Clostridium IV 0.150 0.210 0.250 1.140 
Clostridium XlVb 0.020 0.140 0.100 0.110 Fastidiosipila 0.000 0.000 0.000 0.000 
Hespellia 0.010 0.000 0.000 0.020 Flavonifractor 0.050 0.210 0.490 0.100 
Howardella 0.010 0.010 0.010 0.070 Hydrogenoanaerobacterium 0.000 0.000 0.000 0.010 
Lachnobacterium 0.000 0.000 0.000 0.000 Oscillibacter 0.040 0.020 0.020 0.520 
Lactonifactor 0.000 0.010 0.020 0.030 Papillibacter 0.000 0.000 0.000 0.060 
Marvinbryantia 0.000 0.020 0.000 0.010 Pseudoflavonifractor 0.000 0.000 0.000 0.050 
Moryella 0.000 0.030 0.060 0.010 Saccharofermentans 0.000 0.000 0.000 0.000 
Oribacterium 0.070 0.030 0.040 0.100 Sporobacter 0.070 0.030 0.040 0.680 
Parasporobacterium 0.000 0.000 0.000 0.000 Subdoligranulum 0.050 0.180 0.210 0.500 
Pseudobutyrivibrio 0.010 0.010 0.010 0.030 Pelospora 0.000 0.000 0.000 0.000 
Robinsoniella 0.000 0.000 0.000 0.010 Thermohydrogenium 0.010 0.000 0.000 0.000 
Shuttleworthia 0.000 0.000 0.000 0.000 Unclassified 0.000 0.000 0.000 0.000 
Syntrophococcus 0.000 0.000 0.020 0.000 Unclassified 0.050 0.040 0.010 0.380 
Peptococcus 0.110 0.120 0.150 0.650 Allobaculum 0.000 0.000 0.000 0.000 
Unclassified 0.000 0.000 0.000 0.010 Bulleidia 0.010 0.030 0.000 0.040 
Peptostreptococcus 0.020 0.070 0.080 0.030 Clostridium XVIII 0.220 0.490 0.760 0.190 
Sporacetigenium 0.000 0.000 0.000 0.000 Coprobacillus 0.000 0.000 0.050 0.020 
Unclassified 0.090 0.020 0.080 0.180 Erysipelothrix 0.010 0.000 0.000 0.000 
Acetanaerobacterium 0.000 0.000 0.000 0.010 Holdemania 0.000 0.000 0.000 0.050 
Acetivibrio 0.000 0.000 0.000 0.020 Solobacterium 0.010 0.020 0.070 0.020 
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Table S5. Genus-level proportions of bacterial taxa with relative abundances < 0.5% sequenced from infant meconium specimens (n = 107) and maternal faecal specimens 
(n = 90) sampled at birth, infant faecal specimens sampled at 4-12 (n = 72) and 20-28 (n = 36) weeks of age (continued) 
Genera (< 0.5%) 
Relative abundance (%) 
Genera (< 0.5%) 
Relative abundance (%) 
Infants at 
birth 
Infants at  
4 to 12 weeks 
Infants at  





Infants at  
4 to 12 weeks 
Infants at  
20 to 28 weeks 
Maternal 
at birth 
Turicibacter 0.230 0.120 0.210 0.490 Megasphaera 0.220 0.620 0.950 0.240 
Unclassified 0.160 0.250 0.130 0.450 Mitsuokella 0.050 0.040 0.050 0.130 
Acidaminococcus 0.050 0.120 0.140 0.130 Negativicoccus 0.000 0.100 0.000 0.000 
Phascolarctobacterium 0.000 0.010 0.000 0.010 Selenomonas 0.010 0.010 0.000 0.000 
Succiniclasticum 0.000 0.000 0.000 0.000 Sporomusa 0.000 0.000 0.000 0.000 
Unclassified 0.020 0.030 0.020 0.080 Unclassified 0.020 0.200 0.290 0.130 
Allisonella 0.010 0.050 0.040 0.160 Unclassified 0.000 0.000 0.020 0.010 
Anaeroglobus 0.000 0.000 0.000 0.000 OD1 genus incertae sedis 0.000 0.000 0.000 0.000 
Anaerosinus 0.000 0.010 0.020 0.000 OP11 genus incertae sedis 0.000 0.000 0.000 0.000 
Centipeda 0.000 0.000 0.000 0.000 TM7 genus incertae sedis 0.770 0.140 0.030 0.030 
Dialister 0.170 0.360 0.280 0.550 Unclassified 0.010 0.000 0.000 0.010 









Table S6. Significant differences in proportions of bacterial OTUs from infant meconium specimens (n = 107) 
when compared to maternal faecal specimens sampled at birth (n = 90) 
Taxon level Bacterial OTUs Rate ratio p-value 
Higher proportions 
from maternal or 
infant specimens 
Phylum Actinobacteria 1.7 <0.0001 I 
Class Actinobacteria 1.7 <0.0001 I 
Order Actinomycetales 9.8 <0.0001 I 
Order Coriobacteriales 0.6 <0.0001 M 
Family Coriobacteriaceae 0.6 <0.0001 M 
Genus Olsenella 0.6 0.0002 M 
Genus Unclassified 0.4 <0.0001 M 
Phylum Bacteroidetes 0.6 <0.0001 M 
Class Bacteroidia 0.4 <0.0001 M 
Order Bacteroidales 0.4 <0.0001 M 
Family Porphyromonadaceae 0.5 <0.0001 M 
Family Prevotellaceae 0.4 <0.0001 M 
Genus Prevotella 0.5 <0.0001 M 
Family Bacteroidaceae 0.3 <0.0001 M 
Genus Bacteroides 0.3 0.03753 M 
Class Unclassified 0.3 <0.0001 M 
Order Unclassified 0.3 <0.0001 M 
Family Unclassified 0.3 <0.0001 M 
Genus Unclassified 0.3 <0.0001 M 
Phylum Proteobacteria 14.7 <0.0001 I 
Class Alphaproteobacteria 19.3 <0.0001 I 
Order Caulobacterales 35.0 <0.0001 I 
Family Caulobacteraceae 35.0 <0.0001 I 
Genus Brevundimonas 170.0 <0.0001 I 
Order Rhizobiales 12.0 <0.0001 I 
Family Aurantimonadaceae 33.5 <0.0001 I 
Genus Aurantimonas 34.2 <0.0001 I 
Family Hyphomicrobiaceae 2.5 <0.0001 I 
Family Unclassified 26.9 <0.0001 I 
Genus Unclassified 26.9 <0.0001 I 
Order Rhodobacterales 25.5 <0.0001 I 
Family Rhodobacteraceae 25.5 <0.0001 I 
Order Sphingomonadales 25.8 <0.0001 I 
Family Sphingomonadaceae 25.1 <0.0001 I 
Genus Sphingomonas 21.2 <0.0001 I 
Order Unclassified 22.5 <0.0001 I 
Family Unclassified 22.5 <0.0001 I 
Genus Unclassified 22.5 <0.0001 I 
Class Betaproteobacteria 15.2 <0.0001 I 




Table S6. Significant differences in proportions of bacterial OTUs from infant meconium specimens (n = 107) 
when compared to maternal faecal specimens sampled at birth (n = 90) (continued) 
Taxon level Bacterial OTUs Rate ratio p-value 
Higher proportions 
from maternal or 
infant specimens 
Family Comamonadaceae 19.8 <0.0001 I 
Genus Unclassified 26.2 <0.0001 I 
Family Oxalobacteraceae 15.2 <0.0001 I 
Genus Naxibacter 20.2 <0.0001 I 
Class Gammaproteobacteria 15.3 <0.0001 I 
Order Enterobacteriales 9.5 <0.0001 I 
Family Enterobacteriaceae 9.5 <0.0001 I 
Genus Unclassified 9.1 <0.0001 I 
Order Aeromonadales 12.6 <0.0001 I 
Family Aeromonadaceae 29.0 <0.0001 I 
Genus Aeromonas 29.0 <0.0001 I 
Order Alteromonadales 17.9 <0.0001 I 
Family Shewanellaceae 17.4 <0.0001 I 
Genus Shewanella 17.4 <0.0001 I 
Order Pseudomonadales 16.0 <0.0001 I 
Family Moraxellaceae 15.1 <0.0001 I 
Genus Acinetobacter 14.9 <0.0001 I 
Family Pseudomonadaceae 17.1 <0.0001 I 
Genus Pseudomonas 13.5 <0.0001 I 
Order Xanthomonadales 21.5 <0.0001 I 
Family Xanthomonadaceae 21.5 <0.0001 I 
Phylum Firmicutes 0.3 <0.0001 M 
Class Bacilli 3.7 <0.0001 I 
Order Bacillales 18.1 <0.0001 I 
Order Lactobacillales 2.5 <0.0001 I 
Family Lactobacillaceae 1.4 0.0179 I 
Family Streptococcaceae 2.6 <0.0001 I 
Genus Streptococcus 2.6 <0.0001 I 
Class Clostridia 0.2 <0.0001 M 
Order Clostridiales 0.2 <0.0001 M 
Family Lachnospiraceae 0.2 <0.0001 M 
Genus Anaerostipes 0.2 <0.0001 M 
Genus Blautia 0.3 <0.0001 M 
Genus Clostridium XlVa 0.4 <0.0001 M 
Genus Coprococcus 0.3 <0.0001 M 
Genus Dorea 0.4 <0.0001 M 
Genus Lachnospiracea incertae sedis 0.2 <0.0001 M 
Genus Roseburia 0.2 <0.0001 M 





Table S6. Significant differences in proportions of bacterial OTUs from infant meconium specimens (n = 107) 
when compared to maternal faecal specimens sampled at birth (n = 90) (continued) 
Taxon level Bacterial OTUs Rate ratio p-value 
Higher proportions 
from maternal or 
infant specimens 
Family Peptostreptococcaceae 0.6 0.0059 M 
Genus Clostridium XI 0.6 0.0047 M 
Family Ruminococcaceae 0.2 <0.0001 M 
Genus Clostridium IV 0.2 <0.0001 M 
Genus Faecalibacterium 0.2 <0.0001 M 
Genus Ruminococcus 0.2 <0.0001 M 
Genus Sporobacter 0.2 <0.0001 M 
Genus Unclassified 0.2 <0.0001 M 
Family Unclassified 0.2 <0.0001 M 
Genus Unclassified 0.2 <0.0001 M 
Class Erysipelotrichia 0.5 <0.0001 M 
Order Erysipelotrichales 0.5 <0.0001 M 
Family Erysipelotrichaceae 0.5 <0.0001 M 
Genus Catenibacterium 0.7 0.0007 M 
Genus Erysipelotrichaceae incertae sedis 0.4 <0.0001 M 
Class Negativicutes 0.6 <0.0001 M 
Order Selenomonadales 0.6 <0.0001 M 
Family Veillonellaceae 0.6 <0.0001 M 
Class Unclassified 0.2 <0.0001 M 
Order Unclassified 0.2 <0.0001 M 
Family Unclassified 0.2 <0.0001 M 
Genus Unclassified 0.2 <0.0001 M 
Phylum Unclassified 0.5 <0.0001 M 
Class Unclassified 0.5 <0.0001 M 
Order Unclassified 0.5 <0.0001 M 
Family Unclassified 0.5 <0.0001 M 
Genus Unclassified 0.5 <0.0001 M 













Table S7. Significant differences in proportions of bacterial OTUs from infant faecal specimens at 4 to 12 weeks 
of age (n = 72) when compared to maternal faecal specimens sampled at birth (n = 90) 
Taxon level Bacterial OTUs Rate ratio p-value 
Higher proportions 
from maternal or 
infant specimens 
Phylum Actinobacteria 4.9 <0.0001 I 
Class Actinobacteria 4.9 <0.0001 I 
Order Actinomycetales 5.1 <0.0001 I 
Order Bifidobacteriales 9.8 <0.0001 I 
Family Bifidobacteriaceae 9.8 <0.0001 I 
Genus Bifidobacterium 10.0 <0.0001 I 
Order Coriobacteriales 2.3 <0.0001 I 
Family Coriobacteriaceae 2.3 <0.0001 I 
Genus Collinsella 3.6 <0.0001 I 
Genus Olsenella 1.9 <0.0001 I 
Genus Unclassified 1.9 <0.0001 I 
Phylum Bacteroidetes 0.7 0.0281 M 
Class Bacteroidia    
Order Bacteroidales    
Family Prevotellaceae 0.7 0.0333 M 
Class Unclassified 0.2 <0.0001 M 
Order Unclassified 0.2 <0.0001 M 
Family Unclassified 0.2 <0.0001 M 
Genus Unclassified 0.2 <0.0001 M 
Phylum Proteobacteria 4.5 <0.0001 I 
Class Alphaproteobacteria 4.1 <0.0001 I 
Order Rhizobiales 3.1 <0.0001 I 
Class Betaproteobacteria 3.6 <0.0001 I 
Order Burkholderiales 3.9 <0.0001 I 
Class Gammaproteobacteria 6.6 <0.0001 I 
Order Enterobacteriales 15.3 <0.0001 I 
Family Enterobacteriaceae 15.3 <0.0001 I 
Genus Unclassified 17.5 <0.0001 I 
Order Pseudomonadales 5.0 <0.0001 I 
Family Moraxellaceae 4.9 <0.0001 I 
Genus Acinetobacter 4.9 <0.0001 I 
Phylum Firmicutes 0.6 <0.0001 M 
Class Bacilli 14.4 <0.0001 I 
Order Lactobacillales 15.1 <0.0001 I 
Family Lactobacillaceae 12.3 <0.0001 I 
Genus Lactobacillus 14.4 <0.0001 I 
Family Streptococcaceae 18.5 <0.0001 I 





Table S7. Significant differences in proportions of bacterial OTUs from infant faecal specimens at 4 to 12 weeks 
of age (n = 72) when compared to maternal faecal specimens sampled at birth (n = 90) (continued) 
Taxon level Bacterial taxa Rate ratio p-value 
Higher proportions 
from maternal or 
infant specimens 
Class Clostridia 0.3 <0.0001 M 
Order Clostridiales 0.3 <0.0001 M 
Family Lachnospiraceae 0.4 <0.0001 M 
Genus Anaerostipes 0.1 <0.0001 M 
Genus Blautia 0.3 <0.0001 M 
Genus Coprococcus 0.3 <0.0001 M 
Genus Dorea 0.5 <0.0001 M 
Genus Lachnospiracea incertae sedis 0.8 0.0480 M 
Genus Roseburia 0.0 <0.0001 M 
Genus Unclassified 0.3 <0.0001 M 
Family Peptococcaceae 0.2 <0.0001 M 
Genus Peptococcus 0.2 <0.0001 M 
Family Peptostreptococcaceae 0.5 <0.0001 M 
Genus Clostridium XI 0.5 <0.0001 M 
Family Ruminococcaceae 0.1 <0.0001 M 
Genus Clostridium IV 0.2 <0.0001 M 
Genus Faecalibacterium 0.1 <0.0001 M 
Genus Oscillibacter 0.1 <0.0001 M 
Genus Ruminococcus 0.0 <0.0001 M 
Genus Sporobacter 0.0 <0.0001 M 
Genus Unclassified 0.0 <0.0001 M 
Family Unclassified 0.1 <0.0001 M 
Genus Unclassified 0.1 <0.0001 M 
Class Negativicutes 2.2 <0.0001 I 
Order Selenomonadales 2.2 <0.0001 I 
Family Veillonellaceae 2.4 <0.0001 I 
Genus Dialister 0.6 0.0318 M 
Class Unclassified 0.3 <0.0001 M 
Order Unclassified 0.3 <0.0001 M 
Family Unclassified 0.3 <0.0001 M 
Genus Unclassified 0.3 <0.0001 M 
Phylum Unclassified 0.3 <0.0001 M 
Class Unclassified 0.3 <0.0001 M 
Order Unclassified 0.3 <0.0001 M 
Family Unclassified 0.3 <0.0001 M 
Genus Unclassified 0.3 <0.0001 M 






Table S8. Significant differences in proportions of bacterial OTUs from infant faecal specimens at 20 to 28 
weeks of age (n = 36) when compared to maternal faecal specimens sampled at birth (n = 90) 
Taxon level Bacterial OTUs Rate ratio p-value 
Higher proportions 
from maternal or 
infant specimens 
Phylum Actinobacteria 3.2 <0.0001 I 
Class Actinobacteria 3.2 <0.0001 I 
Order Actinomycetales 3.6 <0.0001 I 
Order Bifidobacteriales 7.0 <0.0001 I 
Family Bifidobacteriaceae 7.0 <0.0001 I 
Genus Bifidobacterium 7.2 <0.0001 I 
Order Coriobacteriales   I 
Genus Collinsella 2.0 0.0031 I 
Genus Olsenella 0.6 0.0239 I 
Phylum Bacteroidetes 0.7 0.0183 M 
Class Bacteroidia 0.7 0.0457 M 
Order Bacteroidales 0.7 0.0457 M 
Family Porphyromonadaceae 0.6 0.0037 M 
Family Prevotellaceae 0.6 0.0167 M 
Phylum Proteobacteria 2.8 <0.0001 I 
Class Alphaproteobacteria 2.6 <0.0001 I 
Order Rhizobiales 2.0 <0.0001 I 
Class Betaproteobacteria 2.3 <0.0001 I 
Order Burkholderiales 2.4 <0.0001 I 
Class Gammaproteobacteria 4.0 <0.0001 I 
Order Enterobacteriales 10.6 <0.0001 I 
Family Enterobacteriaceae 10.6 <0.0001 I 
Order Pseudomonadales 2.5 0.0172 I 
Phylum Firmicutes 0.8 <0.0001 M 
Class Bacilli 9.0 <0.0001 I 
Order Lactobacillales 9.5 <0.0001 I 
Family Lactobacillaceae 6.7 <0.0001 I 
Genus Lactobacillus 7.7 <0.0001 I 
Family Streptococcaceae 10.7 <0.0001 I 
Genus Streptococcus 10.1 <0.0001 I 
Class Clostridia 0.6 <0.0001 M 
Order Clostridiales 0.6 <0.0001 M 
Genus Blautia 0.7 0.0209 M 
Genus Clostridium_XlVa 2.0 0.0001 M 
Genus Coprococcus 0.5 0.0148 M 
Genus Lachnospiracea incertae sedis 1.6 0.0002 M 
Genus Roseburia 0.3 0.0044 M 
Family Peptococcaceae 0.2 0.0034 M 





Table S8. Significant differences in proportions of bacterial OTUs from infant faecal specimens at 20 to 28 
weeks of age (n = 36) when compared to maternal faecal specimens sampled at birth (n = 90) (continued) 
Taxon level Bacterial OTUs Rate ratio p-value 
Higher proportions 
from maternal or 
infant specimens 
Family Ruminococcaceae 0.2 <0.0001 M 
Genus Clostridium IV 0.3 <0.0001 M 
Genus Faecalibacterium 0.3 <0.0001 M 
Genus Oscillibacter 0.1 <0.0001 M 
Genus Ruminococcus 0.2 <0.0001 M 
Genus Sporobacter 0.1 <0.0001 M 
Genus Unclassified 0.2 <0.0001 M 
Family Unclassified 0.2 <0.0001 M 
Genus Unclassified 0.2 <0.0001 M 
Class Negativicutes 2.2 <0.0001 I 
Order Selenomonadales 2.2 <0.0001 I 
Family Veillonellaceae 2.5 <0.0001 I 
Class Unclassified 0.3 <0.0001 M 
Order Unclassified 0.3 <0.0001 M 
Family Unclassified 0.3 <0.0001 M 
Genus Unclassified 0.3 <0.0001 M 
Phylum Unclassified 0.3 <0.0001 M 
Class Unclassified 0.3 <0.0001 M 
Order Unclassified 0.3 <0.0001 M 
Family Unclassified 0.3 <0.0001 M 
Genus Unclassified 0.3 <0.0001 M 


















Table S9 Changes in bacterial proportions of infant faecal specimens from birth until 28 weeks of age (n = 215) 
Taxon level Bacterial OTUs 
Increase/ 
decrease over time 
Rate Ratio p-value 
Phylum Actinobacteria  1.02 0.0274 
Class Actinobacteria  1.02 0.0274 
Order Actinomycetales  0.95 <0.0001 
Family Geodermatophilaceae  0.93 <0.0001 
Genus Blastococcus  0.94 <0.0001 
Order Bifidobacteriales  1.05 <0.0001 
Family Bifidobacteriaceae  1.05 <0.0001 
Genus Bifidobacterium  1.05 <0.0001 
Phylum Bacteroidetes    
Class Bacteroidia    
Family Bacteroidaceae  1.07 0.0325 
Genus Bacteroides  1.07 0.0325 
Class Sphingobacteria  0.84 0.0124 
Order Sphingobacteriales  0.84 0.0124 
Class Flavobacteria  0.87 <0.0001 
Order Flavobacteriales  0.87 <0.0001 
Family Flavobacteriaceae  0.87 <0.0001 
Phylum Proteobacteria  0.92 <0.0001 
Class Alphaproteobacteria  0.90 <0.0001 
Order Caulobacterales  0.88 <0.0001 
Family Caulobacteraceae  0.88 <0.0001 
Genus Brevundimonas  0.73 0.0369 
Genus Caulobacter  0.96 <0.0001 
Genus Phenylobacterium  0.75 0.0369 
Order Rhizobiales  0.91 <0.0001 
Family Aurantimonadaceae  0.88 <0.0001 
Genus Aurantimonas  0.88 <0.0001 
Family Hyphomicrobiaceae  0.95 <0.0001 
Genus Devosia  0.89 <0.0001 
Family Rhizobiaceae  0.93 <0.0001 
Genus Rhizobium  0.93 <0.0001 
Family Unclassified  0.89 <0.0001 
Genus Unclassified  0.89 <0.0001 
Order Rhodobacterales  0.90 <0.0001 
Family Rhodobacteraceae  0.90 <0.0001 
Genus Unclassified  0.94 <0.0001 
Order Rhodospirillales  0.85 <0.0001 
Family Rhodospirillaceae  0.84 <0.0001 
Order Sphingomonadales  0.88 <0.0001 
Family Sphingomonadaceae  0.89 <0.0001 





Table S9. Changes in bacterial proportions of infant faecal specimens from birth until 28 weeks of age (n = 215) 
(continued) 
Taxon level Bacterial OTUs 
Increase/ 
decrease over time 
Rate Ratio p-value 
Order Unclassified  0.89 <0.0001 
Family Unclassified  0.87 <0.0001 
Genus Unclassified  0.89 <0.0001 
Class Betaproteobacteria  0.91 <0.0001 
Order Burkholderiales  0.91 <0.0001 
Family Burkholderiaceae  0.90 <0.0001 
Family Burkholderiales incertae sedis  0.85 <0.0001 
Genus Aquabacterium  0.86 <0.0001 
Family Comamonadaceae  0.90 <0.0001 
Genus Acidovorax  0.94 <0.0001 
Genus Unclassified  0.86 <0.0001 
Family Oxalobacteraceae  0.89 <0.0001 
Genus Massilia  0.83 <0.0001 
Genus Naxibacter  0.91 <0.0001 
Family Unclassified  0.90 <0.0001 
Genus Unclassified  0.90 <0.0001 
Class Deltaproteobacteria  0.93 <0.0001 
Class Gammaproteobacteria  0.93 <0.0001 
Order Aeromonadales  0.89 <0.0001 
Family Aeromonadaceae  0.87 <0.0001 
Genus Aeromonas  0.87 <0.0001 
Order Alteromonadales  0.92 <0.0001 
Family Shewanellaceae  0.92 <0.0001 
Genus XShewanella  0.92 <0.0001 
Order Pseudomonadales  0.91 <0.0001 
Family Moraxellaceae  0.91 <0.0001 
Genus Acinetobacter  0.91 <0.0001 
Family Pseudomonadaceae  0.91 <0.0001 
Genus Pseudomonas  0.93 <0.0001 
Order Xanthomonadales  0.88 <0.0001 
Family Xanthomonadaceae  0.88 <0.0001 
Genus Lysobacter  0.86 <0.0001 
Phylum Firmicutes  1.04 <0.0001 
Class Bacilli  1.02 0.0055 
Order Bacillales  0.93 <0.0001 
Family Staphylococcaceae  0.94 0.0110 
Order Lactobacillales  1.03 0.0008 
Family Enterococcaceae    






Table S9.Changes in bacterial proportions of infant faecal specimens from birth until 28 weeks of age (n = 215) 
(continued) 
Taxon level Bacterial OTUs 
Increase/ 
decrease over time 
Rate Ratio p-value 
Family Lactobacillaceae  1.05 <0.0001 
Genus Lactobacillus  1.05 0.0002 
Family Leuconostocaceae  1.04 0.0002 
Genus Weissella  1.04 0.0002 
Family Unclassified  1.04 0.0233 
Genus Unclassified  1.04 0.023 
Class Clostridia  1.05 <0.0001 
Order Clostridiales  1.05 <0.0001 
Family Lachnospiraceae  1.07 <0.0001 
Genus Blautia  1.05 <0.0001 
Genus Clostridium XlVa  1.06 <0.0001 
Genus Dorea  1.06 <0.0001 
Genus Lachnospiracea incertae sedis  1.09 <0.0001 
Genus Unclassified  1.09 <0.0001 
Family Peptostreptococcaceae    
Genus Clostridium XI  1.03 0.0330 
Family Ruminococcaceae  1.04 <0.0001 
Genus Faecalibacterium  1.04 0.0031 
Genus Unclassified  1.03 0.0391 
Family Unclassified  1.03 0.0022 
Genus Unclassified  1.03 0.0022 
Class Erysipelotrichia  1.03 0.0031 
Order Erysipelotrichales  1.03 0.0031 
Family  Erysipelotrichaceae  1.03 0.0031 
Genus Erysipelotrichaceae incertae sedis  1.04 0.0041 
Class Negativicutes  1.03 0.0108 
Order Selenomonadales  1.03 0.0108 
Family Veillonellaceae  1.03 0.0067 
Genus Veillonella  1.04 0.0233 
Phylum Unclassified  0.98 0.0274 
Class Unclassified  0.98 0.0274 
Order Unclassified  0.98 0.0274 
Family Unclassified  0.98 0.0274 
Genus Unclassified  0.98 0.0274 









Table S10. Genera identified from meconium specimens (n = 107) which have previously been reported from 
meconium specimens in the literature 
Genus 
Abundance (%) 
identified in this study 




Gosalbes et al. 
(2012) 21 
Madan et al. 
(2012) 41 
Moles et al. 
(2013) 22 
Ardissone et al. 
(2014) 15 
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B)  Supplementary figures 
 
 
Figure S1. Bacterial proportions of the genera from the phylum Actinobacteria for infant meconium specimens sampled 
at birth as well as infant faecal specimens sampled at 4-12 and 20-28 week of age 
Only the most abundant genera are labelled in the pie charts. Proportions of genera from the phylum Actinobacteria 
identified from A) infant meconium specimens sampled at birth (n = 107); B) infant faecal specimens sampled at 4-12 










GENERAL DISCUSSION AND CONCLUSION 
 
Early life is regarded the most important period during which GIT microbiota are 
established.1 Conventionally it has been reported that initial colonization occurs during the process 
of birth2–9 and that these bacterial profiles are shaped by a number of external factors such as the 
mode of delivery, feeding practices and medication.10 More recently, reports on in-utero bacterial 
colonization of the “sterile” fetus11–17 have revolutionised our ideas around infantile GIT 
colonization.18,19 Despite the increased interest in microbiota profiles from meconium specimens 
during the last decade; few studies have included meconium specimens when longitudinally profiling 
GIT microbiota from the healthy infants early in life.11,12 To the best of our knowledge, this is the 
largest study to provide information on faecal bacterial dynamics from healthy term infants in which 
meconium specimens were inluded. The results generated by this study essentially provide a high-
throughput overview of the bacterial profiles from a large number of meconium specimens. Results 
from this study also show how these bacterial profiles change throughout the first seven months of 
life. In addition, this study provides insights into the influencing factors involved in shaping early life 
faecal bacterial profiles.   
 Using Illumina Mi-Seq sequencing technology we were able to sequence 16 596 332 reads from 
305 faecal specimens, for which the median number of reads per specimen was sufficient for GIT 
microbiota analysis.20,21 However, when using any sequencing technology one needs to bear in mind 
that sequencing results are not error free and quality control measures are therefore essential in any 
microbiota study.22,23 Following the use of an independent bio-informatics workflow (to accurately 
filter and remove erroneous reads and sequencing artifacts), we noted a reduction of 25% in the 
total number of reads sequenced. These types of reductions in the number of reads sequenced are 
expected when performing quality control steps (such as the removal of sequencing artifacts and 
trimming of low quality reads) on reads sequences by Illumina Miseq sequencing platforms.23,24 A 
recent study by Sinclair and colleagues24 reported on the reliability and biases of Illumina Miseq 
platforms by performing paired-end sequencing on the 16S rRNA gene extracted and amplified from 
sediment specimens. Sinclair and colleagues24 reported a 50% reduction in the number of reads 
sequenced following quality control processes. In addition to the efficiency of the sequencing 
approach itself, experimental approaches towards library preparation prior to sequencing are just as 
important and also need to be carefully planned and executed. We observed that low template 
concentrations used for library preparation may have impacted on the reproducibility of our 
sequencing approach, as previously reported.25 This in turn may also impact on diversity measures,26 
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since we observed very high intra-individual diversity indices from the meconium specimens 
compared to the other faecal specimens under study. Of note, in this study, meconium specimens 
had the lowest template concentrations and the lowest reproducibility measures. In addition to the 
downstream effects of low template concentrations, we also suspected contamination in our 
sequencing run after classifying OTUs from our non-template controls. These were corrected for 
during data analysis, and resulted in 10% of the OTUs classified being removed from our faecal 
specimens analysed. A number of potential contaminant sources, such as specimen collection, the 
nucleic acid extraction steps, PCR amplification steps and the sequencing process itself have 
previously been reported to affect sequencing results.27,28 We were able to rule out potential 
contamination resulting from the nucleic acid extraction and sequencing procedures from our data 
set. We did, however, suspect that contamination occurred during the process of amplification;29–31 
either from the use of contaminated laboratory reagents32 or cross-contamination between 
wells.27,33–35 Even though we did not include controls to establish a baseline for reagent 
contamination, we did observe that approximately 10% of the “contaminating genera” identified 
fom our two non-template controls have been previously reported as laboratory reagent 
contaminants (Table 3). In addition, the effect of cross-contamination during the amplification 
process is also highly probable in our study due to the fact that i) the majority of our specimens 
provided low template concentrations for library preparation;34–38 ii) we performed repeat 
amplification of a marker gene and had possible exposure to aerosilized amplicons;27,39 and iii) that 
the majority of contaminating genera observed from our non-template controls were genera 
commonly characterised from the human GIT (Table 3). Correcting for contamination, however, was 
unlikely to have had a significant impact on downstream data analysis since very low levels of 
contaminants were present.  
 Despite the low template concentrations used for meconium specimens in this study, we 
successfully managed to classify bacteria from all meconium specimens analysed. Our findings on 
the bacterial profiles colonizing the meconium specimens were in agreement with previous studies. 
11–13,40,41 We found that the most abundant phylum classified from the meconium cohort was the 
phylum Proteobacteria, followed by the phylum Firmicutes. Complete linkage clustering analysis 
clearly grouped infant and maternal faecal specimens into two primary clusters and none of the 
respective mother-infant pairs clustered at low clustering distances. In contrast to the findings from 
the specimens sampled at birth; we did observe a change in infant faecal bacterial profiles towards 
more adult-like profiles at later stages in life. Therefore, our findings suggest that maternal-fetal 
bacterial translocations may only have a modest effect on the overall bacterial composition 
identified from meconium, but its effect may become clearer at later stages of life. This may be 
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explained by reports of mainly the phyla Proteobacteria and Firmicutes colonizing 
meconium,11,13,42,41 some of which have been identified as bacteria playing a role in priming the 
infant GIT for strict anaerobic bacterial colonization later in life.43–45  
 Although only few studies have characterised longitudinal bacterial profiles from meconium of 
healthy term infants to date,11,46 external factors influencing these profiles are still understudied. In 
our healthy cohort, only maternal education level and infant gender were significantly associated 
with phyla from the family Firmicutes. In agreement with previous studies,11,42,47 we also found that 
mode of delivery does not alter profiles of meconium microbiota and the effect of mode of delivery 
only becomes apparent at later stages of life. At 4-12 weeks of age, we found that both residential 
area and gestational age had a significant effect on specific bacterial taxa. The effect of residential 
area is of interest, as we observed changes in infant faecal bacterial profiles over a short period of 
time (4-12 weeks of age) from two ethnogeographic populations within the same sub-district in the 
Cape-Winelands. Our findings showed that infants residing in Mbekweni (comprising of a black 
African population) had lower proportions of the phylum Actinobacteria (down to the genus 
Bifidobacterium), but higher proportions of the phylum Firmicutes compared to infants residing in 
TC Newman (comprising of a mixed race population). The influence of geographical location on GIT 
microbiota has been reported by a number of studies and has been attributed to varying 
environmental pressures such as differences in genetic backgrounds, diets and cultural practices of 
different ethnogeographical populations and regional lifestyle.10 To the best of our knowledge, our 
study is the first to associate geographical influence on a cohort residing within two residential areas 
from the same sub-district at less than three months of age. This highlights the importance of the 
community setting to which a young infant is exposed. Another interesting finding in this study is the 
observation that HIV-exposed infants had higher proportions of the genus Leuconostoc, as well as 
higher bacterial diversity indices. To date, the effect of maternal HIV status on faecal bacterial 
profiles of their offspring has not yet been reported. Of note, the factor most prominently 
influencing bacterial proportions within our study was an increase in infant age. This was clearly 
emphasised by the significant changes in proportions of 87 bacterial taxa from infant faecal 
specimens during the first 28 weeks of life. Although a number of studies have reported on changes 
in bacterial profiles over time, only few studies have reported on changes in bacterial profiles which 
included meconium specimens when analysing healthy infants.11,46 
 One of the limitations of our study was the possibility that not all meconium specimens may 
have been collected at hospital by the DCHS’s clinical team. In the event that a first stool was not 
passed by the newborn during hospitalisation, the responsibility fell upon the participating mother 
to collect this specimen at home. This resulted in the data capturers having to rely on the 
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information provided by the mother and not by the DCHS clinical team for select specimens from the 
DCHS cohort. Despite this possible limitation, we did observe distinct bacterial profiles for the 
meconium specimens analysed in our study when compared to specimens collected at later stages in 
life. Other limitations to our study were low template concentrations obtained from meconium 
specimens and the suspicion of contamination during library preparation. Low template 
concentrations were clearly related to less reproducible results which may have resulted in 
“skewed” diversity measures from meconium specimens as shown by the very high intra-individual 
diversity measurements obtained from the first stool passed by infants.41,47–52 On the other hand, the 
inter-individual diversity measures observed in our study were in agreement with previous 
findings.48–51,53 Since we were not in the position to repeat any of the experimental steps towards 
sequencing (due to limited volumes of extracted nucleic acid exported to JCVI, USA) we decided to 
correct for contamination during data analysis. Our approach to computationally remove 
contaminating OTUs observed from all sequencing reactions performed (prior to conducting 
microbiome data analyses), is becoming apparent for next-generation sequencing datasets.32,54,55 
The final limitation from our study was the limited clinical data available for association studies. We 
were not able to determine, for example, the effect of medication (such as antibiotics) on the 
maternal and infant microbiota profiles. Neither were we in the position to determine the effect of 
infant HIV status on infantile faecal bacterial profiles, since none of the infants were HIV-infected.  
 In conclusion, our study provides a detailed description of the dynamics of infant faecal 
bacterial profiles during the first seven months of life, which includes meconium specimens. 
Although we could not directly address the hypothesis suggesting in-utero transfer of maternal GIT 
microbiota to the fetus; our study shows that infant and maternal faecal bacterial profiles are very 
different at birth up until seven months of life. In order to effectively address the pathways behind 
in-utero bacterial transfer from the maternal GIT to the fetus; studies need to consider analysing a 
range of specimens which may include maternal faecal specimens, cord blood, amniotic fluid, 
placenta as well as meconium. Since other hypotheses suggest in-utero translocation of maternal 
oral and vaginal bacteria,56–59 studies should also attempt to analyse the microbiota from maternal 
oral and vaginal specimens in conjunction with uterine and faecal specimens. Even though a number 
of studies have reported on bacterial colonization of the uterine, meconium and maternal oral and 
faecal specimens using a range of techniques (some of which included high-throughput 
sequencing);11–17,60 to the best of our knowledge no studies have analysed microbiota from more 
than two sample types from a single cohort. In addition, future studies also need to contemplate the 
use of techniques such as high-throughput culture or viability PCRs to provide an overview of viable 
microbiota profiles from these specimens.60 Information on the dynamics of viable cells from 
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uterine, meconium and infant faecal specimens may contribute greatly to our insights on the 
mechanisms behind in-utero colonization and microbial succession over time.60 Considering that we 
conducted a pilot study on the dynamics of infant faecal bacterial profiles during the first seven 
months of life; we plan to perform a more extensive study using larger sample sizes from the DCHS 
cohort which will include additional timepoints. This will allow us to optimally determine the 
progression of meconium faecal bacterial profiles to infant-like and finally adult-like profiles within a 
poor African community. Of note, our interesting findings on the higher bacterial diversities from 
HIV-exposed infants need to be extended and these infants should be followed up for longer periods 
of time to determine whether the effect of maternal HIV status is retained later in life. 
 Moreover, we suggest that studies should include a range of clinical characteristics to better 
understand the effect of prenatal factors such as medical interventions and maternal characteristics 
on meconium microbiota as well as subsequent microbiota profiles during infancy. Additionally, 
longitudinal studies need to also include meconium specimens when performing association studies 
with disease states developed later in life. Good examples of this have been highlighted by 
associations between specific meconium microbiota (reported to incite inflammatory reponses) and 
respiratory diseases and premature birth.11,13 Of note, further investigation of meconium microbiota 
and their interaction with the host may provide innovative therapies for the prevention of 
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